data_2lvr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lvr _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 120.908 0.385 . . . . 1.8999999999999999 111.045 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -109.09 173.98 6.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.066 -0.515 . . . . 0.77000000000000002 111.071 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.79 -53.45 4.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.099 0.476 . . . . 1.05 111.73 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -106.74 146.6 33.4 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.622 -0.717 . . . . 1.9299999999999999 110.994 -169.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.96 -28.58 41.86 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.848 2.366 . . . . 0.88 111.231 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.506 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . -64.32 -32.1 83.08 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.779 -0.646 . . . . 0.38 111.507 175.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.3 -28.68 59.81 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 121.014 -0.275 . . . . 1.0700000000000001 110.839 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.49 ' O ' HG22 ' A' ' 23' ' ' VAL . 8.6 mt -68.47 -34.22 75.56 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 109.458 -0.571 . . . . 1.8500000000000001 109.458 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.506 ' HG3' ' O ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -76.11 -33.94 59.47 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 119.037 -1.065 . . . . 2.6600000000000001 109.746 -177.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.565 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.5 OUTLIER -66.54 -35.36 80.05 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.479 -1.237 . . . . 4.4299999999999997 108.944 172.147 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.636 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 71.6 t60 -72.29 -49.51 34.22 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.05 -0.977 . . . . 0.51000000000000001 111.459 -176.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 19' ' ' LEU . 74.6 t -64.24 -37.57 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 115.695 -0.684 . . . . 1.0900000000000001 110.556 -172.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -69.81 -20.66 63.44 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.057 -0.52 . . . . 3.3999999999999999 110.446 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.636 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 9.9 mm -64.93 -34.79 72.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.396 -0.366 . . . . 1.9299999999999999 110.17 172.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 . . . . . 0 CA--C 1.519 -0.237 0 C-N-CA 120.895 -0.322 . . . . 0.34000000000000002 110.871 177.138 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 . . . . . 0 C--O 1.233 0.185 0 N-CA-C 112.278 0.473 . . . . 1.8999999999999999 112.278 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -132.62 165.25 24.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.549 -0.75 . . . . 0.77000000000000002 109.859 175.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.29 -35.32 13.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.936 -0.574 . . . . 1.05 112.44 -171.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.88 147.81 49.58 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 120.589 0.233 . . . . 1.9299999999999999 110.806 -174.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.42 -22.93 51.54 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.605 2.203 . . . . 0.88 109.082 168.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.536 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -61.22 -43.35 99.5 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 114.48 -1.237 . . . . 0.38 111.845 172.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -76.65 -27.91 55.81 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 120.775 -0.37 . . . . 1.0700000000000001 110.868 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.693 ' O ' HG22 ' A' ' 23' ' ' VAL . 9.5 mt -66.66 -39.25 88.1 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 109.277 -0.638 . . . . 1.8500000000000001 109.277 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 9.1 pt20 -72.47 -37.66 68.43 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.977 0.894 . . . . 2.6600000000000001 110.468 -175.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.555 ' O ' ' HD3' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -67.54 -34.29 76.78 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 113.899 -1.501 . . . . 4.4299999999999997 107.969 176.368 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.741 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 74.8 t60 -69.25 -39.54 78.4 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 114.317 -1.31 . . . . 0.51000000000000001 111.845 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.693 HG22 ' O ' ' A' ' 19' ' ' LEU . 87.7 t -67.07 -36.47 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 C-N-CA 119.364 -0.935 . . . . 1.0900000000000001 109.874 -174.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.2 mmm-85 -63.08 -28.59 70.18 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.198 -0.455 . . . . 3.3999999999999999 110.413 173.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.741 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 20.0 mm -59.44 -50.53 79.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.773 -0.649 . . . . 1.9299999999999999 110.63 176.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 . . . . . 0 CA--C 1.519 -0.245 0 CA-C-N 116.204 -0.453 . . . . 0.34000000000000002 110.922 178.708 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 . . . . . 0 C--O 1.237 0.435 0 CA-C-O 120.905 0.383 . . . . 1.8999999999999999 111.266 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -125.6 149.23 48.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.77000000000000002 110.383 174.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.11 -12.72 59.98 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.7 1.0 . . . . 1.05 113.7 -167.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -142.87 151.15 55.73 Favored Pre-proline 0 C--N 1.324 -0.505 0 C-N-CA 120.831 -0.348 . . . . 1.9299999999999999 110.939 -173.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -66.06 -22.28 55.05 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.628 2.219 . . . . 0.88 109.445 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.4 -53.26 47.33 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 114.462 -1.245 . . . . 0.38 111.66 171.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -65.32 -26.19 67.94 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 115.719 -0.241 . . . . 1.0700000000000001 111.154 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.49 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.8 mm? -70.45 -34.3 72.29 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 109.315 -0.624 . . . . 1.8500000000000001 109.315 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -72.35 -41.8 66.05 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 119.735 -0.786 . . . . 2.6600000000000001 110.324 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.572 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -61.3 -39.43 90.42 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.498 -1.228 . . . . 4.4299999999999997 108.765 175.213 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.593 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 59.5 t60 -75.17 -46.85 31.49 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 114.311 -1.313 . . . . 0.51000000000000001 112.02 -170.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 19' ' ' LEU . 95.8 t -67.54 -34.55 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 C-N-CA 119.849 -0.74 . . . . 1.0900000000000001 110.498 -172.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -75.16 -11.79 60.16 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.109 -0.636 . . . . 3.3999999999999999 110.61 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.593 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 9.5 mm -70.67 -45.73 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.935 -0.394 . . . . 1.9299999999999999 109.935 171.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 40.5 m-70 . . . . . 0 CA--C 1.519 -0.218 0 CA-C-O 121.083 0.468 . . . . 0.34000000000000002 110.224 177.245 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 . . . . . 0 C--O 1.233 0.198 0 N-CA-C 111.651 0.241 . . . . 1.8999999999999999 111.651 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.41 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 98.4 m-85 -108.97 165.83 11.29 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.793 0.33 . . . . 0.77000000000000002 110.432 176.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.77 -39.01 18.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.923 -0.58 . . . . 1.05 112.415 -175.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 13.4 m-20 -118.43 142.12 30.86 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.081 -0.508 . . . . 1.9299999999999999 111.844 -168.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 15' ' ' ASP . 17.0 Cg_exo -66.28 -25.36 49.76 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.982 2.454 . . . . 0.88 111.015 175.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.531 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -62.83 -33.29 86.56 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.574 -0.739 . . . . 0.38 111.884 176.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -80.24 -29.4 38.42 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.549 -0.46 . . . . 1.0700000000000001 110.674 177.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.488 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.7 mm? -68.55 -34.17 75.36 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 109.633 -0.506 . . . . 1.8500000000000001 109.633 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.531 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 3.9 pt20 -74.26 -37.82 63.64 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 119.514 -0.875 . . . . 2.6600000000000001 110.256 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.572 ' O ' HG13 ' A' ' 25' ' ' ILE . 1.1 tmt_? -68.09 -34.86 77.2 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.305 -1.316 . . . . 4.4299999999999997 108.293 175.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.59 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 33.1 t60 -71.37 -50.04 36.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.735 -1.121 . . . . 0.51000000000000001 111.747 -175.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 19' ' ' LEU . 99.4 t -65.45 -34.08 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-N 115.824 -0.625 . . . . 1.0900000000000001 110.102 -173.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.497 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 59.7 mtp180 -75.0 -8.87 57.75 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.924 -0.58 . . . . 3.3999999999999999 110.874 177.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.59 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 57.1 mt -74.14 -48.95 35.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.923 -0.399 . . . . 1.9299999999999999 109.923 172.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 . . . . . 0 N--CA 1.463 0.212 0 CA-C-N 115.967 -0.561 . . . . 0.34000000000000002 111.297 -178.947 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 . . . . . 0 CA--C 1.517 -0.299 0 CA-C-O 121.038 0.447 . . . . 1.8999999999999999 111.176 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -137.39 162.77 32.72 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.332 -0.849 . . . . 0.77000000000000002 110.286 174.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.0 -20.18 22.39 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.771 0.656 . . . . 1.05 112.771 -170.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -141.08 150.03 57.61 Favored Pre-proline 0 C--N 1.326 -0.445 0 C-N-CA 121.033 -0.267 . . . . 1.9299999999999999 110.776 -174.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.09 -22.0 48.13 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.811 2.34 . . . . 0.88 109.193 169.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.587 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -57.13 -44.68 93.07 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 114.532 -1.213 . . . . 0.38 111.885 172.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.547 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -77.84 -22.38 50.03 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 121.037 -0.265 . . . . 1.0700000000000001 110.992 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.553 ' O ' HG21 ' A' ' 23' ' ' VAL . 2.6 mm? -73.38 -35.14 65.88 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 109.528 -0.545 . . . . 1.8500000000000001 109.528 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.587 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 16.9 pt20 -75.16 -35.52 61.61 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.672 -0.811 . . . . 2.6600000000000001 109.91 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -68.18 -32.29 72.44 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.433 -1.258 . . . . 4.4299999999999997 108.829 173.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.565 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 46.6 t60 -71.59 -46.41 59.37 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 114.756 -1.111 . . . . 0.51000000000000001 111.787 -176.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.553 HG21 ' O ' ' A' ' 19' ' ' LEU . 60.8 t -66.62 -32.7 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 C-N-CA 119.822 -0.751 . . . . 1.0900000000000001 109.719 -175.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -59.3 -29.97 67.99 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.609 -0.723 . . . . 3.3999999999999999 111.49 171.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.565 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 79.6 mt -64.82 -52.85 49.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.308 -0.406 . . . . 1.9299999999999999 110.68 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 121.15 0.5 . . . . 0.34000000000000002 110.6 178.137 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.969 0.414 . . . . 1.8999999999999999 111.815 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.566 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 97.0 m-85 -129.46 176.42 7.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.878 -0.601 . . . . 0.77000000000000002 110.458 174.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -95.52 -40.28 9.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.178 0.513 . . . . 1.05 112.16 -173.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -112.26 139.91 23.04 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.657 -0.702 . . . . 1.9299999999999999 111.672 -167.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -64.47 -32.83 59.22 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.799 2.332 . . . . 0.88 110.333 173.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.449 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -63.6 -29.94 76.15 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.226 -0.897 . . . . 0.38 112.042 177.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -82.01 -30.78 31.34 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 120.801 -0.36 . . . . 1.0700000000000001 111.154 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.566 ' CD2' ' HB2' ' A' ' 13' ' ' PHE . 2.2 mm? -70.92 -31.4 68.0 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 109.746 -0.464 . . . . 1.8500000000000001 109.746 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 12.8 pt20 -75.56 -36.93 60.29 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 119.367 -0.933 . . . . 2.6600000000000001 110.229 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.443 ' HA ' ' HD2' ' A' ' 21' ' ' ARG . 0.9 OUTLIER -70.22 -32.54 70.46 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.34 -1.3 . . . . 4.4299999999999997 108.777 174.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.498 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 55.7 t60 -66.69 -47.89 71.01 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 114.32 -1.309 . . . . 0.51000000000000001 111.053 -177.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.546 HG21 ' O ' ' A' ' 19' ' ' LEU . 98.0 t -64.51 -34.49 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 115.666 -0.697 . . . . 1.0900000000000001 109.895 -176.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -63.55 -25.65 68.34 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 112.314 0.487 . . . . 3.3999999999999999 112.314 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.498 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 83.8 mt -65.25 -45.15 94.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.966 -0.383 . . . . 1.9299999999999999 109.966 175.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.34000000000000002 110.17 175.594 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 . . . . . 0 N--CA 1.451 -0.397 0 CA-C-O 120.626 0.251 . . . . 1.8999999999999999 111.203 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -128.17 156.73 42.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.273 0.559 . . . . 0.77000000000000002 110.981 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.68 -40.81 61.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.434 -0.803 . . . . 1.05 112.58 -176.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -109.31 137.05 20.14 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 115.804 -0.634 . . . . 1.9299999999999999 111.413 -166.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.91 -30.85 57.43 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.509 2.139 . . . . 0.88 110.308 174.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.75 -37.08 89.29 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.269 -0.878 . . . . 0.38 111.907 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -76.15 -25.23 55.11 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 111.401 0.148 . . . . 1.0700000000000001 111.401 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.46 ' O ' HG22 ' A' ' 23' ' ' VAL . 2.7 mm? -75.43 -29.32 59.69 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 109.15 -0.685 . . . . 1.8500000000000001 109.15 177.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -70.34 -43.21 70.68 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.302 -0.863 . . . . 2.6600000000000001 109.823 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.626 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -64.68 -34.41 78.24 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.064 -1.425 . . . . 4.4299999999999997 108.71 174.268 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.552 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 29.0 t60 -67.93 -53.6 25.07 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 114.537 -1.21 . . . . 0.51000000000000001 111.419 -174.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 19' ' ' LEU . 98.1 t -64.4 -34.71 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 115.59 -0.732 . . . . 1.0900000000000001 110.175 -174.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -69.47 -20.15 63.75 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.239 -0.437 . . . . 3.3999999999999999 111.459 176.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.626 HG12 ' O ' ' A' ' 21' ' ' ARG . 27.6 mm -65.6 -49.1 79.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 109.586 -0.524 . . . . 1.9299999999999999 109.586 173.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 . . . . . 0 CA--C 1.52 -0.184 0 CA-C-N 115.797 -0.638 . . . . 0.34000000000000002 111.261 -179.321 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 121.223 0.535 . . . . 1.8999999999999999 111.882 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -127.54 166.08 18.67 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.562 -0.745 . . . . 0.77000000000000002 110.481 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.56 -45.21 62.91 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.42 0.526 . . . . 1.05 112.42 -176.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -117.17 144.44 33.74 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.248 -0.433 . . . . 1.9299999999999999 111.656 -166.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.72 -26.26 39.19 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.792 2.328 . . . . 0.88 110.909 176.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.52 -35.08 89.49 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.333 -0.849 . . . . 0.38 111.627 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.49 -25.94 62.48 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 121.067 -0.253 . . . . 1.0700000000000001 110.409 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.557 ' O ' HG23 ' A' ' 23' ' ' VAL . 3.1 mm? -70.38 -30.24 67.1 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.818 -0.808 . . . . 1.8500000000000001 108.818 177.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.52 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 83.0 mm-40 -70.02 -43.31 71.59 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.772 0.796 . . . . 2.6600000000000001 110.177 178.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.39 -33.17 75.32 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.359 -1.291 . . . . 4.4299999999999997 108.359 175.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.587 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 59.0 t60 -69.36 -45.38 69.53 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 114.532 -1.213 . . . . 0.51000000000000001 111.414 -176.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 19' ' ' LEU . 95.7 t -65.82 -32.53 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 C-N-CA 119.982 -0.687 . . . . 1.0900000000000001 109.822 -175.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 20' ' ' GLN . 14.9 mmm180 -67.11 -19.82 65.69 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.174 -0.466 . . . . 3.3999999999999999 111.597 174.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.587 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 72.2 mt -68.23 -47.8 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 109.862 -0.421 . . . . 1.9299999999999999 109.862 174.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 . . . . . 0 CA--C 1.518 -0.258 0 CA-C-O 121.247 0.546 . . . . 0.34000000000000002 109.586 174.584 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 . . . . . 0 C--O 1.235 0.338 0 N-CA-C 111.573 0.212 . . . . 1.8999999999999999 111.573 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -130.77 162.5 29.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.152 0.501 . . . . 0.77000000000000002 110.952 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.67 -32.53 23.57 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.55 -0.75 . . . . 1.05 112.192 -171.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -123.53 142.79 39.85 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.767 -0.651 . . . . 1.9299999999999999 111.63 -168.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.57 -24.15 42.31 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.691 2.261 . . . . 0.88 111.02 174.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.636 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . -69.51 -32.1 71.27 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.559 -0.746 . . . . 0.38 111.44 174.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.36 -26.79 58.83 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 122.564 -0.374 . . . . 1.0700000000000001 110.813 178.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.588 ' O ' HG23 ' A' ' 23' ' ' VAL . 12.6 mt -70.49 -34.28 72.18 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 109.468 -0.567 . . . . 1.8500000000000001 109.468 178.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.636 ' HG3' ' O ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -78.03 -31.78 50.62 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 119.375 -0.93 . . . . 2.6600000000000001 110.171 -177.218 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -67.69 -37.74 82.71 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 113.928 -1.487 . . . . 4.4299999999999997 108.291 171.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.554 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 66.1 t60 -67.49 -44.69 77.91 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.354 -1.294 . . . . 0.51000000000000001 111.358 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 19' ' ' LEU . 93.8 t -68.08 -29.8 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 C-N-CA 120.147 -0.621 . . . . 1.0900000000000001 110.011 -175.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -61.32 -24.76 66.67 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.753 -0.658 . . . . 3.3999999999999999 111.035 171.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 75.7 mt -70.01 -47.66 67.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.399 -0.364 . . . . 1.9299999999999999 110.882 175.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 . . . . . 0 N--CA 1.467 0.386 0 C-N-CA 120.661 -0.416 . . . . 0.34000000000000002 110.159 176.566 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 . . . . . 0 C--O 1.235 0.33 0 CA-C-O 120.985 0.421 . . . . 1.8999999999999999 111.966 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -128.69 -179.49 5.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.645 -0.707 . . . . 0.77000000000000002 109.782 172.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -105.99 -35.23 7.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.878 0.37 . . . . 1.05 111.991 -173.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.405 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 1.0 OUTLIER -115.58 147.36 38.69 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.298 -0.41 . . . . 1.9299999999999999 110.658 -173.531 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 15' ' ' ASP . 20.2 Cg_exo -65.28 -22.37 60.56 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.532 2.155 . . . . 0.88 109.277 170.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -53.45 -53.21 36.48 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.316 -1.311 . . . . 0.38 111.954 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -73.91 -21.99 59.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.833 -0.183 . . . . 1.0700000000000001 111.438 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.571 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.7 mm? -73.49 -32.08 64.09 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 109.675 -0.491 . . . . 1.8500000000000001 109.675 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -76.57 -39.31 53.06 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.764 0.792 . . . . 2.6600000000000001 110.201 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.529 ' HD3' ' HD2' ' A' ' 24' ' ' ARG . 8.6 tpp180 -64.9 -31.82 73.23 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.217 -1.356 . . . . 4.4299999999999997 108.418 174.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.628 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 35.6 t60 -68.4 -45.78 71.77 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.214 -1.357 . . . . 0.51000000000000001 111.783 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 19' ' ' LEU . 85.9 t -66.32 -38.38 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 C-N-CA 119.97 -0.692 . . . . 1.0900000000000001 110.351 -173.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.529 ' HD2' ' HD3' ' A' ' 21' ' ' ARG . 9.1 ptp180 -70.44 -10.93 60.43 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.056 0.455 . . . . 3.3999999999999999 110.75 177.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.628 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 45.9 mt -73.75 -42.23 54.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.477 -0.329 . . . . 1.9299999999999999 110.284 171.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 . . . . . 0 N--CA 1.463 0.203 0 CA-C-N 116.338 -0.392 . . . . 0.34000000000000002 111.276 -179.091 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 120.838 0.352 . . . . 1.8999999999999999 111.865 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -128.66 149.7 50.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.909 -0.587 . . . . 0.77000000000000002 110.59 175.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.12 -33.45 67.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.429 -0.805 . . . . 1.05 112.638 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -121.83 142.39 36.04 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 115.867 -0.606 . . . . 1.9299999999999999 110.983 -168.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -66.11 -28.38 48.83 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.612 2.208 . . . . 0.88 110.304 173.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.583 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . -68.76 -22.5 75.47 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.3 -0.864 . . . . 0.38 111.735 174.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -80.57 -26.63 37.82 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 122.561 -0.376 . . . . 1.0700000000000001 110.3 175.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.689 ' O ' HG22 ' A' ' 23' ' ' VAL . 12.0 mt -71.97 -35.76 69.63 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 109.205 -0.665 . . . . 1.8500000000000001 109.205 177.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.583 ' HG3' ' O ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -73.55 -36.27 65.62 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 119.553 -0.859 . . . . 2.6600000000000001 109.974 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -59.88 -41.78 92.31 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.336 -1.302 . . . . 4.4299999999999997 108.668 171.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.595 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 39.3 t60 -66.5 -36.56 83.01 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 113.346 -1.752 . . . . 0.51000000000000001 112.064 -176.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.689 HG22 ' O ' ' A' ' 19' ' ' LEU . 49.0 t -72.83 -27.82 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 C-N-CA 119.093 -1.043 . . . . 1.0900000000000001 109.695 -175.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 20' ' ' GLN . 13.6 mmt180 -59.35 -36.09 75.07 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.109 -0.7 . . . . 3.3999999999999999 109.109 171.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.595 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 19.0 mm -61.29 -43.76 97.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 114.841 -1.072 . . . . 1.9299999999999999 111.627 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 . . . . . 0 C--N 1.328 -0.352 0 N-CA-C 112.494 0.553 . . . . 0.34000000000000002 112.494 -175.564 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 . . . . . 0 C--O 1.232 0.154 0 N-CA-C 111.628 0.232 . . . . 1.8999999999999999 111.628 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -124.72 164.37 20.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.129 0.49 . . . . 0.77000000000000002 110.525 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.65 -37.37 15.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.491 -0.777 . . . . 1.05 112.219 -172.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -117.94 139.86 27.06 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.976 -0.556 . . . . 1.9299999999999999 110.949 -167.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.553 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 38.0 Cg_exo -59.83 -34.74 95.54 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.822 2.348 . . . . 0.88 110.946 174.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.97 -35.69 91.77 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.365 -0.834 . . . . 0.38 112.032 176.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.85 -31.86 71.13 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 121.19 -0.204 . . . . 1.0700000000000001 110.847 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.522 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.8 mm? -68.86 -29.36 67.65 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 108.942 -0.762 . . . . 1.8500000000000001 108.942 178.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.553 ' HG2' ' O ' ' A' ' 16' ' ' PRO . 10.3 mm-40 -74.81 -41.15 60.49 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-O 121.65 0.738 . . . . 2.6600000000000001 109.899 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -67.77 -32.42 72.99 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.423 -1.262 . . . . 4.4299999999999997 109.111 176.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.514 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 60.4 t60 -72.35 -45.26 60.65 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 114.88 -1.054 . . . . 0.51000000000000001 111.32 -175.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 19' ' ' LEU . 84.4 t -67.16 -32.34 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 C-N-CA 119.945 -0.702 . . . . 1.0900000000000001 109.967 -175.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.536 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 17.6 mtp180 -63.09 -28.78 70.31 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.969 -0.56 . . . . 3.3999999999999999 110.986 174.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 26.8 mm -64.69 -45.41 95.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-O 120.827 0.346 . . . . 1.9299999999999999 110.723 175.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 . . . . . 0 C--N 1.33 -0.259 0 CA-C-O 121.068 0.461 . . . . 0.34000000000000002 110.677 177.394 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 120.456 0.17 . . . . 1.8999999999999999 111.245 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -135.07 148.38 49.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.731 0.776 . . . . 0.77000000000000002 110.918 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.83 -36.12 82.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.469 -1.241 . . . . 1.05 113.384 -171.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -129.04 142.87 46.65 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.921 0.391 . . . . 1.9299999999999999 110.966 -169.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.508 ' O ' ' HG3' ' A' ' 20' ' ' GLN . 32.5 Cg_endo -64.86 -24.6 60.95 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.859 2.373 . . . . 0.88 111.311 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.97 -42.13 98.18 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.89 -0.672 . . . . 0.38 111.438 173.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -70.86 -22.38 62.31 Favored 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 122.946 -0.149 . . . . 1.0700000000000001 110.845 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.544 ' O ' HG23 ' A' ' 23' ' ' VAL . 3.4 mm? -75.65 -26.4 57.67 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.185 -0.672 . . . . 1.8500000000000001 109.185 175.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.508 ' HG3' ' O ' ' A' ' 16' ' ' PRO . 72.4 mt-30 -74.12 -42.82 59.44 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.909 0.862 . . . . 2.6600000000000001 109.356 176.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.578 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -61.19 -35.93 78.49 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.945 -1.48 . . . . 4.4299999999999997 109.19 172.716 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.532 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 10.0 t60 -67.08 -48.78 67.17 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.616 -1.175 . . . . 0.51000000000000001 111.584 -175.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 19' ' ' LEU . 93.4 t -67.28 -35.89 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 C-N-CA 119.98 -0.688 . . . . 1.0900000000000001 110.805 -172.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.7 -9.93 59.01 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.874 -0.331 . . . . 3.3999999999999999 111.0 176.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 21' ' ' ARG . 19.5 mm -75.59 -42.93 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 109.683 -0.488 . . . . 1.9299999999999999 109.683 172.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 . . . . . 0 CA--C 1.519 -0.228 0 CA-C-O 121.01 0.433 . . . . 0.34000000000000002 110.428 176.899 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 . . . . . 0 C--O 1.235 0.334 0 CA-C-O 120.631 0.253 . . . . 1.8999999999999999 111.501 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.41 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 96.0 m-85 -126.37 141.52 51.87 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.873 0.844 . . . . 0.77000000000000002 111.515 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.19 -36.38 77.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.258 -1.337 . . . . 1.05 113.736 -172.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.453 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 23.4 m-20 -115.37 141.71 27.62 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 116.098 -0.501 . . . . 1.9299999999999999 111.482 -164.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 15' ' ' ASP . 12.6 Cg_exo -67.45 -32.24 32.44 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.747 2.298 . . . . 0.88 110.322 174.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.19 -36.93 92.49 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.134 -0.939 . . . . 0.38 111.736 176.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.556 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -69.44 -28.17 65.89 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.984 -0.108 . . . . 1.0700000000000001 110.937 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.522 ' O ' HG21 ' A' ' 23' ' ' VAL . 2.6 mm? -71.41 -31.35 67.15 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.125 -0.694 . . . . 1.8500000000000001 109.125 177.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.612 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 79.8 mt-30 -68.97 -44.32 73.18 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 119.951 -0.7 . . . . 2.6600000000000001 109.985 177.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.703 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.3 OUTLIER -61.16 -40.38 93.65 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.257 -1.338 . . . . 4.4299999999999997 108.553 174.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.609 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 39.4 t60 -65.64 -49.65 67.87 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 113.607 -1.633 . . . . 0.51000000000000001 111.927 -171.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.522 HG21 ' O ' ' A' ' 19' ' ' LEU . 59.3 t -66.58 -34.63 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 C-N-CA 119.843 -0.743 . . . . 1.0900000000000001 109.868 -175.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.612 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 78.4 mtt-85 -66.32 -27.04 67.59 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.629 -0.714 . . . . 3.3999999999999999 110.558 175.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.703 HG12 ' O ' ' A' ' 21' ' ' ARG . 24.6 mm -62.11 -50.39 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.063 -0.517 . . . . 1.9299999999999999 110.548 175.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 116.177 -0.465 . . . . 0.34000000000000002 111.212 -179.096 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.705 0.288 . . . . 1.8999999999999999 111.431 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.418 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 98.5 m-85 -131.58 169.16 16.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.77000000000000002 110.126 173.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.2 -51.64 8.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.232 0.539 . . . . 1.05 112.139 -174.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -105.53 142.25 24.35 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.291 -0.868 . . . . 1.9299999999999999 111.859 -165.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -63.26 -27.53 72.14 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.89 2.393 . . . . 0.88 110.753 171.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.489 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -69.27 -24.18 76.08 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.459 -0.791 . . . . 0.38 111.753 176.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -84.27 -28.1 27.41 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 122.587 -0.361 . . . . 1.0700000000000001 110.854 178.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.546 ' O ' HG21 ' A' ' 23' ' ' VAL . 2.4 mm? -74.26 -29.83 61.85 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 109.509 -0.552 . . . . 1.8500000000000001 109.509 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 13.1 pt20 -75.89 -35.55 59.81 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.41 -0.916 . . . . 2.6600000000000001 109.752 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -64.28 -39.8 94.67 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.18 -1.373 . . . . 4.4299999999999997 108.764 170.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.501 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 48.1 t60 -67.06 -49.35 65.4 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.092 -1.413 . . . . 0.51000000000000001 111.952 -174.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.546 HG21 ' O ' ' A' ' 19' ' ' LEU . 63.3 t -66.58 -31.86 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 C-N-CA 120.029 -0.668 . . . . 1.0900000000000001 109.755 -175.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -69.51 -7.38 37.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.503 -0.771 . . . . 3.3999999999999999 111.465 174.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 81.0 mt -83.86 -47.48 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 109.616 -0.512 . . . . 1.9299999999999999 109.616 171.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 121.267 0.556 . . . . 0.34000000000000002 110.661 178.259 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 120.662 0.267 . . . . 1.8999999999999999 111.104 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.549 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 92.0 m-85 -131.8 158.58 40.89 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.266 0.555 . . . . 0.77000000000000002 110.663 176.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.53 -36.46 26.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.36 -0.836 . . . . 1.05 112.909 -171.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -124.01 138.92 31.47 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-O 120.827 0.346 . . . . 1.9299999999999999 111.128 -168.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.45 -29.73 79.31 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.125 2.55 . . . . 0.88 111.278 176.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.54 -36.33 93.05 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.747 -0.66 . . . . 0.38 111.566 175.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.99 -31.84 64.78 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.608 -0.296 . . . . 1.0700000000000001 111.015 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.549 ' CD2' ' HB2' ' A' ' 13' ' ' PHE . 2.7 mm? -66.29 -34.67 78.52 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 109.292 -0.632 . . . . 1.8500000000000001 109.292 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -73.78 -38.31 64.71 Favored 'General case' 0 N--CA 1.432 -1.325 0 C-N-CA 119.125 -1.03 . . . . 2.6600000000000001 110.556 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.564 ' O ' HG12 ' A' ' 25' ' ' ILE . 7.1 tpt180 -65.42 -37.09 85.89 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.713 -1.131 . . . . 4.4299999999999997 108.641 175.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.529 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 63.3 t60 -73.66 -48.13 34.69 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.041 -1.436 . . . . 0.51000000000000001 111.559 -174.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.508 HG21 ' O ' ' A' ' 19' ' ' LEU . 72.8 t -64.63 -31.62 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 CA-C-N 116.014 -0.539 . . . . 1.0900000000000001 110.557 -173.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -76.56 -14.31 60.02 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 120.382 -0.527 . . . . 3.3999999999999999 110.685 177.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 21' ' ' ARG . 18.7 mm -69.37 -45.56 78.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 109.747 -0.464 . . . . 1.9299999999999999 109.747 173.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 . . . . . 0 CA--C 1.519 -0.214 0 CA-C-O 121.293 0.568 . . . . 0.34000000000000002 109.52 172.963 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.701 0.286 . . . . 1.8999999999999999 111.31 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -129.16 155.18 45.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.443 0.639 . . . . 0.77000000000000002 110.762 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.02 -28.77 29.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.02 -0.991 . . . . 1.05 111.351 -175.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -120.76 135.46 24.73 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.28 -0.873 . . . . 1.9299999999999999 110.981 -166.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.37 -25.45 35.93 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.241 1.961 . . . . 0.88 110.27 172.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.487 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -67.95 -27.95 73.54 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.961 -1.018 . . . . 0.38 111.478 173.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -78.4 -25.91 46.27 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 120.943 -0.303 . . . . 1.0700000000000001 110.667 178.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.629 ' O ' HG22 ' A' ' 23' ' ' VAL . 2.7 mm? -69.62 -35.25 75.1 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 109.663 -0.495 . . . . 1.8500000000000001 109.663 178.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 12.0 pt20 -76.18 -36.02 58.87 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 119.415 -0.914 . . . . 2.6600000000000001 110.105 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.422 ' O ' HG13 ' A' ' 25' ' ' ILE . 7.2 tpm_? -61.08 -40.21 92.84 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.857 -1.519 . . . . 4.4299999999999997 108.191 172.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.61 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 37.8 t60 -70.33 -44.46 68.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.723 -1.58 . . . . 0.51000000000000001 112.183 -174.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.629 HG22 ' O ' ' A' ' 19' ' ' LEU . 61.4 t -66.15 -35.77 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 C-N-CA 119.682 -0.807 . . . . 1.0900000000000001 110.101 -174.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -62.2 -25.52 67.83 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.127 -0.488 . . . . 3.3999999999999999 111.126 173.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.61 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 79.9 mt -67.96 -44.07 85.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 1.9299999999999999 110.791 176.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 . . . . . 0 N--CA 1.465 0.276 0 CA-C-O 120.565 0.221 . . . . 0.34000000000000002 111.359 179.762 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 . . . . . 0 C--O 1.233 0.217 0 N-CA-C 112.38 0.511 . . . . 1.8999999999999999 112.38 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -129.12 167.05 18.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.9 -0.591 . . . . 0.77000000000000002 110.705 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.03 -2.45 37.19 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.153 0.797 . . . . 1.05 113.153 -170.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -155.51 150.33 20.5 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 120.816 -0.354 . . . . 1.9299999999999999 110.109 -176.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.44 -22.61 65.57 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.855 2.37 . . . . 0.88 109.531 169.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.536 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -57.22 -48.36 80.69 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 114.382 -1.281 . . . . 0.38 111.89 172.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -72.73 -25.41 61.21 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 121.07 -0.252 . . . . 1.0700000000000001 110.781 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.521 ' O ' HG22 ' A' ' 23' ' ' VAL . 2.5 mm? -72.1 -36.22 69.41 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.094 -0.706 . . . . 1.8500000000000001 109.094 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 17.0 pt20 -77.81 -33.84 52.29 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 119.729 -0.788 . . . . 2.6600000000000001 109.94 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.446 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.5 OUTLIER -65.44 -36.2 83.22 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.648 -1.16 . . . . 4.4299999999999997 108.741 173.29 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.555 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 47.1 t60 -73.42 -46.1 50.58 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 114.7 -1.136 . . . . 0.51000000000000001 111.683 -174.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 19' ' ' LEU . 97.5 t -66.07 -34.38 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 C-N-CA 119.866 -0.734 . . . . 1.0900000000000001 110.019 -175.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 16.8 mtp180 -62.73 -26.81 68.88 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.109 -0.496 . . . . 3.3999999999999999 111.077 173.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.555 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 18.3 mm -69.22 -44.32 80.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.427 -0.351 . . . . 1.9299999999999999 110.63 176.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 . . . . . 0 N--CA 1.464 0.263 0 CA-C-O 121.217 0.532 . . . . 0.34000000000000002 110.626 176.354 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 . . . . . 0 N--CA 1.454 -0.249 0 N-CA-C 112.562 0.579 . . . . 1.8999999999999999 112.562 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -124.65 169.33 12.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.381 -0.827 . . . . 0.77000000000000002 110.35 173.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.61 -36.19 13.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.238 -0.437 . . . . 1.05 112.125 -173.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.439 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.7 OUTLIER -113.58 151.58 44.66 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-O 120.977 0.417 . . . . 1.9299999999999999 110.369 -174.685 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 15' ' ' ASP . 12.2 Cg_exo -71.61 -23.53 23.0 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.159 2.573 . . . . 0.88 108.465 170.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.07 -41.87 98.21 Favored Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 113.889 -1.505 . . . . 0.38 111.553 172.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -77.49 -25.52 50.45 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 121.158 -0.217 . . . . 1.0700000000000001 111.417 -177.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.54 ' O ' HG21 ' A' ' 23' ' ' VAL . 8.0 mt -71.29 -38.47 71.78 Favored 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 120.014 -0.674 . . . . 1.8500000000000001 109.208 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.443 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 21.4 mt-30 -76.69 -31.96 57.59 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 119.294 -0.962 . . . . 2.6600000000000001 110.701 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.07 -38.17 89.9 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.998 -1.001 . . . . 4.4299999999999997 108.489 171.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.608 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 71.3 t60 -73.56 -45.72 51.72 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 114.427 -1.261 . . . . 0.51000000000000001 112.01 -174.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.54 HG21 ' O ' ' A' ' 19' ' ' LEU . 99.0 t -66.29 -31.06 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 C-N-CA 119.721 -0.792 . . . . 1.0900000000000001 110.14 -174.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 32.9 mtm180 -75.06 -6.96 52.26 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.993 -0.549 . . . . 3.3999999999999999 110.652 175.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.608 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 68.6 mt -78.41 -50.25 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.683 -0.488 . . . . 1.9299999999999999 109.683 169.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 . . . . . 0 N--CA 1.462 0.146 0 CA-C-O 121.275 0.559 . . . . 0.34000000000000002 110.458 177.953 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 110.604 -0.147 . . . . 1.8999999999999999 110.604 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -127.27 166.39 17.87 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.33 0.586 . . . . 0.77000000000000002 111.431 -177.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.41 -28.09 21.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.147 -0.933 . . . . 1.05 113.266 -167.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -136.71 150.17 69.27 Favored Pre-proline 0 C--N 1.327 -0.378 0 C-N-CA 121.102 -0.239 . . . . 1.9299999999999999 110.436 -176.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -65.03 -24.05 60.37 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.536 2.157 . . . . 0.88 109.184 168.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.551 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -59.12 -37.31 91.51 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 114.281 -1.327 . . . . 0.38 111.842 172.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -80.33 -28.69 38.1 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.733 -0.387 . . . . 1.0700000000000001 110.651 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.52 ' O ' HG22 ' A' ' 23' ' ' VAL . 13.8 mt -71.13 -30.11 66.08 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 120.346 -0.541 . . . . 1.8500000000000001 109.614 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.551 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 27.6 pt20 -74.93 -40.69 60.69 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 119.373 -0.931 . . . . 2.6600000000000001 109.964 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.419 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.7 OUTLIER -70.95 -27.04 63.45 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.49 -1.232 . . . . 4.4299999999999997 109.336 177.075 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.536 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 63.1 t60 -73.46 -48.04 36.69 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 114.934 -1.03 . . . . 0.51000000000000001 111.536 -177.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 19' ' ' LEU . 84.6 t -66.35 -29.27 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 C-N-CA 119.823 -0.751 . . . . 1.0900000000000001 109.649 -175.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 41.9 mtt180 -61.98 -35.58 78.91 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.915 -0.584 . . . . 3.3999999999999999 110.992 171.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 26.4 mm -61.72 -45.4 98.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.335 -0.393 . . . . 1.9299999999999999 110.635 177.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 . . . . . 0 CA--C 1.519 -0.231 0 CA-C-N 116.131 -0.486 . . . . 0.34000000000000002 110.244 176.588 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.7 mtt . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 120.612 0.244 . . . . 7.5199999999999996 111.01 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -95.84 117.57 66.34 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.261 0.553 . . . . 5.4299999999999997 110.977 -177.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -91.86 178.33 1.62 Allowed 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.906 2.404 . . . . 1.54 112.116 173.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.581 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . 65.0 m-85 -113.18 102.49 10.43 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.396 -0.965 . . . . 1.47 108.396 171.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.53 HG12 ' HG2' ' A' ' 12' ' ' GLN . 16.8 m -90.56 143.13 11.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.306 0.574 . . . . 1.0900000000000001 111.685 -172.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.603 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 46.9 t -68.25 121.45 16.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.249 -0.887 . . . . 0.20999999999999999 110.148 175.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.1 mm -67.02 -21.29 28.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.203 -0.453 . . . . 1.3300000000000001 111.074 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -93.34 -35.01 13.27 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.351 0.5 . . . . 2.2200000000000002 112.351 -172.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.9 p -128.41 -3.13 5.53 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.029 -0.668 . . . . 0.27000000000000002 112.514 -175.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 64.87 52.05 1.67 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.579 -0.737 . . . . 2.0800000000000001 112.617 175.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -106.12 128.41 53.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.658 -0.701 . . . . 4.3700000000000001 109.246 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.53 ' HG2' HG12 ' A' ' 5' ' ' VAL . 64.8 mt-30 -85.33 114.45 22.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.908 0.385 . . . . 1.8999999999999999 111.045 -175.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -109.09 173.98 6.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.066 -0.515 . . . . 0.77000000000000002 111.071 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.79 -53.45 4.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.099 0.476 . . . . 1.05 111.73 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -106.74 146.6 33.4 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.622 -0.717 . . . . 1.9299999999999999 110.994 -169.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.96 -28.58 41.86 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.848 2.366 . . . . 0.88 111.231 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.506 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . -64.32 -32.1 83.08 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.779 -0.646 . . . . 0.38 111.507 175.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.3 -28.68 59.81 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 121.014 -0.275 . . . . 1.0700000000000001 110.839 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.581 ' CD1' ' HB3' ' A' ' 4' ' ' TYR . 8.6 mt -68.47 -34.22 75.56 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 109.458 -0.571 . . . . 1.8500000000000001 109.458 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.506 ' HG3' ' O ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -76.11 -33.94 59.47 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 119.037 -1.065 . . . . 2.6600000000000001 109.746 -177.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.565 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.5 OUTLIER -66.54 -35.36 80.05 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.479 -1.237 . . . . 4.4299999999999997 108.944 172.147 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.636 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 71.6 t60 -72.29 -49.51 34.22 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.05 -0.977 . . . . 0.51000000000000001 111.459 -176.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 19' ' ' LEU . 74.6 t -64.24 -37.57 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 115.695 -0.684 . . . . 1.0900000000000001 110.556 -172.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 11.0 ptm180 -69.81 -20.66 63.44 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.057 -0.52 . . . . 3.3999999999999999 110.446 178.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.636 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 9.9 mm -64.93 -34.79 72.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.396 -0.366 . . . . 1.9299999999999999 110.17 172.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -68.24 -36.81 80.04 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 120.895 -0.322 . . . . 0.34000000000000002 110.871 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -39.88 79.28 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 120.194 -0.602 . . . . 2.2400000000000002 110.16 175.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.83 -56.69 3.49 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.816 -0.629 . . . . 2.3599999999999999 112.064 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -66.71 -29.74 69.8 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.194 0.521 . . . . 3.9199999999999999 110.683 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 47.5 pttt . . . . . 0 C--O 1.251 1.139 0 CA-C-O 117.923 -1.037 . . . . 7.4000000000000004 110.185 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.521 ' HG2' ' HG3' ' A' ' 2' ' ' LYS . 51.3 ttm . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 120.702 0.287 . . . . 7.5199999999999996 110.484 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.521 ' HG3' ' HG2' ' A' ' 1' ' ' MET . 91.4 mttt -118.65 128.16 26.13 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.44 -0.346 . . . . 5.4299999999999997 110.106 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.72 173.13 11.37 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 121.897 1.732 . . . . 1.54 110.212 171.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.51 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . 91.0 m-85 -89.52 89.58 7.9 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.438 0.637 . . . . 1.47 109.478 -176.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.485 HG11 ' HG2' ' A' ' 12' ' ' GLN . 32.9 m -84.39 144.94 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 114.947 -1.024 . . . . 1.0900000000000001 110.98 -177.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.528 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 37.9 t -60.51 130.86 48.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.022 -0.99 . . . . 0.20999999999999999 110.547 177.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.453 HD13 ' N ' ' A' ' 7' ' ' ILE . 3.2 mp -70.66 -25.64 26.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.311 -0.859 . . . . 1.3300000000000001 110.288 -175.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -91.68 -53.77 4.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.531 . . . . 2.2200000000000002 111.306 -175.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.2 p -108.71 1.4 21.12 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.213 0.53 . . . . 0.27000000000000002 111.596 -169.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 59.23 43.23 17.29 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.149 -0.932 . . . . 2.0800000000000001 112.895 173.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.704 ' HE ' ' HA ' ' A' ' 11' ' ' ARG . 0.5 OUTLIER -103.83 140.92 36.99 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.036 -0.357 . . . . 4.3700000000000001 110.036 175.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.485 ' HG2' HG11 ' A' ' 5' ' ' VAL . 28.4 mt-30 -77.63 132.96 38.5 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.278 0.473 . . . . 1.8999999999999999 112.278 -174.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -132.62 165.25 24.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.549 -0.75 . . . . 0.77000000000000002 109.859 175.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.29 -35.32 13.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.936 -0.574 . . . . 1.05 112.44 -171.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.88 147.81 49.58 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 120.589 0.233 . . . . 1.9299999999999999 110.806 -174.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.42 -22.93 51.54 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.605 2.203 . . . . 0.88 109.082 168.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.536 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -61.22 -43.35 99.5 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 114.48 -1.237 . . . . 0.38 111.845 172.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -76.65 -27.91 55.81 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 120.775 -0.37 . . . . 1.0700000000000001 110.868 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.693 ' O ' HG22 ' A' ' 23' ' ' VAL . 9.5 mt -66.66 -39.25 88.1 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 109.277 -0.638 . . . . 1.8500000000000001 109.277 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 9.1 pt20 -72.47 -37.66 68.43 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.977 0.894 . . . . 2.6600000000000001 110.468 -175.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.615 HH22 ' HG3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -67.54 -34.29 76.78 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 113.899 -1.501 . . . . 4.4299999999999997 107.969 176.368 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.741 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 74.8 t60 -69.25 -39.54 78.4 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 114.317 -1.31 . . . . 0.51000000000000001 111.845 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.693 HG22 ' O ' ' A' ' 19' ' ' LEU . 87.7 t -67.07 -36.47 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 C-N-CA 119.364 -0.935 . . . . 1.0900000000000001 109.874 -174.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.2 mmm-85 -63.08 -28.59 70.18 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.198 -0.455 . . . . 3.3999999999999999 110.413 173.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.741 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 20.0 mm -59.44 -50.53 79.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.773 -0.649 . . . . 1.9299999999999999 110.63 176.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -62.35 -30.55 71.26 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.204 -0.453 . . . . 0.34000000000000002 110.922 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.428 ' HB ' ' HG2' ' A' ' 29' ' ' GLU . 1.3 m -68.7 -24.53 64.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.124 -0.489 . . . . 2.2400000000000002 110.542 -176.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.67 -11.49 52.15 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.074 -0.584 . . . . 2.3599999999999999 113.282 174.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.428 ' HG2' ' HB ' ' A' ' 27' ' ' THR . 8.0 pt-20 -73.95 -31.85 63.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.604 0.24 . . . . 3.9199999999999999 111.601 -177.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.615 ' HG3' HH22 ' A' ' 21' ' ' ARG . 52.6 tptt . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.35 -0.833 . . . . 7.4000000000000004 109.923 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 N--CA 1.481 1.093 0 CA-C-O 121.048 0.451 . . . . 7.5199999999999996 110.974 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.539 ' HB2' ' HD3' ' A' ' 3' ' ' PRO . 5.2 mptp? -66.79 -50.24 45.18 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 116.126 -0.488 . . . . 5.4299999999999997 110.571 175.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 2' ' ' LYS . 55.5 Cg_exo -59.89 173.63 1.65 Allowed 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.367 2.045 . . . . 1.54 113.15 173.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.525 ' O ' HD22 ' A' ' 19' ' ' LEU . 79.8 m-85 -117.35 126.35 52.53 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.015 -1.448 . . . . 1.47 109.769 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.567 HG12 ' HG2' ' A' ' 12' ' ' GLN . 3.5 m -94.47 149.34 4.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 115.975 -0.557 . . . . 1.0900000000000001 111.066 -174.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.465 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 48.6 t -71.43 128.67 36.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.745 -0.661 . . . . 0.20999999999999999 110.534 177.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.415 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.3 mp -71.06 -27.82 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 115.402 -0.817 . . . . 1.3300000000000001 110.498 -176.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -90.32 -44.2 9.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 2.2200000000000002 111.584 -171.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.7 p -120.31 0.48 10.61 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 119.694 -0.803 . . . . 0.27000000000000002 112.423 -171.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 63.99 57.02 1.36 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.417 -0.811 . . . . 2.0800000000000001 112.385 172.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -121.59 130.98 53.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.811 -0.631 . . . . 4.3700000000000001 109.606 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.567 ' HG2' HG12 ' A' ' 5' ' ' VAL . 30.2 mt-30 -77.54 131.17 37.75 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 120.905 0.383 . . . . 1.8999999999999999 111.266 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -125.6 149.23 48.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.77000000000000002 110.383 174.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.11 -12.72 59.98 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.7 1.0 . . . . 1.05 113.7 -167.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -142.87 151.15 55.73 Favored Pre-proline 0 C--N 1.324 -0.505 0 C-N-CA 120.831 -0.348 . . . . 1.9299999999999999 110.939 -173.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.462 ' HG3' ' CE1' ' A' ' 4' ' ' TYR . 18.2 Cg_exo -66.06 -22.28 55.05 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.628 2.219 . . . . 0.88 109.445 168.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.4 -53.26 47.33 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 114.462 -1.245 . . . . 0.38 111.66 171.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -65.32 -26.19 67.94 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 115.719 -0.241 . . . . 1.0700000000000001 111.154 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.525 HD22 ' O ' ' A' ' 4' ' ' TYR . 2.8 mm? -70.45 -34.3 72.29 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 109.315 -0.624 . . . . 1.8500000000000001 109.315 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -72.35 -41.8 66.05 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 119.735 -0.786 . . . . 2.6600000000000001 110.324 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.572 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -61.3 -39.43 90.42 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.498 -1.228 . . . . 4.4299999999999997 108.765 175.213 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.593 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 59.5 t60 -75.17 -46.85 31.49 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 114.311 -1.313 . . . . 0.51000000000000001 112.02 -170.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 19' ' ' LEU . 95.8 t -67.54 -34.55 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 C-N-CA 119.849 -0.74 . . . . 1.0900000000000001 110.498 -172.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.459 ' HA ' HG22 ' A' ' 27' ' ' THR . 10.0 ptp180 -75.16 -11.79 60.16 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.109 -0.636 . . . . 3.3999999999999999 110.61 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.593 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 9.5 mm -70.67 -45.73 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.935 -0.394 . . . . 1.9299999999999999 109.935 171.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 40.5 m-70 -65.86 -50.96 62.69 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.083 0.468 . . . . 0.34000000000000002 110.224 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.513 ' O ' HG21 ' A' ' 27' ' ' THR . 9.3 t -87.71 52.03 2.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.931 0.872 . . . . 2.2400000000000002 110.418 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.26 59.03 0.42 Allowed Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.479 -0.782 . . . . 2.3599999999999999 111.75 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -78.71 -40.83 32.64 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 123.459 0.704 . . . . 3.9199999999999999 110.813 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.8 tptm . . . . . 0 C--N 1.316 -0.855 0 CA-C-O 118.538 -0.744 . . . . 7.4000000000000004 109.695 178.272 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 121.003 0.43 . . . . 7.5199999999999996 110.208 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.487 ' HD2' ' HD2' ' A' ' 3' ' ' PRO . 58.5 tptt -88.93 113.06 54.49 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.018 -0.537 . . . . 5.4299999999999997 110.615 -178.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.487 ' HD2' ' HD2' ' A' ' 2' ' ' LYS . 71.3 Cg_endo -84.4 174.76 7.7 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.664 2.243 . . . . 1.54 111.304 175.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.6 ' O ' HD21 ' A' ' 19' ' ' LEU . 87.4 m-85 -119.38 113.15 20.35 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 109.206 -0.664 . . . . 1.47 109.206 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.524 HG13 ' HA ' ' A' ' 12' ' ' GLN . 29.7 m -106.37 139.69 26.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.761 -0.654 . . . . 1.0900000000000001 111.097 -171.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.515 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 39.1 t -63.42 122.76 17.03 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.905 -0.589 . . . . 0.20999999999999999 109.548 175.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.0 mp -70.67 -25.92 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-N 115.573 -0.74 . . . . 1.3300000000000001 109.964 -176.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -90.99 -43.05 10.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.953 -0.567 . . . . 2.2200000000000002 111.885 -169.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.6 p -118.04 -3.2 11.14 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 119.752 -0.779 . . . . 0.27000000000000002 112.055 -175.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 65.07 79.65 0.25 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.506 -0.77 . . . . 2.0800000000000001 112.654 175.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 96.5 mtt180 -138.47 132.88 31.97 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.783 -0.644 . . . . 4.3700000000000001 109.337 174.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.524 ' HA ' HG13 ' A' ' 5' ' ' VAL . 30.0 mt-30 -87.36 112.58 22.25 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.651 0.241 . . . . 1.8999999999999999 111.651 -177.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.41 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 98.4 m-85 -108.97 165.83 11.29 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.793 0.33 . . . . 0.77000000000000002 110.432 176.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.77 -39.01 18.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.923 -0.58 . . . . 1.05 112.415 -175.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 13.4 m-20 -118.43 142.12 30.86 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.081 -0.508 . . . . 1.9299999999999999 111.844 -168.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 15' ' ' ASP . 17.0 Cg_exo -66.28 -25.36 49.76 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.982 2.454 . . . . 0.88 111.015 175.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.531 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -62.83 -33.29 86.56 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.574 -0.739 . . . . 0.38 111.884 176.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -80.24 -29.4 38.42 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.549 -0.46 . . . . 1.0700000000000001 110.674 177.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.6 HD21 ' O ' ' A' ' 4' ' ' TYR . 2.7 mm? -68.55 -34.17 75.36 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 109.633 -0.506 . . . . 1.8500000000000001 109.633 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.531 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 3.9 pt20 -74.26 -37.82 63.64 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 119.514 -0.875 . . . . 2.6600000000000001 110.256 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.572 ' O ' HG13 ' A' ' 25' ' ' ILE . 1.1 tmt_? -68.09 -34.86 77.2 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.305 -1.316 . . . . 4.4299999999999997 108.293 175.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.59 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 33.1 t60 -71.37 -50.04 36.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.735 -1.121 . . . . 0.51000000000000001 111.747 -175.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 19' ' ' LEU . 99.4 t -65.45 -34.08 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-N 115.824 -0.625 . . . . 1.0900000000000001 110.102 -173.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.497 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 59.7 mtp180 -75.0 -8.87 57.75 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.924 -0.58 . . . . 3.3999999999999999 110.874 177.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.59 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 57.1 mt -74.14 -48.95 35.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.923 -0.399 . . . . 1.9299999999999999 109.923 172.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 -62.11 -50.56 71.44 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.967 -0.561 . . . . 0.34000000000000002 111.297 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.441 HG21 ' HB2' ' A' ' 30' ' ' LYS . 5.6 m -86.46 -26.38 24.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.077 -0.51 . . . . 2.2400000000000002 111.992 -173.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.0 -62.28 3.32 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.025 -0.607 . . . . 2.3599999999999999 112.944 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -80.11 -54.06 6.12 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.497 0.665 . . . . 3.9199999999999999 110.822 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.441 ' HB2' HG21 ' A' ' 27' ' ' THR . 17.5 mmtp . . . . . 0 C--O 1.246 0.906 0 CA-C-N 114.809 -1.087 . . . . 7.4000000000000004 109.806 -175.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtm . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 110.048 -0.353 . . . . 7.5199999999999996 110.048 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.514 ' HB2' ' HD3' ' A' ' 3' ' ' PRO . 55.2 mtpt -75.3 -54.46 2.44 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 109.493 -0.558 . . . . 5.4299999999999997 109.493 176.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 2' ' ' LYS . 88.4 Cg_endo -80.22 170.58 16.1 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.502 1.468 . . . . 1.54 110.276 165.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.597 ' CE2' ' HD3' ' A' ' 16' ' ' PRO . 84.8 m-85 -124.05 117.33 24.46 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 116.169 -0.469 . . . . 1.47 109.801 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.9 m -101.99 147.68 8.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.047 -0.524 . . . . 1.0900000000000001 111.186 -173.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 10' ' ' GLN . 52.6 t -67.71 129.96 41.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.988 -0.551 . . . . 0.20999999999999999 109.888 175.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.491 HD11 ' N ' ' A' ' 7' ' ' ILE . 3.6 mp -78.3 -25.25 13.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.756 -0.656 . . . . 1.3300000000000001 109.785 -176.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 39.7 t60 -87.53 -47.13 8.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.8 -0.636 . . . . 2.2200000000000002 111.327 -171.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.7 p -115.27 -9.39 12.22 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 119.956 -0.698 . . . . 0.27000000000000002 111.655 -176.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 6' ' ' CYS . 96.2 mt-30 67.64 79.36 0.22 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.454 -0.794 . . . . 2.0800000000000001 112.593 175.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -142.01 144.23 33.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.463 -0.789 . . . . 4.3700000000000001 109.566 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -80.69 138.72 36.37 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.038 0.447 . . . . 1.8999999999999999 111.176 -173.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -137.39 162.77 32.72 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.332 -0.849 . . . . 0.77000000000000002 110.286 174.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.0 -20.18 22.39 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.771 0.656 . . . . 1.05 112.771 -170.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -141.08 150.03 57.61 Favored Pre-proline 0 C--N 1.326 -0.445 0 C-N-CA 121.033 -0.267 . . . . 1.9299999999999999 110.776 -174.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.597 ' HD3' ' CE2' ' A' ' 4' ' ' TYR . 17.1 Cg_exo -67.09 -22.0 48.13 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.811 2.34 . . . . 0.88 109.193 169.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.587 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -57.13 -44.68 93.07 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 114.532 -1.213 . . . . 0.38 111.885 172.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.547 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -77.84 -22.38 50.03 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 121.037 -0.265 . . . . 1.0700000000000001 110.992 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.553 ' O ' HG21 ' A' ' 23' ' ' VAL . 2.6 mm? -73.38 -35.14 65.88 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 109.528 -0.545 . . . . 1.8500000000000001 109.528 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.587 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 16.9 pt20 -75.16 -35.52 61.61 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.672 -0.811 . . . . 2.6600000000000001 109.91 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -68.18 -32.29 72.44 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.433 -1.258 . . . . 4.4299999999999997 108.829 173.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.565 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 46.6 t60 -71.59 -46.41 59.37 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 114.756 -1.111 . . . . 0.51000000000000001 111.787 -176.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.553 HG21 ' O ' ' A' ' 19' ' ' LEU . 60.8 t -66.62 -32.7 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 C-N-CA 119.822 -0.751 . . . . 1.0900000000000001 109.719 -175.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -59.3 -29.97 67.99 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.609 -0.723 . . . . 3.3999999999999999 111.49 171.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.565 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 79.6 mt -64.82 -52.85 49.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.308 -0.406 . . . . 1.9299999999999999 110.68 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -62.19 -47.6 83.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.15 0.5 . . . . 0.34000000000000002 110.6 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.1 m -85.49 49.57 1.79 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.434 0.635 . . . . 2.2400000000000002 110.793 -176.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.69 37.32 2.08 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.813 -0.631 . . . . 2.3599999999999999 113.04 -178.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -81.19 -34.24 32.45 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.126 -0.694 . . . . 3.9199999999999999 109.126 176.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.7 tttm . . . . . 0 C--O 1.25 1.081 0 CA-C-N 115.239 -0.891 . . . . 7.4000000000000004 109.529 175.47 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 120.869 0.366 . . . . 7.5199999999999996 110.264 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -108.12 140.31 21.55 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.325 -0.62 . . . . 5.4299999999999997 109.325 177.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -54.12 167.27 1.26 Allowed 'Trans proline' 0 CA--C 1.512 -0.624 0 C-N-CA 123.258 2.639 . . . . 1.54 113.713 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.562 ' CZ ' ' HG3' ' A' ' 16' ' ' PRO . 91.9 m-85 -104.66 123.87 48.35 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 113.971 -1.468 . . . . 1.47 109.564 -174.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.509 HG12 ' HG2' ' A' ' 12' ' ' GLN . 22.3 m -111.17 149.65 13.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.951 -0.568 . . . . 1.0900000000000001 111.092 -172.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.453 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 47.9 t -76.46 115.4 16.17 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.017 -0.538 . . . . 0.20999999999999999 109.823 176.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.457 HD13 ' N ' ' A' ' 7' ' ' ILE . 3.1 mp -69.42 -23.65 26.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.531 0.681 . . . . 1.3300000000000001 109.602 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.419 ' HB3' ' CD2' ' A' ' 26' ' ' HIS . 2.5 t-80 -81.42 -40.92 22.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.151 -0.931 . . . . 2.2200000000000002 112.018 -171.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.6 p -126.52 -5.65 6.46 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 120.163 -0.615 . . . . 0.27000000000000002 112.129 -177.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 69.8 67.77 0.24 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.778 0.831 . . . . 2.0800000000000001 112.266 175.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -134.44 135.48 42.56 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.627 -0.715 . . . . 4.3700000000000001 109.716 175.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.509 ' HG2' HG12 ' A' ' 5' ' ' VAL . 70.4 mt-30 -84.23 133.95 34.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.969 0.414 . . . . 1.8999999999999999 111.815 -176.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.566 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 97.0 m-85 -129.46 176.42 7.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.878 -0.601 . . . . 0.77000000000000002 110.458 174.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -95.52 -40.28 9.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.178 0.513 . . . . 1.05 112.16 -173.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -112.26 139.91 23.04 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.657 -0.702 . . . . 1.9299999999999999 111.672 -167.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.562 ' HG3' ' CZ ' ' A' ' 4' ' ' TYR . 17.4 Cg_exo -64.47 -32.83 59.22 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.799 2.332 . . . . 0.88 110.333 173.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.449 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -63.6 -29.94 76.15 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.226 -0.897 . . . . 0.38 112.042 177.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -82.01 -30.78 31.34 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 120.801 -0.36 . . . . 1.0700000000000001 111.154 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.566 ' CD2' ' HB2' ' A' ' 13' ' ' PHE . 2.2 mm? -70.92 -31.4 68.0 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 109.746 -0.464 . . . . 1.8500000000000001 109.746 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 12.8 pt20 -75.56 -36.93 60.29 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 119.367 -0.933 . . . . 2.6600000000000001 110.229 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.443 ' HA ' ' HD2' ' A' ' 21' ' ' ARG . 0.9 OUTLIER -70.22 -32.54 70.46 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.34 -1.3 . . . . 4.4299999999999997 108.777 174.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.498 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 55.7 t60 -66.69 -47.89 71.01 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 114.32 -1.309 . . . . 0.51000000000000001 111.053 -177.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.546 HG21 ' O ' ' A' ' 19' ' ' LEU . 98.0 t -64.51 -34.49 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 115.666 -0.697 . . . . 1.0900000000000001 109.895 -176.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -63.55 -25.65 68.34 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 112.314 0.487 . . . . 3.3999999999999999 112.314 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.498 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 83.8 mt -65.25 -45.15 94.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.966 -0.383 . . . . 1.9299999999999999 109.966 175.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.419 ' CD2' ' HB3' ' A' ' 8' ' ' HIS . 74.8 m-70 -71.02 -50.82 29.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.34000000000000002 110.17 175.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.2 m -84.01 51.49 2.07 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.46 -0.791 . . . . 2.2400000000000002 111.111 -174.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.11 63.99 4.22 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.043 -0.599 . . . . 2.3599999999999999 111.784 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -69.4 -60.58 2.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.031 0.444 . . . . 3.9199999999999999 110.512 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt . . . . . 0 C--O 1.247 0.964 0 CA-C-N 115.478 -0.783 . . . . 7.4000000000000004 110.01 179.642 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptp . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.545 0.212 . . . . 7.5199999999999996 111.197 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.52 100.42 2.05 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 109.349 -0.611 . . . . 5.4299999999999997 109.349 -178.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -59.85 178.19 0.4 Allowed 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 123.513 2.809 . . . . 1.54 114.324 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.461 ' O ' HD22 ' A' ' 19' ' ' LEU . 95.6 m-85 -103.3 122.04 43.97 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.126 -1.397 . . . . 1.47 108.847 177.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.483 HG11 ' HG2' ' A' ' 12' ' ' GLN . 17.3 m -110.93 151.12 13.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.008 0.432 . . . . 1.0900000000000001 111.675 -172.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.402 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 48.9 t -77.44 129.76 36.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.688 -0.687 . . . . 0.20999999999999999 109.828 177.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.478 HD11 ' N ' ' A' ' 7' ' ' ILE . 3.8 mp -79.3 -23.72 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 115.459 -0.792 . . . . 1.3300000000000001 110.066 -178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -91.46 -36.87 13.52 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.274 0.472 . . . . 2.2200000000000002 112.274 -171.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.419 ' SG ' ' HG2' ' A' ' 11' ' ' ARG . 15.7 p -124.53 -1.09 8.06 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 119.592 -0.843 . . . . 0.27000000000000002 112.627 -176.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 67.01 60.66 0.51 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.775 -0.648 . . . . 2.0800000000000001 112.1 173.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.419 ' HG2' ' SG ' ' A' ' 9' ' ' CYS . 37.1 mmt180 -121.56 151.35 40.45 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.462 -0.57 . . . . 4.3700000000000001 109.462 175.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.483 ' HG2' HG11 ' A' ' 5' ' ' VAL . 70.7 mt-30 -109.39 123.79 49.92 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.626 0.251 . . . . 1.8999999999999999 111.203 -174.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -128.17 156.73 42.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.273 0.559 . . . . 0.77000000000000002 110.981 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.68 -40.81 61.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.434 -0.803 . . . . 1.05 112.58 -176.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -109.31 137.05 20.14 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 115.804 -0.634 . . . . 1.9299999999999999 111.413 -166.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.452 ' HD3' ' CE1' ' A' ' 4' ' ' TYR . 32.1 Cg_endo -64.91 -30.85 57.43 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.509 2.139 . . . . 0.88 110.308 174.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.75 -37.08 89.29 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.269 -0.878 . . . . 0.38 111.907 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -76.15 -25.23 55.11 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 111.401 0.148 . . . . 1.0700000000000001 111.401 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.461 HD22 ' O ' ' A' ' 4' ' ' TYR . 2.7 mm? -75.43 -29.32 59.69 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 109.15 -0.685 . . . . 1.8500000000000001 109.15 177.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -70.34 -43.21 70.68 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.302 -0.863 . . . . 2.6600000000000001 109.823 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.626 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -64.68 -34.41 78.24 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.064 -1.425 . . . . 4.4299999999999997 108.71 174.268 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.552 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 29.0 t60 -67.93 -53.6 25.07 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 114.537 -1.21 . . . . 0.51000000000000001 111.419 -174.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 19' ' ' LEU . 98.1 t -64.4 -34.71 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 115.59 -0.732 . . . . 1.0900000000000001 110.175 -174.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.582 ' HB3' ' HB3' ' A' ' 30' ' ' LYS . 35.5 mtt180 -69.47 -20.15 63.75 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.239 -0.437 . . . . 3.3999999999999999 111.459 176.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.626 HG12 ' O ' ' A' ' 21' ' ' ARG . 27.6 mm -65.6 -49.1 79.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 109.586 -0.524 . . . . 1.9299999999999999 109.586 173.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -63.34 -51.2 66.93 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.797 -0.638 . . . . 0.34000000000000002 111.261 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.604 HG21 ' H ' ' A' ' 29' ' ' GLU . 12.2 t -79.49 -17.4 54.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.255 -0.43 . . . . 2.2400000000000002 111.743 -172.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.98 11.46 74.36 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.629 -0.796 . . . . 2.3599999999999999 112.887 177.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.604 ' H ' HG21 ' A' ' 27' ' ' THR . 47.5 mt-10 -86.4 11.85 11.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.869 0.366 . . . . 3.9199999999999999 111.545 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.582 ' HB3' ' HB3' ' A' ' 24' ' ' ARG . 19.2 pttp . . . . . 0 C--O 1.244 0.807 0 CA-C-O 118.307 -0.854 . . . . 7.4000000000000004 110.14 177.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 120.652 0.263 . . . . 7.5199999999999996 110.731 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 2' ' ' LYS . 39.0 pttt -114.76 82.54 8.25 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 121.276 0.56 . . . . 5.4299999999999997 110.062 172.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -69.54 177.18 5.68 Favored 'Trans proline' 0 CA--C 1.513 -0.569 0 C-N-CA 122.682 2.255 . . . . 1.54 112.957 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.635 ' O ' HD22 ' A' ' 19' ' ' LEU . 83.8 m-85 -113.41 118.15 33.74 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 113.989 -1.46 . . . . 1.47 108.577 177.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.627 ' HA ' ' HA ' ' A' ' 12' ' ' GLN . 19.3 m -101.04 150.85 5.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 121.236 0.541 . . . . 1.0900000000000001 111.364 -173.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.412 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 43.0 t -71.37 122.06 19.66 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.446 -0.797 . . . . 0.20999999999999999 110.534 176.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.442 HD11 ' N ' ' A' ' 7' ' ' ILE . 1.8 mp -66.76 -26.58 37.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.486 -0.779 . . . . 1.3300000000000001 110.959 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -88.9 -34.69 16.85 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.191 0.441 . . . . 2.2200000000000002 112.191 -171.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.6 p -129.98 2.24 4.81 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 119.672 -0.811 . . . . 0.27000000000000002 112.824 -175.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 65.16 46.12 2.81 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.165 0.586 . . . . 2.0800000000000001 112.52 172.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -114.57 127.23 55.68 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.623 -0.51 . . . . 4.3700000000000001 109.623 176.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.627 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 11.1 pt20 -88.28 135.2 33.57 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.223 0.535 . . . . 1.8999999999999999 111.882 -173.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -127.54 166.08 18.67 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.562 -0.745 . . . . 0.77000000000000002 110.481 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.56 -45.21 62.91 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.42 0.526 . . . . 1.05 112.42 -176.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -117.17 144.44 33.74 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.248 -0.433 . . . . 1.9299999999999999 111.656 -166.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.49 ' HD3' ' CE1' ' A' ' 4' ' ' TYR . 39.4 Cg_endo -67.72 -26.26 39.19 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.792 2.328 . . . . 0.88 110.909 176.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.52 -35.08 89.49 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.333 -0.849 . . . . 0.38 111.627 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.49 -25.94 62.48 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 121.067 -0.253 . . . . 1.0700000000000001 110.409 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.635 HD22 ' O ' ' A' ' 4' ' ' TYR . 3.1 mm? -70.38 -30.24 67.1 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.818 -0.808 . . . . 1.8500000000000001 108.818 177.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.52 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 83.0 mm-40 -70.02 -43.31 71.59 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.772 0.796 . . . . 2.6600000000000001 110.177 178.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.39 -33.17 75.32 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.359 -1.291 . . . . 4.4299999999999997 108.359 175.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.587 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 59.0 t60 -69.36 -45.38 69.53 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 114.532 -1.213 . . . . 0.51000000000000001 111.414 -176.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 19' ' ' LEU . 95.7 t -65.82 -32.53 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 C-N-CA 119.982 -0.687 . . . . 1.0900000000000001 109.822 -175.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 20' ' ' GLN . 14.9 mmm180 -67.11 -19.82 65.69 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.174 -0.466 . . . . 3.3999999999999999 111.597 174.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.587 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 72.2 mt -68.23 -47.8 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 109.862 -0.421 . . . . 1.9299999999999999 109.862 174.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -65.13 -42.18 94.13 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.247 0.546 . . . . 0.34000000000000002 109.586 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.3 m -83.18 49.47 1.55 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.436 -0.802 . . . . 2.2400000000000002 109.76 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.56 33.59 2.54 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.556 -0.747 . . . . 2.3599999999999999 112.624 -176.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.607 ' HG3' ' HG3' ' A' ' 30' ' ' LYS . 11.1 pt-20 -85.18 -21.5 29.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.17 0.509 . . . . 3.9199999999999999 109.719 176.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.607 ' HG3' ' HG3' ' A' ' 29' ' ' GLU . 28.0 mtpp . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.365 -0.826 . . . . 7.4000000000000004 109.469 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.2 mmm . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 120.959 0.409 . . . . 7.5199999999999996 111.346 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -85.72 116.14 64.46 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.196 -0.668 . . . . 5.4299999999999997 109.196 171.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.06 175.74 7.13 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.484 2.123 . . . . 1.54 111.439 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.507 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . 96.5 m-85 -90.91 102.37 15.14 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.331 -0.618 . . . . 1.47 109.331 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.485 HG12 ' HA ' ' A' ' 12' ' ' GLN . 32.7 m -95.17 148.05 5.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.661 -0.7 . . . . 1.0900000000000001 111.478 -175.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.527 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 45.0 t -65.61 125.08 24.1 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.253 -0.885 . . . . 0.20999999999999999 110.484 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.6 mm -68.75 -22.04 26.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.783 -0.644 . . . . 1.3300000000000001 111.05 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -91.6 -38.58 12.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.023 -0.535 . . . . 2.2200000000000002 111.713 -173.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.4 p -128.88 -0.36 5.34 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 119.793 -0.763 . . . . 0.27000000000000002 112.727 -171.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 65.53 43.65 3.29 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.816 0.673 . . . . 2.0800000000000001 112.816 175.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.421 ' H ' ' HB3' ' A' ' 6' ' ' CYS . 19.6 mmm180 -97.27 136.44 37.75 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.843 -0.428 . . . . 4.3700000000000001 109.843 175.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.485 ' HA ' HG12 ' A' ' 5' ' ' VAL . 88.6 mt-30 -88.98 124.31 34.13 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.134 0.271 . . . . 1.8999999999999999 111.573 -172.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -130.77 162.5 29.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.152 0.501 . . . . 0.77000000000000002 110.952 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.67 -32.53 23.57 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.55 -0.75 . . . . 1.05 112.192 -171.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -123.53 142.79 39.85 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.767 -0.651 . . . . 1.9299999999999999 111.63 -168.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.421 ' HD3' ' CE1' ' A' ' 4' ' ' TYR . 41.5 Cg_endo -67.57 -24.15 42.31 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.691 2.261 . . . . 0.88 111.02 174.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.636 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . -69.51 -32.1 71.27 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.559 -0.746 . . . . 0.38 111.44 174.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.36 -26.79 58.83 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 122.564 -0.374 . . . . 1.0700000000000001 110.813 178.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.588 ' O ' HG23 ' A' ' 23' ' ' VAL . 12.6 mt -70.49 -34.28 72.18 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 109.468 -0.567 . . . . 1.8500000000000001 109.468 178.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.636 ' HG3' ' O ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -78.03 -31.78 50.62 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 119.375 -0.93 . . . . 2.6600000000000001 110.171 -177.218 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -67.69 -37.74 82.71 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 113.928 -1.487 . . . . 4.4299999999999997 108.291 171.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.554 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 66.1 t60 -67.49 -44.69 77.91 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.354 -1.294 . . . . 0.51000000000000001 111.358 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 19' ' ' LEU . 93.8 t -68.08 -29.8 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 C-N-CA 120.147 -0.621 . . . . 1.0900000000000001 110.011 -175.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -61.32 -24.76 66.67 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.753 -0.658 . . . . 3.3999999999999999 111.035 171.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 75.7 mt -70.01 -47.66 67.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.399 -0.364 . . . . 1.9299999999999999 110.882 175.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -63.28 -35.5 80.55 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.661 -0.416 . . . . 0.34000000000000002 110.159 176.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.72 28.57 1.49 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.85 -0.614 . . . . 2.2400000000000002 109.85 177.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.82 68.72 2.5 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.481 -0.781 . . . . 2.3599999999999999 111.562 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -87.1 -22.08 25.62 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.538 0.685 . . . . 3.9199999999999999 109.609 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm . . . . . 0 C--O 1.251 1.179 0 CA-C-N 114.774 -1.103 . . . . 7.4000000000000004 109.39 175.223 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ptm . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 121.35 0.595 . . . . 7.5199999999999996 110.783 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.507 ' HZ2' ' HB2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER 179.71 118.84 0.21 Allowed Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.435 -0.802 . . . . 5.4299999999999997 109.39 178.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.485 ' HD2' ' HD3' ' A' ' 2' ' ' LYS . 72.9 Cg_endo -74.47 167.56 26.85 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.803 1.669 . . . . 1.54 111.607 176.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.52 ' O ' HD22 ' A' ' 19' ' ' LEU . 84.3 m-85 -129.25 123.38 31.78 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.454 -0.794 . . . . 1.47 109.558 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.504 HG13 ' HG2' ' A' ' 12' ' ' GLN . 27.1 m -106.87 147.31 12.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 115.675 -0.693 . . . . 1.0900000000000001 111.166 -175.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.3 t -66.55 132.06 47.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.35 -0.841 . . . . 0.20999999999999999 110.977 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.424 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.4 mp -71.83 -27.76 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-N 115.015 -0.993 . . . . 1.3300000000000001 110.101 -176.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -89.4 -50.07 6.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.911 -0.586 . . . . 2.2200000000000002 111.595 -172.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.1 p -114.58 -2.32 13.15 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.308 -0.557 . . . . 0.27000000000000002 112.138 -170.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 59.67 58.94 2.69 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.265 -0.879 . . . . 2.0800000000000001 112.702 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.6 ' HA ' ' NE ' ' A' ' 11' ' ' ARG . 5.2 mmp_? -112.38 141.51 46.03 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.477 -0.564 . . . . 4.3700000000000001 109.477 173.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.504 ' HG2' HG13 ' A' ' 5' ' ' VAL . 86.9 mt-30 -89.97 128.62 36.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.985 0.421 . . . . 1.8999999999999999 111.966 -173.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -128.69 -179.49 5.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.645 -0.707 . . . . 0.77000000000000002 109.782 172.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -105.99 -35.23 7.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.878 0.37 . . . . 1.05 111.991 -173.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.405 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 1.0 OUTLIER -115.58 147.36 38.69 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.298 -0.41 . . . . 1.9299999999999999 110.658 -173.531 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 15' ' ' ASP . 20.2 Cg_exo -65.28 -22.37 60.56 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.532 2.155 . . . . 0.88 109.277 170.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -53.45 -53.21 36.48 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.316 -1.311 . . . . 0.38 111.954 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -73.91 -21.99 59.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.833 -0.183 . . . . 1.0700000000000001 111.438 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.571 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.7 mm? -73.49 -32.08 64.09 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 109.675 -0.491 . . . . 1.8500000000000001 109.675 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -76.57 -39.31 53.06 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.764 0.792 . . . . 2.6600000000000001 110.201 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.529 ' HD3' ' HD2' ' A' ' 24' ' ' ARG . 8.6 tpp180 -64.9 -31.82 73.23 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.217 -1.356 . . . . 4.4299999999999997 108.418 174.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.628 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 35.6 t60 -68.4 -45.78 71.77 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.214 -1.357 . . . . 0.51000000000000001 111.783 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 19' ' ' LEU . 85.9 t -66.32 -38.38 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 C-N-CA 119.97 -0.692 . . . . 1.0900000000000001 110.351 -173.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.529 ' HD2' ' HD3' ' A' ' 21' ' ' ARG . 9.1 ptp180 -70.44 -10.93 60.43 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.056 0.455 . . . . 3.3999999999999999 110.75 177.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.628 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 45.9 mt -73.75 -42.23 54.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.477 -0.329 . . . . 1.9299999999999999 110.284 171.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -65.59 -33.52 76.09 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.338 -0.392 . . . . 0.34000000000000002 111.276 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.21 -41.77 60.86 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.431 -0.508 . . . . 2.2400000000000002 110.868 175.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.18 -22.76 2.94 Favored Glycine 0 CA--C 1.52 0.373 0 CA-C-N 116.018 -0.537 . . . . 2.3599999999999999 113.27 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -61.95 -46.04 91.06 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.003 0.43 . . . . 3.9199999999999999 111.615 -176.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.4 tptm . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.644 -0.693 . . . . 7.4000000000000004 110.046 -177.405 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 110.25 -0.278 . . . . 7.5199999999999996 110.25 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -77.77 123.27 86.47 Favored Pre-proline 0 C--N 1.331 -0.196 0 N-CA-C 109.917 -0.401 . . . . 5.4299999999999997 109.917 176.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.77 175.05 11.44 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.708 2.272 . . . . 1.54 112.432 -177.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -104.58 106.41 16.89 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.79 -0.818 . . . . 1.47 108.79 177.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.491 HG11 ' HG2' ' A' ' 12' ' ' GLN . 12.6 m -92.04 144.72 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.412 0.625 . . . . 1.0900000000000001 111.665 -173.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.454 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 44.8 t -56.43 132.15 50.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.142 -0.935 . . . . 0.20999999999999999 111.262 178.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.459 HD11 ' N ' ' A' ' 7' ' ' ILE . 3.5 mp -74.31 -25.94 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 115.1 -0.955 . . . . 1.3300000000000001 110.654 -176.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -93.34 -43.28 8.86 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.597 -0.441 . . . . 2.2200000000000002 112.076 -173.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.9 p -121.44 -0.69 9.75 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 119.761 -0.776 . . . . 0.27000000000000002 112.326 -173.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 60.38 81.4 0.18 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.66 -0.7 . . . . 2.0800000000000001 112.057 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 28.9 ttm180 -138.17 136.86 37.06 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 108.969 -0.752 . . . . 4.3700000000000001 108.969 177.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.491 ' HG2' HG11 ' A' ' 5' ' ' VAL . 86.0 mt-30 -81.82 125.79 31.09 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.838 0.352 . . . . 1.8999999999999999 111.865 -172.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -128.66 149.7 50.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.909 -0.587 . . . . 0.77000000000000002 110.59 175.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.12 -33.45 67.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.429 -0.805 . . . . 1.05 112.638 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -121.83 142.39 36.04 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 115.867 -0.606 . . . . 1.9299999999999999 110.983 -168.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -66.11 -28.38 48.83 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.612 2.208 . . . . 0.88 110.304 173.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.583 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . -68.76 -22.5 75.47 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.3 -0.864 . . . . 0.38 111.735 174.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -80.57 -26.63 37.82 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 122.561 -0.376 . . . . 1.0700000000000001 110.3 175.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.689 ' O ' HG22 ' A' ' 23' ' ' VAL . 12.0 mt -71.97 -35.76 69.63 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 109.205 -0.665 . . . . 1.8500000000000001 109.205 177.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.583 ' HG3' ' O ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -73.55 -36.27 65.62 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 119.553 -0.859 . . . . 2.6600000000000001 109.974 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -59.88 -41.78 92.31 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.336 -1.302 . . . . 4.4299999999999997 108.668 171.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.595 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 39.3 t60 -66.5 -36.56 83.01 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 113.346 -1.752 . . . . 0.51000000000000001 112.064 -176.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.689 HG22 ' O ' ' A' ' 19' ' ' LEU . 49.0 t -72.83 -27.82 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 C-N-CA 119.093 -1.043 . . . . 1.0900000000000001 109.695 -175.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 20' ' ' GLN . 13.6 mmt180 -59.35 -36.09 75.07 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.109 -0.7 . . . . 3.3999999999999999 109.109 171.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.595 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 19.0 mm -61.29 -43.76 97.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 114.841 -1.072 . . . . 1.9299999999999999 111.627 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -74.75 -51.83 13.15 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.494 0.553 . . . . 0.34000000000000002 112.494 -175.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.415 HG23 ' H ' ' A' ' 29' ' ' GLU . 14.9 t -127.5 -32.49 2.41 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.187 -0.605 . . . . 2.2400000000000002 111.738 -173.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 24' ' ' ARG . . . 82.25 -13.75 37.71 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.746 -0.74 . . . . 2.3599999999999999 112.885 176.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.415 ' H ' HG23 ' A' ' 27' ' ' THR . 36.4 mt-10 -63.55 -46.15 87.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.243 0.544 . . . . 3.9199999999999999 110.203 178.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.4 mttm . . . . . 0 C--O 1.245 0.845 0 CA-C-O 118.068 -0.968 . . . . 7.4000000000000004 110.011 -176.909 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 121.068 0.461 . . . . 7.5199999999999996 110.478 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.59 ' HD3' ' HD2' ' A' ' 3' ' ' PRO . 16.9 tppt? -142.23 121.94 8.03 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.953 -0.567 . . . . 5.4299999999999997 109.969 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.59 ' HD2' ' HD3' ' A' ' 2' ' ' LYS . 96.6 Cg_endo -78.15 174.42 12.49 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.316 2.011 . . . . 1.54 111.648 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.514 ' O ' HD23 ' A' ' 19' ' ' LEU . 61.2 m-85 -106.49 111.32 23.84 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.849 -0.797 . . . . 1.47 108.849 -178.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.448 HG13 ' HG2' ' A' ' 12' ' ' GLN . 33.3 m -101.99 148.45 7.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.225 0.536 . . . . 1.0900000000000001 111.36 -173.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.531 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 35.7 t -70.91 124.58 24.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.598 -0.728 . . . . 0.20999999999999999 110.183 177.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.413 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.7 mp -70.2 -24.09 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 115.401 -0.818 . . . . 1.3300000000000001 110.462 -176.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -91.76 -41.6 10.59 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.693 -0.403 . . . . 2.2200000000000002 111.788 -172.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.6 p -121.55 1.42 10.07 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 119.988 -0.685 . . . . 0.27000000000000002 112.575 -172.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 66.03 48.06 1.83 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.929 0.714 . . . . 2.0800000000000001 112.929 170.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -117.4 144.31 45.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.652 -0.249 . . . . 4.3700000000000001 110.437 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.448 ' HG2' HG13 ' A' ' 5' ' ' VAL . 68.8 mt-30 -91.72 128.22 37.47 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.253 0.346 . . . . 1.8999999999999999 111.628 -172.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -124.72 164.37 20.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.129 0.49 . . . . 0.77000000000000002 110.525 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.65 -37.37 15.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.491 -0.777 . . . . 1.05 112.219 -172.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -117.94 139.86 27.06 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.976 -0.556 . . . . 1.9299999999999999 110.949 -167.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.553 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 38.0 Cg_exo -59.83 -34.74 95.54 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.822 2.348 . . . . 0.88 110.946 174.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.97 -35.69 91.77 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.365 -0.834 . . . . 0.38 112.032 176.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.85 -31.86 71.13 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 121.19 -0.204 . . . . 1.0700000000000001 110.847 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.522 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.8 mm? -68.86 -29.36 67.65 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 108.942 -0.762 . . . . 1.8500000000000001 108.942 178.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.553 ' HG2' ' O ' ' A' ' 16' ' ' PRO . 10.3 mm-40 -74.81 -41.15 60.49 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-O 121.65 0.738 . . . . 2.6600000000000001 109.899 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -67.77 -32.42 72.99 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.423 -1.262 . . . . 4.4299999999999997 109.111 176.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.531 ' HD2' ' SG ' ' A' ' 6' ' ' CYS . 60.4 t60 -72.35 -45.26 60.65 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 114.88 -1.054 . . . . 0.51000000000000001 111.32 -175.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 19' ' ' LEU . 84.4 t -67.16 -32.34 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 C-N-CA 119.945 -0.702 . . . . 1.0900000000000001 109.967 -175.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.536 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 17.6 mtp180 -63.09 -28.78 70.31 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.969 -0.56 . . . . 3.3999999999999999 110.986 174.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 26.8 mm -64.69 -45.41 95.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-O 120.827 0.346 . . . . 1.9299999999999999 110.723 175.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -66.23 -27.82 68.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.068 0.461 . . . . 0.34000000000000002 110.677 177.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.1 m -93.5 25.63 3.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.545 0.688 . . . . 2.2400000000000002 110.306 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.85 64.71 3.0 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 111.279 -0.728 . . . . 2.3599999999999999 111.279 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -74.21 -8.94 57.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.023 0.44 . . . . 3.9199999999999999 110.879 -177.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.561 -0.733 . . . . 7.4000000000000004 109.059 175.15 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 120.65 0.262 . . . . 7.5199999999999996 110.358 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.635 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . 28.0 tptp -156.83 -53.2 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.943 -0.572 . . . . 5.4299999999999997 109.821 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.635 ' HD3' ' HB3' ' A' ' 2' ' ' LYS . 97.3 Cg_endo -84.7 -173.75 1.58 Allowed 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 122.124 1.883 . . . . 1.54 111.346 171.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.47 ' O ' HD23 ' A' ' 19' ' ' LEU . 73.3 m-85 -76.99 122.49 24.97 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.435 -0.58 . . . . 1.47 109.435 178.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.476 HG12 ' HG2' ' A' ' 12' ' ' GLN . 16.8 m -112.26 147.82 15.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.386 -0.37 . . . . 1.0900000000000001 110.938 -174.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.442 ' HB3' ' H ' ' A' ' 11' ' ' ARG . 53.5 t -68.51 127.37 32.77 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.953 -0.567 . . . . 0.20999999999999999 110.449 177.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.495 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.1 mp -73.14 -26.98 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 115.103 -0.953 . . . . 1.3300000000000001 109.93 -177.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -86.48 -45.03 11.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.664 -0.698 . . . . 2.2200000000000002 111.974 -172.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.7 p -121.83 0.45 9.77 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 119.88 -0.728 . . . . 0.27000000000000002 112.778 -173.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 66.86 52.99 0.89 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.677 0.621 . . . . 2.0800000000000001 112.677 172.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.65 ' HE ' ' HA ' ' A' ' 11' ' ' ARG . 1.3 mmp_? -115.99 134.71 54.68 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.313 -0.625 . . . . 4.3700000000000001 109.313 177.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.57 ' HB3' ' HG2' ' A' ' 3' ' ' PRO . 23.7 mt-30 -92.65 131.74 37.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.456 0.17 . . . . 1.8999999999999999 111.245 -173.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.486 ' O ' ' HB2' ' A' ' 3' ' ' PRO . 56.1 m-85 -135.07 148.38 49.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.731 0.776 . . . . 0.77000000000000002 110.918 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.83 -36.12 82.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.469 -1.241 . . . . 1.05 113.384 -171.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -129.04 142.87 46.65 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.921 0.391 . . . . 1.9299999999999999 110.966 -169.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.508 ' O ' ' HG3' ' A' ' 20' ' ' GLN . 32.5 Cg_endo -64.86 -24.6 60.95 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.859 2.373 . . . . 0.88 111.311 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.97 -42.13 98.18 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.89 -0.672 . . . . 0.38 111.438 173.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -70.86 -22.38 62.31 Favored 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 122.946 -0.149 . . . . 1.0700000000000001 110.845 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.544 ' O ' HG23 ' A' ' 23' ' ' VAL . 3.4 mm? -75.65 -26.4 57.67 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.185 -0.672 . . . . 1.8500000000000001 109.185 175.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.508 ' HG3' ' O ' ' A' ' 16' ' ' PRO . 72.4 mt-30 -74.12 -42.82 59.44 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.909 0.862 . . . . 2.6600000000000001 109.356 176.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.578 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -61.19 -35.93 78.49 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.945 -1.48 . . . . 4.4299999999999997 109.19 172.716 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.532 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 10.0 t60 -67.08 -48.78 67.17 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.616 -1.175 . . . . 0.51000000000000001 111.584 -175.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 19' ' ' LEU . 93.4 t -67.28 -35.89 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 C-N-CA 119.98 -0.688 . . . . 1.0900000000000001 110.805 -172.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.7 -9.93 59.01 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.874 -0.331 . . . . 3.3999999999999999 111.0 176.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 21' ' ' ARG . 19.5 mm -75.59 -42.93 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 109.683 -0.488 . . . . 1.9299999999999999 109.683 172.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -70.24 -51.62 29.32 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.01 0.433 . . . . 0.34000000000000002 110.428 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.519 ' O ' HG21 ' A' ' 27' ' ' THR . 7.6 t -92.19 52.77 2.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.889 0.852 . . . . 2.2400000000000002 109.494 -178.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.99 53.99 0.39 Allowed Glycine 0 C--N 1.335 0.474 0 CA-C-N 115.158 -0.928 . . . . 2.3599999999999999 113.471 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -74.78 -31.66 61.81 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 121.667 0.746 . . . . 3.9199999999999999 109.521 176.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.6 tptm . . . . . 0 C--O 1.248 1.014 0 CA-C-N 114.86 -1.064 . . . . 7.4000000000000004 109.089 177.753 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 mmt . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 120.862 0.363 . . . . 7.5199999999999996 110.487 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.565 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . 60.5 tttp -68.87 -56.33 9.45 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.043 -0.526 . . . . 5.4299999999999997 110.745 175.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.565 ' HD3' ' HB3' ' A' ' 2' ' ' LYS . 87.2 Cg_endo -79.96 177.5 8.26 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.76 1.64 . . . . 1.54 112.097 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.548 ' O ' HD21 ' A' ' 19' ' ' LEU . 48.2 m-85 -99.85 124.4 45.1 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.539 -0.755 . . . . 1.47 109.018 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.524 HG13 ' HG2' ' A' ' 12' ' ' GLN . 17.8 m -103.43 146.66 10.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.265 0.555 . . . . 1.0900000000000001 111.893 -172.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.551 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 35.2 t -74.01 130.27 39.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.42 -0.809 . . . . 0.20999999999999999 110.337 178.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.447 HD11 ' N ' ' A' ' 7' ' ' ILE . 3.8 mp -79.07 -22.17 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 CA-C-N 115.609 -0.723 . . . . 1.3300000000000001 109.865 -177.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -89.95 -46.52 8.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.834 -0.621 . . . . 2.2200000000000002 111.678 -172.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 18.7 p -114.07 -4.86 13.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.028 -0.669 . . . . 0.27000000000000002 112.258 -173.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 67.38 57.87 0.56 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.693 -0.685 . . . . 2.0800000000000001 112.153 175.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -128.88 141.78 51.17 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.241 -0.436 . . . . 4.3700000000000001 110.084 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.524 ' HG2' HG13 ' A' ' 5' ' ' VAL . 66.8 mt-30 -92.74 125.27 37.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.507 -0.315 . . . . 1.8999999999999999 111.501 -173.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.41 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 96.0 m-85 -126.37 141.52 51.87 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.873 0.844 . . . . 0.77000000000000002 111.515 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.19 -36.38 77.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.258 -1.337 . . . . 1.05 113.736 -172.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.453 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 23.4 m-20 -115.37 141.71 27.62 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 116.098 -0.501 . . . . 1.9299999999999999 111.482 -164.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.489 ' HG3' ' CE1' ' A' ' 4' ' ' TYR . 12.6 Cg_exo -67.45 -32.24 32.44 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.747 2.298 . . . . 0.88 110.322 174.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.19 -36.93 92.49 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.134 -0.939 . . . . 0.38 111.736 176.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.556 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -69.44 -28.17 65.89 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.984 -0.108 . . . . 1.0700000000000001 110.937 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.548 HD21 ' O ' ' A' ' 4' ' ' TYR . 2.6 mm? -71.41 -31.35 67.15 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.125 -0.694 . . . . 1.8500000000000001 109.125 177.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.612 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 79.8 mt-30 -68.97 -44.32 73.18 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 119.951 -0.7 . . . . 2.6600000000000001 109.985 177.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.703 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.3 OUTLIER -61.16 -40.38 93.65 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.257 -1.338 . . . . 4.4299999999999997 108.553 174.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.609 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 39.4 t60 -65.64 -49.65 67.87 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 113.607 -1.633 . . . . 0.51000000000000001 111.927 -171.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.522 HG21 ' O ' ' A' ' 19' ' ' LEU . 59.3 t -66.58 -34.63 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 C-N-CA 119.843 -0.743 . . . . 1.0900000000000001 109.868 -175.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.612 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 78.4 mtt-85 -66.32 -27.04 67.59 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.629 -0.714 . . . . 3.3999999999999999 110.558 175.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.703 HG12 ' O ' ' A' ' 21' ' ' ARG . 24.6 mm -62.11 -50.39 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.063 -0.517 . . . . 1.9299999999999999 110.548 175.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 -62.96 -42.91 99.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.177 -0.465 . . . . 0.34000000000000002 111.212 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.606 HG23 ' HA ' ' A' ' 24' ' ' ARG . 12.0 t -80.69 -0.38 38.0 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.081 -0.509 . . . . 2.2400000000000002 111.552 -173.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.02 14.07 67.65 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.103 -0.57 . . . . 2.3599999999999999 112.479 176.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.495 ' HB3' HG22 ' A' ' 27' ' ' THR . 15.1 tt0 -80.95 -35.07 32.73 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.829 0.347 . . . . 3.9199999999999999 110.528 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.3 tptt . . . . . 0 C--O 1.243 0.742 0 CA-C-O 118.339 -0.839 . . . . 7.4000000000000004 109.876 179.406 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 ttt . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 120.927 0.394 . . . . 7.5199999999999996 110.639 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -107.32 99.24 26.67 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.343 -0.614 . . . . 5.4299999999999997 109.343 174.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.72 173.11 15.0 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.249 1.966 . . . . 1.54 111.85 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.479 ' HB3' ' HG ' ' A' ' 19' ' ' LEU . 9.9 m-85 -108.34 120.79 43.39 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.435 -0.802 . . . . 1.47 109.756 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.489 HG11 ' HG2' ' A' ' 12' ' ' GLN . 23.3 m -108.72 144.31 17.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 116.35 -0.386 . . . . 1.0900000000000001 110.62 -175.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.44 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 33.8 t -68.34 125.29 25.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.076 -0.511 . . . . 0.20999999999999999 109.947 177.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.8 mp -74.3 -23.08 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 115.696 -0.683 . . . . 1.3300000000000001 110.029 -175.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -95.47 -44.85 7.34 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.339 -0.544 . . . . 2.2200000000000002 111.971 -171.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.0 p -112.38 -3.05 14.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.821 -0.752 . . . . 0.27000000000000002 111.469 -175.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 63.45 64.98 0.78 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.896 -1.047 . . . . 2.0800000000000001 112.824 174.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -129.73 134.54 47.67 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.926 -0.579 . . . . 4.3700000000000001 110.234 175.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.489 ' HG2' HG11 ' A' ' 5' ' ' VAL . 15.1 mt-30 -83.18 134.16 34.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.257 -0.429 . . . . 1.8999999999999999 111.431 -176.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.418 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 98.5 m-85 -131.58 169.16 16.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.77000000000000002 110.126 173.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.2 -51.64 8.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.232 0.539 . . . . 1.05 112.139 -174.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -105.53 142.25 24.35 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.291 -0.868 . . . . 1.9299999999999999 111.859 -165.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 4' ' ' TYR . 24.7 Cg_endo -63.26 -27.53 72.14 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.89 2.393 . . . . 0.88 110.753 171.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.489 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -69.27 -24.18 76.08 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.459 -0.791 . . . . 0.38 111.753 176.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -84.27 -28.1 27.41 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 122.587 -0.361 . . . . 1.0700000000000001 110.854 178.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.546 ' O ' HG21 ' A' ' 23' ' ' VAL . 2.4 mm? -74.26 -29.83 61.85 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 109.509 -0.552 . . . . 1.8500000000000001 109.509 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 13.1 pt20 -75.89 -35.55 59.81 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.41 -0.916 . . . . 2.6600000000000001 109.752 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -64.28 -39.8 94.67 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.18 -1.373 . . . . 4.4299999999999997 108.764 170.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.501 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 48.1 t60 -67.06 -49.35 65.4 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.092 -1.413 . . . . 0.51000000000000001 111.952 -174.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.546 HG21 ' O ' ' A' ' 19' ' ' LEU . 63.3 t -66.58 -31.86 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 C-N-CA 120.029 -0.668 . . . . 1.0900000000000001 109.755 -175.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -69.51 -7.38 37.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.503 -0.771 . . . . 3.3999999999999999 111.465 174.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 81.0 mt -83.86 -47.48 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 109.616 -0.512 . . . . 1.9299999999999999 109.616 171.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -68.75 -51.64 39.02 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.267 0.556 . . . . 0.34000000000000002 110.661 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.6 m -105.54 34.95 3.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.861 0.838 . . . . 2.2400000000000002 110.392 -176.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.1 10.49 65.79 Favored Glycine 0 CA--C 1.507 -0.421 0 CA-C-N 115.554 -0.748 . . . . 2.3599999999999999 111.579 176.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -62.62 -38.81 91.66 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.303 0.573 . . . . 3.9199999999999999 110.518 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt . . . . . 0 C--O 1.245 0.862 0 CA-C-O 118.333 -0.841 . . . . 7.4000000000000004 109.793 -178.371 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 mtt . . . . . 0 N--CA 1.478 0.97 0 CA-C-O 120.991 0.424 . . . . 7.5199999999999996 111.075 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -143.55 95.62 5.85 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-O 121.166 0.508 . . . . 5.4299999999999997 110.107 172.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.87 176.17 10.23 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.304 2.003 . . . . 1.54 111.163 176.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.592 ' O ' HD21 ' A' ' 19' ' ' LEU . 54.5 m-85 -101.32 116.01 31.82 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.838 -0.801 . . . . 1.47 108.838 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.562 HG12 ' HG3' ' A' ' 12' ' ' GLN . 16.5 m -105.56 149.5 8.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.322 0.582 . . . . 1.0900000000000001 112.053 -168.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.646 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 4.0 t -76.27 124.05 26.87 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.352 -0.84 . . . . 0.20999999999999999 109.685 176.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.406 HD11 ' N ' ' A' ' 7' ' ' ILE . 3.9 mp -74.55 -19.25 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-N 115.891 -0.595 . . . . 1.3300000000000001 110.101 -175.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -98.65 -35.85 10.06 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.239 -0.584 . . . . 2.2200000000000002 112.327 -172.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.428 ' SG ' ' HG2' ' A' ' 11' ' ' ARG . 15.2 p -118.48 -0.13 11.48 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 119.864 -0.734 . . . . 0.27000000000000002 112.133 -175.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 62.85 53.02 2.54 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.521 -0.763 . . . . 2.0800000000000001 112.365 174.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.428 ' HG2' ' SG ' ' A' ' 9' ' ' CYS . 24.1 mmt180 -123.58 149.67 45.03 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.932 -0.395 . . . . 4.3700000000000001 109.932 178.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.562 ' HG3' HG12 ' A' ' 5' ' ' VAL . 2.1 mp0 -94.11 136.0 34.87 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.585 -0.279 . . . . 1.8999999999999999 111.104 -176.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.549 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 92.0 m-85 -131.8 158.58 40.89 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.266 0.555 . . . . 0.77000000000000002 110.663 176.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.53 -36.46 26.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.36 -0.836 . . . . 1.05 112.909 -171.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -124.01 138.92 31.47 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-O 120.827 0.346 . . . . 1.9299999999999999 111.128 -168.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.421 ' HG3' ' CE1' ' A' ' 4' ' ' TYR . 27.0 Cg_exo -62.45 -29.73 79.31 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.125 2.55 . . . . 0.88 111.278 176.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.54 -36.33 93.05 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.747 -0.66 . . . . 0.38 111.566 175.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.99 -31.84 64.78 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.608 -0.296 . . . . 1.0700000000000001 111.015 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.592 HD21 ' O ' ' A' ' 4' ' ' TYR . 2.7 mm? -66.29 -34.67 78.52 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 109.292 -0.632 . . . . 1.8500000000000001 109.292 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -73.78 -38.31 64.71 Favored 'General case' 0 N--CA 1.432 -1.325 0 C-N-CA 119.125 -1.03 . . . . 2.6600000000000001 110.556 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.564 ' O ' HG12 ' A' ' 25' ' ' ILE . 7.1 tpt180 -65.42 -37.09 85.89 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.713 -1.131 . . . . 4.4299999999999997 108.641 175.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.646 ' HD2' ' SG ' ' A' ' 6' ' ' CYS . 63.3 t60 -73.66 -48.13 34.69 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.041 -1.436 . . . . 0.51000000000000001 111.559 -174.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.508 HG21 ' O ' ' A' ' 19' ' ' LEU . 72.8 t -64.63 -31.62 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 CA-C-N 116.014 -0.539 . . . . 1.0900000000000001 110.557 -173.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -76.56 -14.31 60.02 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 120.382 -0.527 . . . . 3.3999999999999999 110.685 177.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 21' ' ' ARG . 18.7 mm -69.37 -45.56 78.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 109.747 -0.464 . . . . 1.9299999999999999 109.747 173.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -65.83 -48.76 70.56 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.293 0.568 . . . . 0.34000000000000002 109.52 172.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.3 m -84.28 49.85 1.75 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.197 -0.91 . . . . 2.2400000000000002 110.377 -177.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -77.36 71.18 2.31 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.153 -0.779 . . . . 2.3599999999999999 111.153 177.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -84.52 -38.63 19.81 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.106 0.479 . . . . 3.9199999999999999 110.865 -177.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.3 mttp . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.6 -0.714 . . . . 7.4000000000000004 109.857 -178.491 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 120.783 0.325 . . . . 7.5199999999999996 110.919 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.462 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . 53.8 tptt -79.42 -51.65 1.21 Allowed Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.634 -0.257 . . . . 5.4299999999999997 110.419 175.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.462 ' HD3' ' HB3' ' A' ' 2' ' ' LYS . 89.0 Cg_endo -78.37 176.22 10.18 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 121.867 1.711 . . . . 1.54 111.338 172.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.428 ' O ' HD21 ' A' ' 19' ' ' LEU . 97.8 m-85 -94.86 114.2 26.03 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.942 0.401 . . . . 1.47 110.035 -178.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.504 HG12 ' HA ' ' A' ' 12' ' ' GLN . 33.6 m -101.81 146.64 9.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.898 -0.592 . . . . 1.0900000000000001 110.821 -177.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.489 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 42.2 t -63.92 126.86 29.03 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.876 -0.602 . . . . 0.20999999999999999 110.234 178.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.412 HD13 ' N ' ' A' ' 7' ' ' ILE . 3.2 mp -67.33 -27.35 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 115.014 -0.993 . . . . 1.3300000000000001 110.515 -174.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -96.76 -45.86 6.5 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.25 -0.58 . . . . 2.2200000000000002 112.162 -171.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.4 p -111.43 -2.0 15.73 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 119.618 -0.833 . . . . 0.27000000000000002 111.916 -172.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 61.36 55.59 2.85 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.102 -0.953 . . . . 2.0800000000000001 112.967 174.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -109.29 141.11 42.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.531 -0.544 . . . . 4.3700000000000001 109.531 172.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.504 ' HA ' HG12 ' A' ' 5' ' ' VAL . 25.5 mt-30 -85.54 129.82 34.73 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.701 0.286 . . . . 1.8999999999999999 111.31 -177.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.471 ' HE2' ' HB2' ' A' ' 6' ' ' CYS . 93.2 m-85 -129.16 155.18 45.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.443 0.639 . . . . 0.77000000000000002 110.762 178.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.02 -28.77 29.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.02 -0.991 . . . . 1.05 111.351 -175.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -120.76 135.46 24.73 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.28 -0.873 . . . . 1.9299999999999999 110.981 -166.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.37 -25.45 35.93 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.241 1.961 . . . . 0.88 110.27 172.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.487 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -67.95 -27.95 73.54 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.961 -1.018 . . . . 0.38 111.478 173.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -78.4 -25.91 46.27 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 120.943 -0.303 . . . . 1.0700000000000001 110.667 178.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.629 ' O ' HG22 ' A' ' 23' ' ' VAL . 2.7 mm? -69.62 -35.25 75.1 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 109.663 -0.495 . . . . 1.8500000000000001 109.663 178.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 12.0 pt20 -76.18 -36.02 58.87 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 119.415 -0.914 . . . . 2.6600000000000001 110.105 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.422 ' O ' HG13 ' A' ' 25' ' ' ILE . 7.2 tpm_? -61.08 -40.21 92.84 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.857 -1.519 . . . . 4.4299999999999997 108.191 172.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.61 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 37.8 t60 -70.33 -44.46 68.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.723 -1.58 . . . . 0.51000000000000001 112.183 -174.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.629 HG22 ' O ' ' A' ' 19' ' ' LEU . 61.4 t -66.15 -35.77 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 C-N-CA 119.682 -0.807 . . . . 1.0900000000000001 110.101 -174.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.563 ' HA ' HG22 ' A' ' 27' ' ' THR . 27.2 mmt180 -62.2 -25.52 67.83 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.127 -0.488 . . . . 3.3999999999999999 111.126 173.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.61 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 79.9 mt -67.96 -44.07 85.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 1.9299999999999999 110.791 176.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -68.36 -42.72 78.79 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.565 0.221 . . . . 0.34000000000000002 111.359 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.563 HG22 ' HA ' ' A' ' 24' ' ' ARG . 9.0 t -71.49 -28.41 63.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.903 0.382 . . . . 2.2400000000000002 110.504 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.2 -13.36 61.86 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.811 -0.709 . . . . 2.3599999999999999 112.876 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.417 ' H ' HG21 ' A' ' 27' ' ' THR . 42.0 mt-10 -53.22 -47.11 69.25 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.001 0.429 . . . . 3.9199999999999999 111.46 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.351 -0.833 . . . . 7.4000000000000004 109.492 177.389 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 ptp . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 120.528 0.204 . . . . 7.5199999999999996 110.668 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.421 ' HB2' ' CD ' ' A' ' 3' ' ' PRO . 98.1 mttt -82.99 -53.82 0.58 Allowed Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.809 -0.441 . . . . 5.4299999999999997 109.809 175.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.421 ' CD ' ' HB2' ' A' ' 2' ' ' LYS . 83.4 Cg_endo -81.19 174.52 10.67 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.646 1.564 . . . . 1.54 110.132 163.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.401 ' O ' HD23 ' A' ' 19' ' ' LEU . 92.0 m-85 -109.72 119.72 40.27 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.967 0.413 . . . . 1.47 110.229 -177.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.444 HG13 ' HG2' ' A' ' 12' ' ' GLN . 31.7 m -104.13 145.2 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 116.003 -0.544 . . . . 1.0900000000000001 110.811 -177.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.559 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 47.2 t -63.85 120.97 12.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.83 -0.623 . . . . 0.20999999999999999 110.158 178.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.443 HD13 ' N ' ' A' ' 7' ' ' ILE . 3.3 mp -71.55 -24.53 23.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.48 0.657 . . . . 1.3300000000000001 110.061 -178.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -85.27 -41.66 15.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.712 -0.676 . . . . 2.2200000000000002 111.764 -172.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.5 p -124.9 -5.13 7.47 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 119.771 -0.772 . . . . 0.27000000000000002 112.344 -174.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 67.99 79.4 0.22 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.008 0.523 . . . . 2.0800000000000001 112.258 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.491 ' HD2' ' CZ ' ' A' ' 13' ' ' PHE . 22.9 ttm180 -142.53 144.44 32.94 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.959 -0.756 . . . . 4.3700000000000001 108.959 174.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.444 ' HG2' HG13 ' A' ' 5' ' ' VAL . 27.2 mt-30 -88.76 129.93 35.45 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.38 0.511 . . . . 1.8999999999999999 112.38 -173.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.491 ' CZ ' ' HD2' ' A' ' 11' ' ' ARG . 96.4 m-85 -129.12 167.05 18.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.9 -0.591 . . . . 0.77000000000000002 110.705 176.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.03 -2.45 37.19 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.153 0.797 . . . . 1.05 113.153 -170.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -155.51 150.33 20.5 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 120.816 -0.354 . . . . 1.9299999999999999 110.109 -176.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.44 -22.61 65.57 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.855 2.37 . . . . 0.88 109.531 169.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.536 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -57.22 -48.36 80.69 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 114.382 -1.281 . . . . 0.38 111.89 172.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -72.73 -25.41 61.21 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 121.07 -0.252 . . . . 1.0700000000000001 110.781 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.521 ' O ' HG22 ' A' ' 23' ' ' VAL . 2.5 mm? -72.1 -36.22 69.41 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.094 -0.706 . . . . 1.8500000000000001 109.094 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 17.0 pt20 -77.81 -33.84 52.29 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 119.729 -0.788 . . . . 2.6600000000000001 109.94 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.446 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.5 OUTLIER -65.44 -36.2 83.22 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.648 -1.16 . . . . 4.4299999999999997 108.741 173.29 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.559 ' HD2' ' SG ' ' A' ' 6' ' ' CYS . 47.1 t60 -73.42 -46.1 50.58 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 114.7 -1.136 . . . . 0.51000000000000001 111.683 -174.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 19' ' ' LEU . 97.5 t -66.07 -34.38 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 C-N-CA 119.866 -0.734 . . . . 1.0900000000000001 110.019 -175.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 16.8 mtp180 -62.73 -26.81 68.88 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.109 -0.496 . . . . 3.3999999999999999 111.077 173.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.555 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 18.3 mm -69.22 -44.32 80.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.427 -0.351 . . . . 1.9299999999999999 110.63 176.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -65.81 -30.79 71.47 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.217 0.532 . . . . 0.34000000000000002 110.626 176.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.5 m -93.14 34.72 1.1 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.426 0.632 . . . . 2.2400000000000002 110.194 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.2 58.86 4.99 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.941 -0.647 . . . . 2.3599999999999999 111.63 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -88.87 -18.86 26.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.86 0.362 . . . . 3.9199999999999999 110.961 -176.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.0 mttm . . . . . 0 C--O 1.247 0.953 0 CA-C-O 118.353 -0.832 . . . . 7.4000000000000004 109.925 178.104 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 109.497 -0.557 . . . . 7.5199999999999996 109.497 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt 55.8 71.43 1.23 Allowed Pre-proline 0 C--O 1.234 0.266 0 O-C-N 123.57 0.544 . . . . 5.4299999999999997 110.492 -174.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -77.69 173.14 14.59 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.332 2.022 . . . . 1.54 112.309 -177.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.488 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . 88.1 m-85 -113.47 99.9 8.11 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.338 -0.846 . . . . 1.47 108.721 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.529 HG13 ' HG2' ' A' ' 12' ' ' GLN . 11.3 m -89.91 142.66 12.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.403 0.621 . . . . 1.0900000000000001 111.959 -171.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.568 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 21.6 t -65.64 119.38 11.03 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.276 -0.874 . . . . 0.20999999999999999 110.132 175.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.415 HD11 ' N ' ' A' ' 7' ' ' ILE . 3.5 mp -71.92 -21.66 21.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.44 0.638 . . . . 1.3300000000000001 110.032 -178.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.456 ' HB3' ' CD2' ' A' ' 26' ' ' HIS . 6.4 t60 -86.72 -36.88 18.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.833 -0.621 . . . . 2.2200000000000002 111.607 -171.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.7 p -126.67 -5.31 6.4 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 120.016 -0.674 . . . . 0.27000000000000002 111.844 -176.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 67.73 56.42 0.57 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.284 -0.871 . . . . 2.0800000000000001 112.442 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 63.1 mtt85 -130.85 138.63 49.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.864 -0.607 . . . . 4.3700000000000001 109.705 175.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.529 ' HG2' HG13 ' A' ' 5' ' ' VAL . 36.1 mt-30 -87.8 138.58 31.34 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.562 0.579 . . . . 1.8999999999999999 112.562 -167.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -124.65 169.33 12.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.381 -0.827 . . . . 0.77000000000000002 110.35 173.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.61 -36.19 13.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.238 -0.437 . . . . 1.05 112.125 -173.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.439 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.7 OUTLIER -113.58 151.58 44.66 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-O 120.977 0.417 . . . . 1.9299999999999999 110.369 -174.685 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.442 ' HG3' ' CE2' ' A' ' 4' ' ' TYR . 12.2 Cg_exo -71.61 -23.53 23.0 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.159 2.573 . . . . 0.88 108.465 170.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.07 -41.87 98.21 Favored Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 113.889 -1.505 . . . . 0.38 111.553 172.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -77.49 -25.52 50.45 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 121.158 -0.217 . . . . 1.0700000000000001 111.417 -177.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.54 ' O ' HG21 ' A' ' 23' ' ' VAL . 8.0 mt -71.29 -38.47 71.78 Favored 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 120.014 -0.674 . . . . 1.8500000000000001 109.208 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.443 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 21.4 mt-30 -76.69 -31.96 57.59 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 119.294 -0.962 . . . . 2.6600000000000001 110.701 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.07 -38.17 89.9 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.998 -1.001 . . . . 4.4299999999999997 108.489 171.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.608 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 71.3 t60 -73.56 -45.72 51.72 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 114.427 -1.261 . . . . 0.51000000000000001 112.01 -174.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.54 HG21 ' O ' ' A' ' 19' ' ' LEU . 99.0 t -66.29 -31.06 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 C-N-CA 119.721 -0.792 . . . . 1.0900000000000001 110.14 -174.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 32.9 mtm180 -75.06 -6.96 52.26 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.993 -0.549 . . . . 3.3999999999999999 110.652 175.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.608 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 68.6 mt -78.41 -50.25 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.683 -0.488 . . . . 1.9299999999999999 109.683 169.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.456 ' CD2' ' HB3' ' A' ' 8' ' ' HIS . 46.0 m-70 -66.22 -52.07 51.44 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.275 0.559 . . . . 0.34000000000000002 110.458 177.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.3 m -112.06 49.55 0.9 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.49 -0.777 . . . . 2.2400000000000002 110.811 -172.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.22 53.88 4.88 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.975 -0.631 . . . . 2.3599999999999999 111.637 177.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -56.68 -47.77 79.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.111 0.481 . . . . 3.9199999999999999 111.105 -176.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.6 mttp . . . . . 0 C--O 1.247 0.93 0 CA-C-N 115.652 -0.703 . . . . 7.4000000000000004 110.048 178.556 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtm . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.829 0.347 . . . . 7.5199999999999996 111.704 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.534 ' H ' ' HD2' ' A' ' 3' ' ' PRO . 87.9 tttt -118.35 -51.93 0.04 OUTLIER Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.049 -0.723 . . . . 5.4299999999999997 109.049 167.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.534 ' HD2' ' H ' ' A' ' 2' ' ' LYS . 95.3 Cg_endo -80.45 175.7 9.92 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.671 1.581 . . . . 1.54 109.815 163.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.423 ' CE1' ' HG3' ' A' ' 16' ' ' PRO . 53.1 m-85 -112.3 99.85 8.34 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.397 0.618 . . . . 1.47 110.001 -176.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.5 HG12 ' HG2' ' A' ' 12' ' ' GLN . 28.8 m -97.4 150.01 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.359 -0.837 . . . . 1.0900000000000001 112.079 -171.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.586 ' HB2' ' HE2' ' A' ' 13' ' ' PHE . 23.6 t -75.81 127.12 32.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.24 -0.891 . . . . 0.20999999999999999 110.111 177.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.497 HD13 ' N ' ' A' ' 7' ' ' ILE . 3.5 mp -78.8 -22.04 12.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.507 0.67 . . . . 1.3300000000000001 109.691 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.465 ' HB3' ' CD2' ' A' ' 26' ' ' HIS . 5.0 t60 -83.76 -44.29 14.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.543 -0.753 . . . . 2.2200000000000002 111.575 -173.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.7 p -121.86 -4.11 9.14 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 119.942 -0.703 . . . . 0.27000000000000002 112.33 -173.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 67.19 57.84 0.58 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.612 -0.722 . . . . 2.0800000000000001 112.469 175.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -119.97 159.86 23.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.668 -0.864 . . . . 4.3700000000000001 108.668 174.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.5 ' HG2' HG12 ' A' ' 5' ' ' VAL . 38.7 mt-30 -106.5 130.15 54.33 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 117.611 0.187 . . . . 1.8999999999999999 110.604 -175.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.586 ' HE2' ' HB2' ' A' ' 6' ' ' CYS . 97.9 m-85 -127.27 166.39 17.87 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.33 0.586 . . . . 0.77000000000000002 111.431 -177.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.41 -28.09 21.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.147 -0.933 . . . . 1.05 113.266 -167.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -136.71 150.17 69.27 Favored Pre-proline 0 C--N 1.327 -0.378 0 C-N-CA 121.102 -0.239 . . . . 1.9299999999999999 110.436 -176.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.423 ' HG3' ' CE1' ' A' ' 4' ' ' TYR . 20.4 Cg_exo -65.03 -24.05 60.37 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.536 2.157 . . . . 0.88 109.184 168.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.551 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -59.12 -37.31 91.51 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 114.281 -1.327 . . . . 0.38 111.842 172.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -80.33 -28.69 38.1 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.733 -0.387 . . . . 1.0700000000000001 110.651 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.52 ' O ' HG22 ' A' ' 23' ' ' VAL . 13.8 mt -71.13 -30.11 66.08 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 120.346 -0.541 . . . . 1.8500000000000001 109.614 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.551 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 27.6 pt20 -74.93 -40.69 60.69 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 119.373 -0.931 . . . . 2.6600000000000001 109.964 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.419 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.7 OUTLIER -70.95 -27.04 63.45 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.49 -1.232 . . . . 4.4299999999999997 109.336 177.075 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.536 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 63.1 t60 -73.46 -48.04 36.69 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 114.934 -1.03 . . . . 0.51000000000000001 111.536 -177.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 19' ' ' LEU . 84.6 t -66.35 -29.27 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 C-N-CA 119.823 -0.751 . . . . 1.0900000000000001 109.649 -175.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 41.9 mtt180 -61.98 -35.58 78.91 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.915 -0.584 . . . . 3.3999999999999999 110.992 171.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 26.4 mm -61.72 -45.4 98.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.335 -0.393 . . . . 1.9299999999999999 110.635 177.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.465 ' CD2' ' HB3' ' A' ' 8' ' ' HIS . 24.5 m-70 -66.1 -45.89 79.58 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.131 -0.486 . . . . 0.34000000000000002 110.244 176.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.7 m -84.73 46.22 1.23 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.662 0.744 . . . . 2.2400000000000002 109.741 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.76 15.49 14.49 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.467 -0.788 . . . . 2.3599999999999999 112.616 -177.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -62.58 -45.26 93.74 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.229 0.538 . . . . 3.9199999999999999 109.864 175.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.191 -0.909 . . . . 7.4000000000000004 109.328 176.599 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 120.908 0.385 . . . . 1.6399999999999999 111.045 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -109.09 173.98 6.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.066 -0.515 . . . . 0.64000000000000001 111.071 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.79 -53.45 4.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.099 0.476 . . . . 0.40999999999999998 111.73 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -106.74 146.6 33.4 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.622 -0.717 . . . . 1.9299999999999999 110.994 -169.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.96 -28.58 41.86 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.848 2.366 . . . . 0.53000000000000003 111.231 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.521 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . -64.32 -32.1 83.08 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.779 -0.646 . . . . 0.28000000000000003 111.507 175.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.3 -28.68 59.81 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 121.014 -0.275 . . . . 0.22 110.839 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 23' ' ' VAL . 8.6 mt -68.47 -34.22 75.56 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 109.458 -0.571 . . . . 1.1000000000000001 109.458 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -76.11 -33.94 59.47 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 119.037 -1.065 . . . . 2.23 109.746 -177.625 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.586 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.5 OUTLIER -66.54 -35.36 80.05 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.479 -1.237 . . . . 3.6000000000000001 108.944 172.147 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.651 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 71.6 t60 -72.29 -49.51 34.22 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.05 -0.977 . . . . 0.39000000000000001 111.459 -176.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 19' ' ' LEU . 74.6 t -64.24 -37.57 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 115.695 -0.684 . . . . 0.34000000000000002 110.556 -172.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -69.81 -20.66 63.44 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.057 -0.52 . . . . 2.96 110.446 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.651 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 9.9 mm -64.93 -34.79 72.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.396 -0.366 . . . . 1.3 110.17 172.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 . . . . . 0 CA--C 1.519 -0.237 0 C-N-CA 120.895 -0.322 . . . . 0.28999999999999998 110.871 177.138 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 . . . . . 0 C--O 1.233 0.185 0 N-CA-C 112.278 0.473 . . . . 1.6399999999999999 112.278 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -132.62 165.25 24.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.549 -0.75 . . . . 0.64000000000000001 109.859 175.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.29 -35.32 13.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.936 -0.574 . . . . 0.40999999999999998 112.44 -171.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.88 147.81 49.58 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 120.589 0.233 . . . . 1.9299999999999999 110.806 -174.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.42 -22.93 51.54 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.605 2.203 . . . . 0.53000000000000003 109.082 168.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.557 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -61.22 -43.35 99.5 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 114.48 -1.237 . . . . 0.28000000000000003 111.845 172.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -76.65 -27.91 55.81 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 120.775 -0.37 . . . . 0.22 110.868 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.698 ' O ' HG23 ' A' ' 23' ' ' VAL . 9.5 mt -66.66 -39.25 88.1 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 109.277 -0.638 . . . . 1.1000000000000001 109.277 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 18.5 pt20 -72.47 -37.66 68.43 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.977 0.894 . . . . 2.23 110.468 -175.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.563 ' O ' ' HD3' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -67.54 -34.29 76.78 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 113.899 -1.501 . . . . 3.6000000000000001 107.969 176.368 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.748 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 74.8 t60 -69.25 -39.54 78.4 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 114.317 -1.31 . . . . 0.39000000000000001 111.845 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 19' ' ' LEU . 87.7 t -67.07 -36.47 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 C-N-CA 119.364 -0.935 . . . . 0.34000000000000002 109.874 -174.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.2 mmm-85 -63.08 -28.59 70.18 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.198 -0.455 . . . . 2.96 110.413 173.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.748 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 20.0 mm -59.44 -50.53 79.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.773 -0.649 . . . . 1.3 110.63 176.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 . . . . . 0 CA--C 1.519 -0.245 0 CA-C-N 116.204 -0.453 . . . . 0.28999999999999998 110.922 178.708 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 . . . . . 0 C--O 1.237 0.435 0 CA-C-O 120.905 0.383 . . . . 1.6399999999999999 111.266 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -125.6 149.23 48.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.64000000000000001 110.383 174.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.11 -12.72 59.98 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.7 1.0 . . . . 0.40999999999999998 113.7 -167.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -142.87 151.15 55.73 Favored Pre-proline 0 C--N 1.324 -0.505 0 C-N-CA 120.831 -0.348 . . . . 1.9299999999999999 110.939 -173.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -66.06 -22.28 55.05 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.628 2.219 . . . . 0.53000000000000003 109.445 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.4 -53.26 47.33 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 114.462 -1.245 . . . . 0.28000000000000003 111.66 171.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -65.32 -26.19 67.94 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 115.719 -0.241 . . . . 0.22 111.154 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.501 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.8 mm? -70.45 -34.3 72.29 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 109.315 -0.624 . . . . 1.1000000000000001 109.315 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -72.35 -41.8 66.05 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 119.735 -0.786 . . . . 2.23 110.324 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.596 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -61.3 -39.43 90.42 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.498 -1.228 . . . . 3.6000000000000001 108.765 175.213 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.608 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 59.5 t60 -75.17 -46.85 31.49 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 114.311 -1.313 . . . . 0.39000000000000001 112.02 -170.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 19' ' ' LEU . 95.8 t -67.54 -34.55 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 C-N-CA 119.849 -0.74 . . . . 0.34000000000000002 110.498 -172.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -75.16 -11.79 60.16 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.109 -0.636 . . . . 2.96 110.61 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.608 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 9.5 mm -70.67 -45.73 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.935 -0.394 . . . . 1.3 109.935 171.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 40.5 m-70 . . . . . 0 CA--C 1.519 -0.218 0 CA-C-O 121.083 0.468 . . . . 0.28999999999999998 110.224 177.245 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 . . . . . 0 C--O 1.233 0.198 0 N-CA-C 111.651 0.241 . . . . 1.6399999999999999 111.651 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.414 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 98.4 m-85 -108.97 165.83 11.29 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.793 0.33 . . . . 0.64000000000000001 110.432 176.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.77 -39.01 18.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.923 -0.58 . . . . 0.40999999999999998 112.415 -175.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.466 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 13.4 m-20 -118.43 142.12 30.86 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.081 -0.508 . . . . 1.9299999999999999 111.844 -168.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 15' ' ' ASP . 17.0 Cg_exo -66.28 -25.36 49.76 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.982 2.454 . . . . 0.53000000000000003 111.015 175.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.549 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -62.83 -33.29 86.56 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.574 -0.739 . . . . 0.28000000000000003 111.884 176.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -80.24 -29.4 38.42 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.549 -0.46 . . . . 0.22 110.674 177.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.523 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.7 mm? -68.55 -34.17 75.36 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 109.633 -0.506 . . . . 1.1000000000000001 109.633 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.549 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 3.9 pt20 -74.26 -37.82 63.64 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 119.514 -0.875 . . . . 2.23 110.256 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.58 ' O ' HG13 ' A' ' 25' ' ' ILE . 1.1 tmt_? -68.09 -34.86 77.2 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.305 -1.316 . . . . 3.6000000000000001 108.293 175.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.607 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 33.1 t60 -71.37 -50.04 36.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.735 -1.121 . . . . 0.39000000000000001 111.747 -175.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 19' ' ' LEU . 99.4 t -65.45 -34.08 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-N 115.824 -0.625 . . . . 0.34000000000000002 110.102 -173.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 59.7 mtp180 -75.0 -8.87 57.75 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.924 -0.58 . . . . 2.96 110.874 177.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.607 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 57.1 mt -74.14 -48.95 35.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.923 -0.399 . . . . 1.3 109.923 172.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 . . . . . 0 N--CA 1.463 0.212 0 CA-C-N 115.967 -0.561 . . . . 0.28999999999999998 111.297 -178.947 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 . . . . . 0 CA--C 1.517 -0.299 0 CA-C-O 121.038 0.447 . . . . 1.6399999999999999 111.176 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.406 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 81.5 m-85 -137.39 162.77 32.72 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.332 -0.849 . . . . 0.64000000000000001 110.286 174.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.0 -20.18 22.39 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.771 0.656 . . . . 0.40999999999999998 112.771 -170.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -141.08 150.03 57.61 Favored Pre-proline 0 C--N 1.326 -0.445 0 C-N-CA 121.033 -0.267 . . . . 1.9299999999999999 110.776 -174.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.427 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 17.1 Cg_exo -67.09 -22.0 48.13 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.811 2.34 . . . . 0.53000000000000003 109.193 169.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.602 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -57.13 -44.68 93.07 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 114.532 -1.213 . . . . 0.28000000000000003 111.885 172.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.574 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -77.84 -22.38 50.03 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 121.037 -0.265 . . . . 0.22 110.992 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.575 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.6 mm? -73.38 -35.14 65.88 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 109.528 -0.545 . . . . 1.1000000000000001 109.528 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.602 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 16.9 pt20 -75.16 -35.52 61.61 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.672 -0.811 . . . . 2.23 109.91 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -68.18 -32.29 72.44 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.433 -1.258 . . . . 3.6000000000000001 108.829 173.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.576 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 46.6 t60 -71.59 -46.41 59.37 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 114.756 -1.111 . . . . 0.39000000000000001 111.787 -176.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 19' ' ' LEU . 60.8 t -66.62 -32.7 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 C-N-CA 119.822 -0.751 . . . . 0.34000000000000002 109.719 -175.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -59.3 -29.97 67.99 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.609 -0.723 . . . . 2.96 111.49 171.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.576 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 79.6 mt -64.82 -52.85 49.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.308 -0.406 . . . . 1.3 110.68 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 121.15 0.5 . . . . 0.28999999999999998 110.6 178.137 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.969 0.414 . . . . 1.6399999999999999 111.815 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.569 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 97.0 m-85 -129.46 176.42 7.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.878 -0.601 . . . . 0.64000000000000001 110.458 174.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -95.52 -40.28 9.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.178 0.513 . . . . 0.40999999999999998 112.16 -173.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -112.26 139.91 23.04 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.657 -0.702 . . . . 1.9299999999999999 111.672 -167.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -64.47 -32.83 59.22 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.799 2.332 . . . . 0.53000000000000003 110.333 173.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.471 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -63.6 -29.94 76.15 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.226 -0.897 . . . . 0.28000000000000003 112.042 177.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -82.01 -30.78 31.34 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 120.801 -0.36 . . . . 0.22 111.154 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.569 ' CD2' ' HB2' ' A' ' 13' ' ' PHE . 2.2 mm? -70.92 -31.4 68.0 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 109.746 -0.464 . . . . 1.1000000000000001 109.746 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 12.8 pt20 -75.56 -36.93 60.29 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 119.367 -0.933 . . . . 2.23 110.229 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.46 ' HA ' ' HD2' ' A' ' 21' ' ' ARG . 0.9 OUTLIER -70.22 -32.54 70.46 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.34 -1.3 . . . . 3.6000000000000001 108.777 174.603 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.513 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 55.7 t60 -66.69 -47.89 71.01 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 114.32 -1.309 . . . . 0.39000000000000001 111.053 -177.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 19' ' ' LEU . 98.0 t -64.51 -34.49 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 115.666 -0.697 . . . . 0.34000000000000002 109.895 -176.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -63.55 -25.65 68.34 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 112.314 0.487 . . . . 2.96 112.314 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.513 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 83.8 mt -65.25 -45.15 94.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.966 -0.383 . . . . 1.3 109.966 175.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.28999999999999998 110.17 175.594 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 . . . . . 0 N--CA 1.451 -0.397 0 CA-C-O 120.626 0.251 . . . . 1.6399999999999999 111.203 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -128.17 156.73 42.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.273 0.559 . . . . 0.64000000000000001 110.981 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.68 -40.81 61.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.434 -0.803 . . . . 0.40999999999999998 112.58 -176.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -109.31 137.05 20.14 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 115.804 -0.634 . . . . 1.9299999999999999 111.413 -166.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.91 -30.85 57.43 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.509 2.139 . . . . 0.53000000000000003 110.308 174.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.75 -37.08 89.29 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.269 -0.878 . . . . 0.28000000000000003 111.907 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.575 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -76.15 -25.23 55.11 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 111.401 0.148 . . . . 0.22 111.401 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.472 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.7 mm? -75.43 -29.32 59.69 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 109.15 -0.685 . . . . 1.1000000000000001 109.15 177.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -70.34 -43.21 70.68 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.302 -0.863 . . . . 2.23 109.823 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.647 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -64.68 -34.41 78.24 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.064 -1.425 . . . . 3.6000000000000001 108.71 174.268 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.575 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 26.7 t-80 -67.93 -53.6 25.07 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 114.537 -1.21 . . . . 0.39000000000000001 111.419 -174.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 19' ' ' LEU . 98.1 t -64.4 -34.71 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 115.59 -0.732 . . . . 0.34000000000000002 110.175 -174.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -69.47 -20.15 63.75 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.239 -0.437 . . . . 2.96 111.459 176.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.647 HG12 ' O ' ' A' ' 21' ' ' ARG . 27.6 mm -65.6 -49.1 79.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 109.586 -0.524 . . . . 1.3 109.586 173.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 . . . . . 0 CA--C 1.52 -0.184 0 CA-C-N 115.797 -0.638 . . . . 0.28999999999999998 111.261 -179.321 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 121.223 0.535 . . . . 1.6399999999999999 111.882 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -127.54 166.08 18.67 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.562 -0.745 . . . . 0.64000000000000001 110.481 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.56 -45.21 62.91 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.42 0.526 . . . . 0.40999999999999998 112.42 -176.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -117.17 144.44 33.74 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.248 -0.433 . . . . 1.9299999999999999 111.656 -166.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.72 -26.26 39.19 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.792 2.328 . . . . 0.53000000000000003 110.909 176.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.52 -35.08 89.49 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.333 -0.849 . . . . 0.28000000000000003 111.627 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.49 -25.94 62.48 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 121.067 -0.253 . . . . 0.22 110.409 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.566 ' O ' HG23 ' A' ' 23' ' ' VAL . 3.1 mm? -70.38 -30.24 67.1 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.818 -0.808 . . . . 1.1000000000000001 108.818 177.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.539 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 83.0 mm-40 -70.02 -43.31 71.59 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.772 0.796 . . . . 2.23 110.177 178.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.39 -33.17 75.32 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.359 -1.291 . . . . 3.6000000000000001 108.359 175.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.598 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 59.0 t60 -69.36 -45.38 69.53 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 114.532 -1.213 . . . . 0.39000000000000001 111.414 -176.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 19' ' ' LEU . 95.7 t -65.82 -32.53 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 C-N-CA 119.982 -0.687 . . . . 0.34000000000000002 109.822 -175.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 20' ' ' GLN . 14.9 mmm180 -67.11 -19.82 65.69 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.174 -0.466 . . . . 2.96 111.597 174.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.598 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 72.2 mt -68.23 -47.8 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 109.862 -0.421 . . . . 1.3 109.862 174.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 . . . . . 0 CA--C 1.518 -0.258 0 CA-C-O 121.247 0.546 . . . . 0.28999999999999998 109.586 174.584 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 . . . . . 0 C--O 1.235 0.338 0 N-CA-C 111.573 0.212 . . . . 1.6399999999999999 111.573 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -130.77 162.5 29.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.152 0.501 . . . . 0.64000000000000001 110.952 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.67 -32.53 23.57 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.55 -0.75 . . . . 0.40999999999999998 112.192 -171.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -123.53 142.79 39.85 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.767 -0.651 . . . . 1.9299999999999999 111.63 -168.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.57 -24.15 42.31 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.691 2.261 . . . . 0.53000000000000003 111.02 174.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.642 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . -69.51 -32.1 71.27 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.559 -0.746 . . . . 0.28000000000000003 111.44 174.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -75.36 -26.79 58.83 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 122.564 -0.374 . . . . 0.22 110.813 178.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.6 ' O ' HG23 ' A' ' 23' ' ' VAL . 12.6 mt -70.49 -34.28 72.18 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 109.468 -0.567 . . . . 1.1000000000000001 109.468 178.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.642 ' HG3' ' O ' ' A' ' 17' ' ' GLY . 5.2 pp0? -78.03 -31.78 50.62 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 119.375 -0.93 . . . . 2.23 110.171 -177.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -67.69 -37.74 82.71 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 113.928 -1.487 . . . . 3.6000000000000001 108.291 171.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.568 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 66.1 t60 -67.49 -44.69 77.91 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.354 -1.294 . . . . 0.39000000000000001 111.358 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 19' ' ' LEU . 93.8 t -68.08 -29.8 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 C-N-CA 120.147 -0.621 . . . . 0.34000000000000002 110.011 -175.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -61.32 -24.76 66.67 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.753 -0.658 . . . . 2.96 111.035 171.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.568 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 75.7 mt -70.01 -47.66 67.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.399 -0.364 . . . . 1.3 110.882 175.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 . . . . . 0 N--CA 1.467 0.386 0 C-N-CA 120.661 -0.416 . . . . 0.28999999999999998 110.159 176.566 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 . . . . . 0 C--O 1.235 0.33 0 CA-C-O 120.985 0.421 . . . . 1.6399999999999999 111.966 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -128.69 -179.49 5.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.645 -0.707 . . . . 0.64000000000000001 109.782 172.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -105.99 -35.23 7.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.878 0.37 . . . . 0.40999999999999998 111.991 -173.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 1.0 OUTLIER -115.58 147.36 38.69 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.298 -0.41 . . . . 1.9299999999999999 110.658 -173.531 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 15' ' ' ASP . 20.2 Cg_exo -65.28 -22.37 60.56 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.532 2.155 . . . . 0.53000000000000003 109.277 170.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -53.45 -53.21 36.48 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.316 -1.311 . . . . 0.28000000000000003 111.954 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.603 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -73.91 -21.99 59.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.833 -0.183 . . . . 0.22 111.438 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.586 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.7 mm? -73.49 -32.08 64.09 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 109.675 -0.491 . . . . 1.1000000000000001 109.675 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -76.57 -39.31 53.06 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.764 0.792 . . . . 2.23 110.201 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.548 ' HD3' ' HD2' ' A' ' 24' ' ' ARG . 8.6 tpp180 -64.9 -31.82 73.23 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.217 -1.356 . . . . 3.6000000000000001 108.418 174.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.639 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 35.6 t60 -68.4 -45.78 71.77 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.214 -1.357 . . . . 0.39000000000000001 111.783 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 19' ' ' LEU . 85.9 t -66.32 -38.38 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 C-N-CA 119.97 -0.692 . . . . 0.34000000000000002 110.351 -173.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.548 ' HD2' ' HD3' ' A' ' 21' ' ' ARG . 9.1 ptp180 -70.44 -10.93 60.43 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.056 0.455 . . . . 2.96 110.75 177.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.639 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 45.9 mt -73.75 -42.23 54.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.477 -0.329 . . . . 1.3 110.284 171.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 . . . . . 0 N--CA 1.463 0.203 0 CA-C-N 116.338 -0.392 . . . . 0.28999999999999998 111.276 -179.091 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 120.838 0.352 . . . . 1.6399999999999999 111.865 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -128.66 149.7 50.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.909 -0.587 . . . . 0.64000000000000001 110.59 175.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.12 -33.45 67.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.429 -0.805 . . . . 0.40999999999999998 112.638 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 58.1 m-20 -121.83 142.39 36.04 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 115.867 -0.606 . . . . 1.9299999999999999 110.983 -168.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 15' ' ' ASP . 17.7 Cg_exo -66.11 -28.38 48.83 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.612 2.208 . . . . 0.53000000000000003 110.304 173.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.601 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . -68.76 -22.5 75.47 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.3 -0.864 . . . . 0.28000000000000003 111.735 174.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -80.57 -26.63 37.82 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 122.561 -0.376 . . . . 0.22 110.3 175.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.696 ' O ' HG23 ' A' ' 23' ' ' VAL . 12.0 mt -71.97 -35.76 69.63 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 109.205 -0.665 . . . . 1.1000000000000001 109.205 177.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.601 ' HG3' ' O ' ' A' ' 17' ' ' GLY . 1.7 pp0? -73.55 -36.27 65.62 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 119.553 -0.859 . . . . 2.23 109.974 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -59.88 -41.78 92.31 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.336 -1.302 . . . . 3.6000000000000001 108.668 171.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.599 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 39.3 t60 -66.5 -36.56 83.01 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 113.346 -1.752 . . . . 0.39000000000000001 112.064 -176.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 19' ' ' LEU . 49.0 t -72.83 -27.82 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 C-N-CA 119.093 -1.043 . . . . 0.34000000000000002 109.695 -175.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 20' ' ' GLN . 13.6 mmt180 -59.35 -36.09 75.07 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.109 -0.7 . . . . 2.96 109.109 171.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.599 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 19.0 mm -61.29 -43.76 97.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 114.841 -1.072 . . . . 1.3 111.627 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 . . . . . 0 C--N 1.328 -0.352 0 N-CA-C 112.494 0.553 . . . . 0.28999999999999998 112.494 -175.564 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 . . . . . 0 C--O 1.232 0.154 0 N-CA-C 111.628 0.232 . . . . 1.6399999999999999 111.628 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -124.72 164.37 20.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.129 0.49 . . . . 0.64000000000000001 110.525 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.65 -37.37 15.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.491 -0.777 . . . . 0.40999999999999998 112.219 -172.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.412 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 45.9 m-20 -117.94 139.86 27.06 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.976 -0.556 . . . . 1.9299999999999999 110.949 -167.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.563 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 38.0 Cg_exo -59.83 -34.74 95.54 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.822 2.348 . . . . 0.53000000000000003 110.946 174.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.97 -35.69 91.77 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.365 -0.834 . . . . 0.28000000000000003 112.032 176.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -68.85 -31.86 71.13 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 121.19 -0.204 . . . . 0.22 110.847 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.534 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.8 mm? -68.86 -29.36 67.65 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 108.942 -0.762 . . . . 1.1000000000000001 108.942 178.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.563 ' HG2' ' O ' ' A' ' 16' ' ' PRO . 10.3 mm-40 -74.81 -41.15 60.49 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-O 121.65 0.738 . . . . 2.23 109.899 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.417 ' O ' HG12 ' A' ' 25' ' ' ILE . 1.1 mpt_? -67.77 -32.42 72.99 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.423 -1.262 . . . . 3.6000000000000001 109.111 176.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.529 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 60.4 t60 -72.35 -45.26 60.65 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 114.88 -1.054 . . . . 0.39000000000000001 111.32 -175.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 19' ' ' LEU . 84.4 t -67.16 -32.34 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 C-N-CA 119.945 -0.702 . . . . 0.34000000000000002 109.967 -175.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 17.6 mtp180 -63.09 -28.78 70.31 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.969 -0.56 . . . . 2.96 110.986 174.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.529 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 26.8 mm -64.69 -45.41 95.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-O 120.827 0.346 . . . . 1.3 110.723 175.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 . . . . . 0 C--N 1.33 -0.259 0 CA-C-O 121.068 0.461 . . . . 0.28999999999999998 110.677 177.394 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 120.456 0.17 . . . . 1.6399999999999999 111.245 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -135.07 148.38 49.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.731 0.776 . . . . 0.64000000000000001 110.918 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.83 -36.12 82.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.469 -1.241 . . . . 0.40999999999999998 113.384 -171.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -129.04 142.87 46.65 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.921 0.391 . . . . 1.9299999999999999 110.966 -169.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.517 ' O ' ' HG3' ' A' ' 20' ' ' GLN . 32.5 Cg_endo -64.86 -24.6 60.95 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.859 2.373 . . . . 0.53000000000000003 111.311 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.97 -42.13 98.18 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.89 -0.672 . . . . 0.28000000000000003 111.438 173.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -70.86 -22.38 62.31 Favored 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 122.946 -0.149 . . . . 0.22 110.845 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.554 ' O ' HG23 ' A' ' 23' ' ' VAL . 3.4 mm? -75.65 -26.4 57.67 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.185 -0.672 . . . . 1.1000000000000001 109.185 175.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.517 ' HG3' ' O ' ' A' ' 16' ' ' PRO . 72.4 mt-30 -74.12 -42.82 59.44 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.909 0.862 . . . . 2.23 109.356 176.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.6 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -61.19 -35.93 78.49 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.945 -1.48 . . . . 3.6000000000000001 109.19 172.716 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.547 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 10.0 t60 -67.08 -48.78 67.17 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.616 -1.175 . . . . 0.39000000000000001 111.584 -175.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 19' ' ' LEU . 93.4 t -67.28 -35.89 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 C-N-CA 119.98 -0.688 . . . . 0.34000000000000002 110.805 -172.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -71.7 -9.93 59.01 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.874 -0.331 . . . . 2.96 111.0 176.46 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.6 HG12 ' O ' ' A' ' 21' ' ' ARG . 19.5 mm -75.59 -42.93 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 109.683 -0.488 . . . . 1.3 109.683 172.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 . . . . . 0 CA--C 1.519 -0.228 0 CA-C-O 121.01 0.433 . . . . 0.28999999999999998 110.428 176.899 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 . . . . . 0 C--O 1.235 0.334 0 CA-C-O 120.631 0.253 . . . . 1.6399999999999999 111.501 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.416 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 96.0 m-85 -126.37 141.52 51.87 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.873 0.844 . . . . 0.64000000000000001 111.515 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.19 -36.38 77.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.258 -1.337 . . . . 0.40999999999999998 113.736 -172.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.477 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 23.4 m-20 -115.37 141.71 27.62 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 116.098 -0.501 . . . . 1.9299999999999999 111.482 -164.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 15' ' ' ASP . 12.6 Cg_exo -67.45 -32.24 32.44 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.747 2.298 . . . . 0.53000000000000003 110.322 174.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.19 -36.93 92.49 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.134 -0.939 . . . . 0.28000000000000003 111.736 176.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.581 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -69.44 -28.17 65.89 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.984 -0.108 . . . . 0.22 110.937 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.526 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.6 mm? -71.41 -31.35 67.15 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.125 -0.694 . . . . 1.1000000000000001 109.125 177.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.612 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 79.8 mt-30 -68.97 -44.32 73.18 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 119.951 -0.7 . . . . 2.23 109.985 177.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.722 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.3 OUTLIER -61.16 -40.38 93.65 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.257 -1.338 . . . . 3.6000000000000001 108.553 174.988 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.623 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 17.2 t-80 -65.64 -49.65 67.87 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 113.607 -1.633 . . . . 0.39000000000000001 111.927 -171.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 19' ' ' LEU . 59.3 t -66.58 -34.63 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 C-N-CA 119.843 -0.743 . . . . 0.34000000000000002 109.868 -175.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.612 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 78.4 mtt-85 -66.32 -27.04 67.59 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.629 -0.714 . . . . 2.96 110.558 175.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.722 HG12 ' O ' ' A' ' 21' ' ' ARG . 24.6 mm -62.11 -50.39 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.063 -0.517 . . . . 1.3 110.548 175.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 116.177 -0.465 . . . . 0.28999999999999998 111.212 -179.096 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.705 0.288 . . . . 1.6399999999999999 111.431 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.416 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 98.5 m-85 -131.58 169.16 16.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.64000000000000001 110.126 173.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.2 -51.64 8.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.232 0.539 . . . . 0.40999999999999998 112.139 -174.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -105.53 142.25 24.35 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.291 -0.868 . . . . 1.9299999999999999 111.859 -165.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -63.26 -27.53 72.14 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.89 2.393 . . . . 0.53000000000000003 110.753 171.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.509 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -69.27 -24.18 76.08 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.459 -0.791 . . . . 0.28000000000000003 111.753 176.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -84.27 -28.1 27.41 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 122.587 -0.361 . . . . 0.22 110.854 178.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.561 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.4 mm? -74.26 -29.83 61.85 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 109.509 -0.552 . . . . 1.1000000000000001 109.509 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 13.1 pt20 -75.89 -35.55 59.81 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.41 -0.916 . . . . 2.23 109.752 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.404 ' O ' HG13 ' A' ' 25' ' ' ILE . 30.3 tpt180 -64.28 -39.8 94.67 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.18 -1.373 . . . . 3.6000000000000001 108.764 170.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.515 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 48.1 t60 -67.06 -49.35 65.4 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.092 -1.413 . . . . 0.39000000000000001 111.952 -174.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 19' ' ' LEU . 63.3 t -66.58 -31.86 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 C-N-CA 120.029 -0.668 . . . . 0.34000000000000002 109.755 -175.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -69.51 -7.38 37.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.503 -0.771 . . . . 2.96 111.465 174.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.515 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 81.0 mt -83.86 -47.48 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 109.616 -0.512 . . . . 1.3 109.616 171.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 121.267 0.556 . . . . 0.28999999999999998 110.661 178.259 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 120.662 0.267 . . . . 1.6399999999999999 111.104 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.553 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 92.0 m-85 -131.8 158.58 40.89 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.266 0.555 . . . . 0.64000000000000001 110.663 176.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.53 -36.46 26.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.36 -0.836 . . . . 0.40999999999999998 112.909 -171.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 6.2 m-20 -124.01 138.92 31.47 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-O 120.827 0.346 . . . . 1.9299999999999999 111.128 -168.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 15' ' ' ASP . 27.0 Cg_exo -62.45 -29.73 79.31 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.125 2.55 . . . . 0.53000000000000003 111.278 176.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.54 -36.33 93.05 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.747 -0.66 . . . . 0.28000000000000003 111.566 175.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.99 -31.84 64.78 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.608 -0.296 . . . . 0.22 111.015 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.553 ' CD2' ' HB2' ' A' ' 13' ' ' PHE . 2.7 mm? -66.29 -34.67 78.52 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 109.292 -0.632 . . . . 1.1000000000000001 109.292 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -73.78 -38.31 64.71 Favored 'General case' 0 N--CA 1.432 -1.325 0 C-N-CA 119.125 -1.03 . . . . 2.23 110.556 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.587 ' O ' HG12 ' A' ' 25' ' ' ILE . 7.1 tpt180 -65.42 -37.09 85.89 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.713 -1.131 . . . . 3.6000000000000001 108.641 175.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.545 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 63.3 t60 -73.66 -48.13 34.69 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.041 -1.436 . . . . 0.39000000000000001 111.559 -174.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 19' ' ' LEU . 72.8 t -64.63 -31.62 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 CA-C-N 116.014 -0.539 . . . . 0.34000000000000002 110.557 -173.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -76.56 -14.31 60.02 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 120.382 -0.527 . . . . 2.96 110.685 177.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.587 HG12 ' O ' ' A' ' 21' ' ' ARG . 18.7 mm -69.37 -45.56 78.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 109.747 -0.464 . . . . 1.3 109.747 173.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 . . . . . 0 CA--C 1.519 -0.214 0 CA-C-O 121.293 0.568 . . . . 0.28999999999999998 109.52 172.963 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.701 0.286 . . . . 1.6399999999999999 111.31 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -129.16 155.18 45.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.443 0.639 . . . . 0.64000000000000001 110.762 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.02 -28.77 29.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.02 -0.991 . . . . 0.40999999999999998 111.351 -175.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -120.76 135.46 24.73 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.28 -0.873 . . . . 1.9299999999999999 110.981 -166.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.37 -25.45 35.93 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.241 1.961 . . . . 0.53000000000000003 110.27 172.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.51 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -67.95 -27.95 73.54 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.961 -1.018 . . . . 0.28000000000000003 111.478 173.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -78.4 -25.91 46.27 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 120.943 -0.303 . . . . 0.22 110.667 178.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.646 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.7 mm? -69.62 -35.25 75.1 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 109.663 -0.495 . . . . 1.1000000000000001 109.663 178.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.51 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 12.0 pt20 -76.18 -36.02 58.87 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 119.415 -0.914 . . . . 2.23 110.105 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.431 ' O ' HG13 ' A' ' 25' ' ' ILE . 7.2 tpm_? -61.08 -40.21 92.84 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.857 -1.519 . . . . 3.6000000000000001 108.191 172.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.621 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 21.0 t-80 -70.33 -44.46 68.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.723 -1.58 . . . . 0.39000000000000001 112.183 -174.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 19' ' ' LEU . 61.4 t -66.15 -35.77 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 C-N-CA 119.682 -0.807 . . . . 0.34000000000000002 110.101 -174.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -62.2 -25.52 67.83 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.127 -0.488 . . . . 2.96 111.126 173.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.621 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 79.9 mt -67.96 -44.07 85.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 1.3 110.791 176.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 . . . . . 0 N--CA 1.465 0.276 0 CA-C-O 120.565 0.221 . . . . 0.28999999999999998 111.359 179.762 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 . . . . . 0 C--O 1.233 0.217 0 N-CA-C 112.38 0.511 . . . . 1.6399999999999999 112.38 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -129.12 167.05 18.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.9 -0.591 . . . . 0.64000000000000001 110.705 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.03 -2.45 37.19 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.153 0.797 . . . . 0.40999999999999998 113.153 -170.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -155.51 150.33 20.5 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 120.816 -0.354 . . . . 1.9299999999999999 110.109 -176.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.44 -22.61 65.57 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.855 2.37 . . . . 0.53000000000000003 109.531 169.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.557 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -57.22 -48.36 80.69 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 114.382 -1.281 . . . . 0.28000000000000003 111.89 172.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -72.73 -25.41 61.21 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 121.07 -0.252 . . . . 0.22 110.781 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.529 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.5 mm? -72.1 -36.22 69.41 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.094 -0.706 . . . . 1.1000000000000001 109.094 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 17.0 pt20 -77.81 -33.84 52.29 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 119.729 -0.788 . . . . 2.23 109.94 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.47 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.5 OUTLIER -65.44 -36.2 83.22 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.648 -1.16 . . . . 3.6000000000000001 108.741 173.29 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.569 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 47.1 t60 -73.42 -46.1 50.58 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 114.7 -1.136 . . . . 0.39000000000000001 111.683 -174.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 19' ' ' LEU . 97.5 t -66.07 -34.38 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 C-N-CA 119.866 -0.734 . . . . 0.34000000000000002 110.019 -175.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 16.8 mtp180 -62.73 -26.81 68.88 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.109 -0.496 . . . . 2.96 111.077 173.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 18.3 mm -69.22 -44.32 80.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.427 -0.351 . . . . 1.3 110.63 176.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 . . . . . 0 N--CA 1.464 0.263 0 CA-C-O 121.217 0.532 . . . . 0.28999999999999998 110.626 176.354 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 . . . . . 0 N--CA 1.454 -0.249 0 N-CA-C 112.562 0.579 . . . . 1.6399999999999999 112.562 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -124.65 169.33 12.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.381 -0.827 . . . . 0.64000000000000001 110.35 173.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.61 -36.19 13.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.238 -0.437 . . . . 0.40999999999999998 112.125 -173.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.7 OUTLIER -113.58 151.58 44.66 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-O 120.977 0.417 . . . . 1.9299999999999999 110.369 -174.685 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 15' ' ' ASP . 12.2 Cg_exo -71.61 -23.53 23.0 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.159 2.573 . . . . 0.53000000000000003 108.465 170.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.07 -41.87 98.21 Favored Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 113.889 -1.505 . . . . 0.28000000000000003 111.553 172.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -77.49 -25.52 50.45 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 121.158 -0.217 . . . . 0.22 111.417 -177.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.557 ' O ' HG23 ' A' ' 23' ' ' VAL . 8.0 mt -71.29 -38.47 71.78 Favored 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 120.014 -0.674 . . . . 1.1000000000000001 109.208 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.444 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 21.4 mt-30 -76.69 -31.96 57.59 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 119.294 -0.962 . . . . 2.23 110.701 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.406 ' O ' HG13 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -65.07 -38.17 89.9 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.998 -1.001 . . . . 3.6000000000000001 108.489 171.86 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.617 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 71.3 t60 -73.56 -45.72 51.72 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 114.427 -1.261 . . . . 0.39000000000000001 112.01 -174.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 19' ' ' LEU . 99.0 t -66.29 -31.06 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 C-N-CA 119.721 -0.792 . . . . 0.34000000000000002 110.14 -174.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 32.9 mtm180 -75.06 -6.96 52.26 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.993 -0.549 . . . . 2.96 110.652 175.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.617 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 68.6 mt -78.41 -50.25 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.683 -0.488 . . . . 1.3 109.683 169.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 . . . . . 0 N--CA 1.462 0.146 0 CA-C-O 121.275 0.559 . . . . 0.28999999999999998 110.458 177.953 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 110.604 -0.147 . . . . 1.6399999999999999 110.604 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -127.27 166.39 17.87 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.33 0.586 . . . . 0.64000000000000001 111.431 -177.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.41 -28.09 21.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.147 -0.933 . . . . 0.40999999999999998 113.266 -167.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -136.71 150.17 69.27 Favored Pre-proline 0 C--N 1.327 -0.378 0 C-N-CA 121.102 -0.239 . . . . 1.9299999999999999 110.436 -176.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -65.03 -24.05 60.37 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.536 2.157 . . . . 0.53000000000000003 109.184 168.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.573 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -59.12 -37.31 91.51 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 114.281 -1.327 . . . . 0.28000000000000003 111.842 172.049 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.562 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -80.33 -28.69 38.1 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.733 -0.387 . . . . 0.22 110.651 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.53 ' O ' HG23 ' A' ' 23' ' ' VAL . 13.8 mt -71.13 -30.11 66.08 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 120.346 -0.541 . . . . 1.1000000000000001 109.614 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.573 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 27.6 pt20 -74.93 -40.69 60.69 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 119.373 -0.931 . . . . 2.23 109.964 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.44 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.7 OUTLIER -70.95 -27.04 63.45 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.49 -1.232 . . . . 3.6000000000000001 109.336 177.075 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.562 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 24.5 t-80 -73.46 -48.04 36.69 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 114.934 -1.03 . . . . 0.39000000000000001 111.536 -177.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 19' ' ' LEU . 84.6 t -66.35 -29.27 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 C-N-CA 119.823 -0.751 . . . . 0.34000000000000002 109.649 -175.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 41.9 mtt180 -61.98 -35.58 78.91 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.915 -0.584 . . . . 2.96 110.992 171.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.511 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 26.4 mm -61.72 -45.4 98.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.335 -0.393 . . . . 1.3 110.635 177.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 . . . . . 0 CA--C 1.519 -0.231 0 CA-C-N 116.131 -0.486 . . . . 0.28999999999999998 110.244 176.588 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.7 mtt . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 120.612 0.244 . . . . 7.1399999999999997 111.01 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -95.84 117.57 66.34 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.261 0.553 . . . . 4.9699999999999998 110.977 -177.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -91.86 178.33 1.62 Allowed 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.906 2.404 . . . . 1.1399999999999999 112.116 173.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.591 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . 65.0 m-85 -113.18 102.49 10.43 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.396 -0.965 . . . . 1.1100000000000001 108.396 171.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.591 HG12 ' HG2' ' A' ' 12' ' ' GLN . 16.8 m -90.56 143.13 11.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.306 0.574 . . . . 0.34999999999999998 111.685 -172.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.595 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 46.9 t -68.25 121.45 16.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.249 -0.887 . . . . 0.20999999999999999 110.148 175.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.1 mm -67.02 -21.29 28.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.203 -0.453 . . . . 0.67000000000000004 111.074 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -93.34 -35.01 13.27 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.351 0.5 . . . . 1.3 112.351 -172.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.9 p -128.41 -3.13 5.53 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.029 -0.668 . . . . 0.27000000000000002 112.514 -175.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 64.87 52.05 1.67 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.579 -0.737 . . . . 1.5800000000000001 112.617 175.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.428 ' H ' ' HB3' ' A' ' 6' ' ' CYS . 25.6 mmt180 -106.12 128.41 53.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.658 -0.701 . . . . 3.6699999999999999 109.246 174.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.591 ' HG2' HG12 ' A' ' 5' ' ' VAL . 64.8 mt-30 -85.33 114.45 22.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.908 0.385 . . . . 1.6399999999999999 111.045 -175.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -109.09 173.98 6.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.066 -0.515 . . . . 0.64000000000000001 111.071 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.79 -53.45 4.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.099 0.476 . . . . 0.40999999999999998 111.73 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -106.74 146.6 33.4 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.622 -0.717 . . . . 1.9299999999999999 110.994 -169.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.96 -28.58 41.86 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.848 2.366 . . . . 0.53000000000000003 111.231 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.521 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . -64.32 -32.1 83.08 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.779 -0.646 . . . . 0.28000000000000003 111.507 175.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.3 -28.68 59.81 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 121.014 -0.275 . . . . 0.22 110.839 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.591 ' CD1' ' HB3' ' A' ' 4' ' ' TYR . 8.6 mt -68.47 -34.22 75.56 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 109.458 -0.571 . . . . 1.1000000000000001 109.458 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -76.11 -33.94 59.47 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 119.037 -1.065 . . . . 2.23 109.746 -177.625 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.586 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.5 OUTLIER -66.54 -35.36 80.05 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.479 -1.237 . . . . 3.6000000000000001 108.944 172.147 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.651 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 71.6 t60 -72.29 -49.51 34.22 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.05 -0.977 . . . . 0.39000000000000001 111.459 -176.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 19' ' ' LEU . 74.6 t -64.24 -37.57 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 115.695 -0.684 . . . . 0.34000000000000002 110.556 -172.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 11.0 ptm180 -69.81 -20.66 63.44 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.057 -0.52 . . . . 2.96 110.446 178.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.651 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 9.9 mm -64.93 -34.79 72.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.396 -0.366 . . . . 1.3 110.17 172.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -68.24 -36.81 80.04 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 120.895 -0.322 . . . . 0.28999999999999998 110.871 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -39.88 79.28 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 120.194 -0.602 . . . . 1.6799999999999999 110.16 175.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.83 -56.69 3.49 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.816 -0.629 . . . . 2.3599999999999999 112.064 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -66.71 -29.74 69.8 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.194 0.521 . . . . 3.9199999999999999 110.683 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 47.5 pttt . . . . . 0 C--O 1.251 1.139 0 CA-C-O 117.923 -1.037 . . . . 6.9100000000000001 110.185 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.541 ' HG2' ' HG3' ' A' ' 2' ' ' LYS . 51.3 ttm . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 120.702 0.287 . . . . 7.1399999999999997 110.484 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.541 ' HG3' ' HG2' ' A' ' 1' ' ' MET . 91.4 mttt -118.65 128.16 26.13 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.44 -0.346 . . . . 4.9699999999999998 110.106 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.72 173.13 11.37 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 121.897 1.732 . . . . 1.1399999999999999 110.212 171.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.528 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . 91.0 m-85 -89.52 89.58 7.9 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.438 0.637 . . . . 1.1100000000000001 109.478 -176.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.501 HG12 ' HG2' ' A' ' 12' ' ' GLN . 32.9 m -84.39 144.94 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 114.947 -1.024 . . . . 0.34999999999999998 110.98 -177.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.518 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 37.9 t -60.51 130.86 48.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.022 -0.99 . . . . 0.20999999999999999 110.547 177.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.522 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.2 mp -70.66 -25.64 26.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.311 -0.859 . . . . 0.67000000000000004 110.288 -175.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -91.68 -53.77 4.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.531 . . . . 1.3 111.306 -175.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.2 p -108.71 1.4 21.12 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.213 0.53 . . . . 0.27000000000000002 111.596 -169.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 59.23 43.23 17.29 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.149 -0.932 . . . . 1.5800000000000001 112.895 173.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.725 ' HE ' ' HA ' ' A' ' 11' ' ' ARG . 0.5 OUTLIER -103.83 140.92 36.99 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.036 -0.357 . . . . 3.6699999999999999 110.036 175.848 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.501 ' HG2' HG12 ' A' ' 5' ' ' VAL . 79.8 mt-30 -77.63 132.96 38.5 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.278 0.473 . . . . 1.6399999999999999 112.278 -174.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -132.62 165.25 24.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.549 -0.75 . . . . 0.64000000000000001 109.859 175.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.29 -35.32 13.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.936 -0.574 . . . . 0.40999999999999998 112.44 -171.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.88 147.81 49.58 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 120.589 0.233 . . . . 1.9299999999999999 110.806 -174.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.42 -22.93 51.54 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.605 2.203 . . . . 0.53000000000000003 109.082 168.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.557 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -61.22 -43.35 99.5 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 114.48 -1.237 . . . . 0.28000000000000003 111.845 172.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -76.65 -27.91 55.81 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 120.775 -0.37 . . . . 0.22 110.868 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.698 ' O ' HG23 ' A' ' 23' ' ' VAL . 9.5 mt -66.66 -39.25 88.1 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 109.277 -0.638 . . . . 1.1000000000000001 109.277 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 18.5 pt20 -72.47 -37.66 68.43 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.977 0.894 . . . . 2.23 110.468 -175.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.639 HH22 ' HG3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -67.54 -34.29 76.78 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 113.899 -1.501 . . . . 3.6000000000000001 107.969 176.368 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.748 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 74.8 t60 -69.25 -39.54 78.4 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 114.317 -1.31 . . . . 0.39000000000000001 111.845 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 19' ' ' LEU . 87.7 t -67.07 -36.47 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 C-N-CA 119.364 -0.935 . . . . 0.34000000000000002 109.874 -174.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.2 mmm-85 -63.08 -28.59 70.18 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.198 -0.455 . . . . 2.96 110.413 173.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.748 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 20.0 mm -59.44 -50.53 79.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.773 -0.649 . . . . 1.3 110.63 176.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -62.35 -30.55 71.26 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.204 -0.453 . . . . 0.28999999999999998 110.922 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.454 ' HB ' ' HG2' ' A' ' 29' ' ' GLU . 1.3 m -68.7 -24.53 64.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.124 -0.489 . . . . 1.6799999999999999 110.542 -176.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.67 -11.49 52.15 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.074 -0.584 . . . . 2.3599999999999999 113.282 174.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.454 ' HG2' ' HB ' ' A' ' 27' ' ' THR . 8.0 pt-20 -73.95 -31.85 63.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.604 0.24 . . . . 3.9199999999999999 111.601 -177.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.639 ' HG3' HH22 ' A' ' 21' ' ' ARG . 52.6 tptt . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.35 -0.833 . . . . 6.9100000000000001 109.923 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 N--CA 1.481 1.093 0 CA-C-O 121.048 0.451 . . . . 7.1399999999999997 110.974 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.561 ' HB2' ' HD3' ' A' ' 3' ' ' PRO . 5.2 mptp? -66.79 -50.24 45.18 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 116.126 -0.488 . . . . 4.9699999999999998 110.571 175.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.561 ' HD3' ' HB2' ' A' ' 2' ' ' LYS . 55.5 Cg_exo -59.89 173.63 1.65 Allowed 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.367 2.045 . . . . 1.1399999999999999 113.15 173.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.504 ' O ' HD21 ' A' ' 19' ' ' LEU . 79.8 m-85 -117.35 126.35 52.53 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.015 -1.448 . . . . 1.1100000000000001 109.769 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.676 HG12 ' HG2' ' A' ' 12' ' ' GLN . 3.5 m -94.47 149.34 4.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 115.975 -0.557 . . . . 0.34999999999999998 111.066 -174.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.456 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 48.6 t -71.43 128.67 36.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.745 -0.661 . . . . 0.20999999999999999 110.534 177.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.493 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.3 mp -71.06 -27.82 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 115.402 -0.817 . . . . 0.67000000000000004 110.498 -176.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -90.32 -44.2 9.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 1.3 111.584 -171.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.7 p -120.31 0.48 10.61 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 119.694 -0.803 . . . . 0.27000000000000002 112.423 -171.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 63.99 57.02 1.36 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.417 -0.811 . . . . 1.5800000000000001 112.385 172.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.442 ' H ' ' HB3' ' A' ' 6' ' ' CYS . 1.6 mmp_? -121.59 130.98 53.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.811 -0.631 . . . . 3.6699999999999999 109.606 177.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.676 ' HG2' HG12 ' A' ' 5' ' ' VAL . 30.2 mt-30 -77.54 131.17 37.75 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 120.905 0.383 . . . . 1.6399999999999999 111.266 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -125.6 149.23 48.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.64000000000000001 110.383 174.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.11 -12.72 59.98 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.7 1.0 . . . . 0.40999999999999998 113.7 -167.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -142.87 151.15 55.73 Favored Pre-proline 0 C--N 1.324 -0.505 0 C-N-CA 120.831 -0.348 . . . . 1.9299999999999999 110.939 -173.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.469 ' HG3' ' CE1' ' A' ' 4' ' ' TYR . 18.2 Cg_exo -66.06 -22.28 55.05 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.628 2.219 . . . . 0.53000000000000003 109.445 168.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.4 -53.26 47.33 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 114.462 -1.245 . . . . 0.28000000000000003 111.66 171.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -65.32 -26.19 67.94 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 115.719 -0.241 . . . . 0.22 111.154 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.504 HD21 ' O ' ' A' ' 4' ' ' TYR . 2.8 mm? -70.45 -34.3 72.29 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 109.315 -0.624 . . . . 1.1000000000000001 109.315 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -72.35 -41.8 66.05 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 119.735 -0.786 . . . . 2.23 110.324 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.596 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -61.3 -39.43 90.42 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.498 -1.228 . . . . 3.6000000000000001 108.765 175.213 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.608 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 59.5 t60 -75.17 -46.85 31.49 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 114.311 -1.313 . . . . 0.39000000000000001 112.02 -170.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 19' ' ' LEU . 95.8 t -67.54 -34.55 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 C-N-CA 119.849 -0.74 . . . . 0.34000000000000002 110.498 -172.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.451 ' HA ' HG22 ' A' ' 27' ' ' THR . 10.0 ptp180 -75.16 -11.79 60.16 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.109 -0.636 . . . . 2.96 110.61 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.608 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 9.5 mm -70.67 -45.73 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.935 -0.394 . . . . 1.3 109.935 171.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 40.5 m-70 -65.86 -50.96 62.69 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.083 0.468 . . . . 0.28999999999999998 110.224 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.518 ' O ' HG23 ' A' ' 27' ' ' THR . 9.3 t -87.71 52.03 2.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.931 0.872 . . . . 1.6799999999999999 110.418 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.26 59.03 0.42 Allowed Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.479 -0.782 . . . . 2.3599999999999999 111.75 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -78.71 -40.83 32.64 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 123.459 0.704 . . . . 3.9199999999999999 110.813 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.421 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 19.8 tptm . . . . . 0 C--N 1.316 -0.855 0 CA-C-O 118.538 -0.744 . . . . 6.9100000000000001 109.695 178.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 121.003 0.43 . . . . 7.1399999999999997 110.208 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.502 ' HD2' ' HD2' ' A' ' 3' ' ' PRO . 58.5 tptt -88.93 113.06 54.49 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.018 -0.537 . . . . 4.9699999999999998 110.615 -178.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.502 ' HD2' ' HD2' ' A' ' 2' ' ' LYS . 71.3 Cg_endo -84.4 174.76 7.7 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.664 2.243 . . . . 1.1399999999999999 111.304 175.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.587 ' O ' HD21 ' A' ' 19' ' ' LEU . 87.4 m-85 -119.38 113.15 20.35 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 109.206 -0.664 . . . . 1.1100000000000001 109.206 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.523 HG12 ' HA ' ' A' ' 12' ' ' GLN . 29.7 m -106.37 139.69 26.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.761 -0.654 . . . . 0.34999999999999998 111.097 -171.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.503 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 39.1 t -63.42 122.76 17.03 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.905 -0.589 . . . . 0.20999999999999999 109.548 175.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.587 HD12 ' H ' ' A' ' 7' ' ' ILE . 4.0 mp -70.67 -25.92 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-N 115.573 -0.74 . . . . 0.67000000000000004 109.964 -176.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -90.99 -43.05 10.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.953 -0.567 . . . . 1.3 111.885 -169.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.6 p -118.04 -3.2 11.14 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 119.752 -0.779 . . . . 0.27000000000000002 112.055 -175.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 65.07 79.65 0.25 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.506 -0.77 . . . . 1.5800000000000001 112.654 175.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 96.5 mtt180 -138.47 132.88 31.97 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.783 -0.644 . . . . 3.6699999999999999 109.337 174.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.523 ' HA ' HG12 ' A' ' 5' ' ' VAL . 30.0 mt-30 -87.36 112.58 22.25 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.651 0.241 . . . . 1.6399999999999999 111.651 -177.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.414 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 98.4 m-85 -108.97 165.83 11.29 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.793 0.33 . . . . 0.64000000000000001 110.432 176.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.77 -39.01 18.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.923 -0.58 . . . . 0.40999999999999998 112.415 -175.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.466 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 13.4 m-20 -118.43 142.12 30.86 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.081 -0.508 . . . . 1.9299999999999999 111.844 -168.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 15' ' ' ASP . 17.0 Cg_exo -66.28 -25.36 49.76 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.982 2.454 . . . . 0.53000000000000003 111.015 175.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.549 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -62.83 -33.29 86.56 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.574 -0.739 . . . . 0.28000000000000003 111.884 176.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -80.24 -29.4 38.42 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.549 -0.46 . . . . 0.22 110.674 177.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.587 HD21 ' O ' ' A' ' 4' ' ' TYR . 2.7 mm? -68.55 -34.17 75.36 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 109.633 -0.506 . . . . 1.1000000000000001 109.633 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.549 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 3.9 pt20 -74.26 -37.82 63.64 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 119.514 -0.875 . . . . 2.23 110.256 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.58 ' O ' HG13 ' A' ' 25' ' ' ILE . 1.1 tmt_? -68.09 -34.86 77.2 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.305 -1.316 . . . . 3.6000000000000001 108.293 175.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.607 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 33.1 t60 -71.37 -50.04 36.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.735 -1.121 . . . . 0.39000000000000001 111.747 -175.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 19' ' ' LEU . 99.4 t -65.45 -34.08 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-N 115.824 -0.625 . . . . 0.34000000000000002 110.102 -173.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 59.7 mtp180 -75.0 -8.87 57.75 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.924 -0.58 . . . . 2.96 110.874 177.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.607 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 57.1 mt -74.14 -48.95 35.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.923 -0.399 . . . . 1.3 109.923 172.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 -62.11 -50.56 71.44 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.967 -0.561 . . . . 0.28999999999999998 111.297 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.474 HG21 ' HB2' ' A' ' 30' ' ' LYS . 5.6 m -86.46 -26.38 24.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.077 -0.51 . . . . 1.6799999999999999 111.992 -173.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.0 -62.28 3.32 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.025 -0.607 . . . . 2.3599999999999999 112.944 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -80.11 -54.06 6.12 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.497 0.665 . . . . 3.9199999999999999 110.822 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.474 ' HB2' HG21 ' A' ' 27' ' ' THR . 17.5 mmtp . . . . . 0 C--O 1.246 0.906 0 CA-C-N 114.809 -1.087 . . . . 6.9100000000000001 109.806 -175.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtm . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 110.048 -0.353 . . . . 7.1399999999999997 110.048 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.554 ' HB2' ' HD3' ' A' ' 3' ' ' PRO . 55.2 mtpt -75.3 -54.46 2.44 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 109.493 -0.558 . . . . 4.9699999999999998 109.493 176.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.554 ' HD3' ' HB2' ' A' ' 2' ' ' LYS . 88.4 Cg_endo -80.22 170.58 16.1 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.502 1.468 . . . . 1.1399999999999999 110.276 165.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.585 ' CE2' ' HD3' ' A' ' 16' ' ' PRO . 84.8 m-85 -124.05 117.33 24.46 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 116.169 -0.469 . . . . 1.1100000000000001 109.801 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.9 m -101.99 147.68 8.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.047 -0.524 . . . . 0.34999999999999998 111.186 -173.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 10' ' ' GLN . 52.6 t -67.71 129.96 41.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.988 -0.551 . . . . 0.20999999999999999 109.888 175.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.6 mp -78.3 -25.25 13.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.756 -0.656 . . . . 0.67000000000000004 109.785 -176.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 39.7 t60 -87.53 -47.13 8.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.8 -0.636 . . . . 1.3 111.327 -171.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.7 p -115.27 -9.39 12.22 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 119.956 -0.698 . . . . 0.27000000000000002 111.655 -176.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 6' ' ' CYS . 96.2 mt-30 67.64 79.36 0.22 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.454 -0.794 . . . . 1.5800000000000001 112.593 175.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.401 ' HA ' ' HD3' ' A' ' 11' ' ' ARG . 2.9 mmt180 -142.01 144.23 33.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.463 -0.789 . . . . 3.6699999999999999 109.566 176.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -80.69 138.72 36.37 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.038 0.447 . . . . 1.6399999999999999 111.176 -173.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.406 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 81.5 m-85 -137.39 162.77 32.72 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.332 -0.849 . . . . 0.64000000000000001 110.286 174.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.0 -20.18 22.39 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.771 0.656 . . . . 0.40999999999999998 112.771 -170.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -141.08 150.03 57.61 Favored Pre-proline 0 C--N 1.326 -0.445 0 C-N-CA 121.033 -0.267 . . . . 1.9299999999999999 110.776 -174.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.585 ' HD3' ' CE2' ' A' ' 4' ' ' TYR . 17.1 Cg_exo -67.09 -22.0 48.13 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.811 2.34 . . . . 0.53000000000000003 109.193 169.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.602 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -57.13 -44.68 93.07 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 114.532 -1.213 . . . . 0.28000000000000003 111.885 172.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.574 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -77.84 -22.38 50.03 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 121.037 -0.265 . . . . 0.22 110.992 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.575 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.6 mm? -73.38 -35.14 65.88 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 109.528 -0.545 . . . . 1.1000000000000001 109.528 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.602 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 16.9 pt20 -75.16 -35.52 61.61 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.672 -0.811 . . . . 2.23 109.91 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -68.18 -32.29 72.44 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.433 -1.258 . . . . 3.6000000000000001 108.829 173.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.576 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 46.6 t60 -71.59 -46.41 59.37 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 114.756 -1.111 . . . . 0.39000000000000001 111.787 -176.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 19' ' ' LEU . 60.8 t -66.62 -32.7 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 C-N-CA 119.822 -0.751 . . . . 0.34000000000000002 109.719 -175.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -59.3 -29.97 67.99 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.609 -0.723 . . . . 2.96 111.49 171.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.576 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 79.6 mt -64.82 -52.85 49.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.308 -0.406 . . . . 1.3 110.68 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -62.19 -47.6 83.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.15 0.5 . . . . 0.28999999999999998 110.6 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.1 m -85.49 49.57 1.79 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.434 0.635 . . . . 1.6799999999999999 110.793 -176.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.69 37.32 2.08 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.813 -0.631 . . . . 2.3599999999999999 113.04 -178.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -81.19 -34.24 32.45 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.126 -0.694 . . . . 3.9199999999999999 109.126 176.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.7 tttm . . . . . 0 C--O 1.25 1.081 0 CA-C-N 115.239 -0.891 . . . . 6.9100000000000001 109.529 175.47 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 120.869 0.366 . . . . 7.1399999999999997 110.264 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -108.12 140.31 21.55 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.325 -0.62 . . . . 4.9699999999999998 109.325 177.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -54.12 167.27 1.26 Allowed 'Trans proline' 0 CA--C 1.512 -0.624 0 C-N-CA 123.258 2.639 . . . . 1.1399999999999999 113.713 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.574 ' CZ ' ' HG3' ' A' ' 16' ' ' PRO . 91.9 m-85 -104.66 123.87 48.35 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 113.971 -1.468 . . . . 1.1100000000000001 109.564 -174.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.6 HG12 ' HG2' ' A' ' 12' ' ' GLN . 22.3 m -111.17 149.65 13.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.951 -0.568 . . . . 0.34999999999999998 111.092 -172.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.445 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 47.9 t -76.46 115.4 16.17 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.017 -0.538 . . . . 0.20999999999999999 109.823 176.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.1 mp -69.42 -23.65 26.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.531 0.681 . . . . 0.67000000000000004 109.602 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.425 ' HB3' ' CD2' ' A' ' 26' ' ' HIS . 2.5 t-80 -81.42 -40.92 22.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.151 -0.931 . . . . 1.3 112.018 -171.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.6 p -126.52 -5.65 6.46 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 120.163 -0.615 . . . . 0.27000000000000002 112.129 -177.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 69.8 67.77 0.24 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.778 0.831 . . . . 1.5800000000000001 112.266 175.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -134.44 135.48 42.56 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.627 -0.715 . . . . 3.6699999999999999 109.716 175.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.6 ' HG2' HG12 ' A' ' 5' ' ' VAL . 70.4 mt-30 -84.23 133.95 34.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.969 0.414 . . . . 1.6399999999999999 111.815 -176.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.569 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 97.0 m-85 -129.46 176.42 7.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.878 -0.601 . . . . 0.64000000000000001 110.458 174.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -95.52 -40.28 9.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.178 0.513 . . . . 0.40999999999999998 112.16 -173.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -112.26 139.91 23.04 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.657 -0.702 . . . . 1.9299999999999999 111.672 -167.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.574 ' HG3' ' CZ ' ' A' ' 4' ' ' TYR . 17.4 Cg_exo -64.47 -32.83 59.22 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.799 2.332 . . . . 0.53000000000000003 110.333 173.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.471 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -63.6 -29.94 76.15 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.226 -0.897 . . . . 0.28000000000000003 112.042 177.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -82.01 -30.78 31.34 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 120.801 -0.36 . . . . 0.22 111.154 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.569 ' CD2' ' HB2' ' A' ' 13' ' ' PHE . 2.2 mm? -70.92 -31.4 68.0 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 109.746 -0.464 . . . . 1.1000000000000001 109.746 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 12.8 pt20 -75.56 -36.93 60.29 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 119.367 -0.933 . . . . 2.23 110.229 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.46 ' HA ' ' HD2' ' A' ' 21' ' ' ARG . 0.9 OUTLIER -70.22 -32.54 70.46 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.34 -1.3 . . . . 3.6000000000000001 108.777 174.603 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.513 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 55.7 t60 -66.69 -47.89 71.01 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 114.32 -1.309 . . . . 0.39000000000000001 111.053 -177.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 19' ' ' LEU . 98.0 t -64.51 -34.49 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 115.666 -0.697 . . . . 0.34000000000000002 109.895 -176.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -63.55 -25.65 68.34 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 112.314 0.487 . . . . 2.96 112.314 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.513 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 83.8 mt -65.25 -45.15 94.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.966 -0.383 . . . . 1.3 109.966 175.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.425 ' CD2' ' HB3' ' A' ' 8' ' ' HIS . 74.8 m-70 -71.02 -50.82 29.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.28999999999999998 110.17 175.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.2 m -84.01 51.49 2.07 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.46 -0.791 . . . . 1.6799999999999999 111.111 -174.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.11 63.99 4.22 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.043 -0.599 . . . . 2.3599999999999999 111.784 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -69.4 -60.58 2.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.031 0.444 . . . . 3.9199999999999999 110.512 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt . . . . . 0 C--O 1.247 0.964 0 CA-C-N 115.478 -0.783 . . . . 6.9100000000000001 110.01 179.642 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptp . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.545 0.212 . . . . 7.1399999999999997 111.197 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.52 100.42 2.05 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 109.349 -0.611 . . . . 4.9699999999999998 109.349 -178.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -59.85 178.19 0.4 Allowed 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 123.513 2.809 . . . . 1.1399999999999999 114.324 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.44 ' CE1' ' HD3' ' A' ' 16' ' ' PRO . 95.6 m-85 -103.3 122.04 43.97 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.126 -1.397 . . . . 1.1100000000000001 108.847 177.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.517 HG12 ' HG2' ' A' ' 12' ' ' GLN . 17.3 m -110.93 151.12 13.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.008 0.432 . . . . 0.34999999999999998 111.675 -172.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.427 ' HB3' ' H ' ' A' ' 11' ' ' ARG . 48.9 t -77.44 129.76 36.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.688 -0.687 . . . . 0.20999999999999999 109.828 177.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.491 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.8 mp -79.3 -23.72 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 115.459 -0.792 . . . . 0.67000000000000004 110.066 -178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -91.46 -36.87 13.52 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.274 0.472 . . . . 1.3 112.274 -171.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.444 ' SG ' ' HG2' ' A' ' 11' ' ' ARG . 15.7 p -124.53 -1.09 8.06 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 119.592 -0.843 . . . . 0.27000000000000002 112.627 -176.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 67.01 60.66 0.51 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.775 -0.648 . . . . 1.5800000000000001 112.1 173.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.444 ' HG2' ' SG ' ' A' ' 9' ' ' CYS . 37.1 mmt180 -121.56 151.35 40.45 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.462 -0.57 . . . . 3.6699999999999999 109.462 175.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.517 ' HG2' HG12 ' A' ' 5' ' ' VAL . 70.7 mt-30 -109.39 123.79 49.92 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.626 0.251 . . . . 1.6399999999999999 111.203 -174.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -128.17 156.73 42.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.273 0.559 . . . . 0.64000000000000001 110.981 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.68 -40.81 61.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.434 -0.803 . . . . 0.40999999999999998 112.58 -176.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -109.31 137.05 20.14 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 115.804 -0.634 . . . . 1.9299999999999999 111.413 -166.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.44 ' HD3' ' CE1' ' A' ' 4' ' ' TYR . 32.1 Cg_endo -64.91 -30.85 57.43 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.509 2.139 . . . . 0.53000000000000003 110.308 174.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.75 -37.08 89.29 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.269 -0.878 . . . . 0.28000000000000003 111.907 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.575 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -76.15 -25.23 55.11 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 111.401 0.148 . . . . 0.22 111.401 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.472 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.7 mm? -75.43 -29.32 59.69 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 109.15 -0.685 . . . . 1.1000000000000001 109.15 177.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -70.34 -43.21 70.68 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.302 -0.863 . . . . 2.23 109.823 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.647 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -64.68 -34.41 78.24 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.064 -1.425 . . . . 3.6000000000000001 108.71 174.268 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.575 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 29.0 t60 -67.93 -53.6 25.07 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 114.537 -1.21 . . . . 0.39000000000000001 111.419 -174.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 19' ' ' LEU . 98.1 t -64.4 -34.71 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 115.59 -0.732 . . . . 0.34000000000000002 110.175 -174.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.6 ' HB3' ' HB3' ' A' ' 30' ' ' LYS . 35.5 mtt180 -69.47 -20.15 63.75 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.239 -0.437 . . . . 2.96 111.459 176.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.647 HG12 ' O ' ' A' ' 21' ' ' ARG . 27.6 mm -65.6 -49.1 79.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 109.586 -0.524 . . . . 1.3 109.586 173.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -63.34 -51.2 66.93 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.797 -0.638 . . . . 0.28999999999999998 111.261 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.692 HG23 ' H ' ' A' ' 29' ' ' GLU . 12.2 t -79.49 -17.4 54.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.255 -0.43 . . . . 1.6799999999999999 111.743 -172.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.98 11.46 74.36 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.629 -0.796 . . . . 2.3599999999999999 112.887 177.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.692 ' H ' HG23 ' A' ' 27' ' ' THR . 47.5 mt-10 -86.4 11.85 11.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.869 0.366 . . . . 3.9199999999999999 111.545 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.6 ' HB3' ' HB3' ' A' ' 24' ' ' ARG . 19.2 pttp . . . . . 0 C--O 1.244 0.807 0 CA-C-O 118.307 -0.854 . . . . 6.9100000000000001 110.14 177.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 120.652 0.263 . . . . 7.1399999999999997 110.731 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 2' ' ' LYS . 39.0 pttt -114.76 82.54 8.25 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 121.276 0.56 . . . . 4.9699999999999998 110.062 172.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -69.54 177.18 5.68 Favored 'Trans proline' 0 CA--C 1.513 -0.569 0 C-N-CA 122.682 2.255 . . . . 1.1399999999999999 112.957 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.602 ' O ' HD21 ' A' ' 19' ' ' LEU . 83.8 m-85 -113.41 118.15 33.74 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 113.989 -1.46 . . . . 1.1100000000000001 108.577 177.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.642 ' HA ' ' HA ' ' A' ' 12' ' ' GLN . 19.3 m -101.04 150.85 5.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 121.236 0.541 . . . . 0.34999999999999998 111.364 -173.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.44 ' HB3' ' H ' ' A' ' 11' ' ' ARG . 43.0 t -71.37 122.06 19.66 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.446 -0.797 . . . . 0.20999999999999999 110.534 176.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 mp -66.76 -26.58 37.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.486 -0.779 . . . . 0.67000000000000004 110.959 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -88.9 -34.69 16.85 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.191 0.441 . . . . 1.3 112.191 -171.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.6 p -129.98 2.24 4.81 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 119.672 -0.811 . . . . 0.27000000000000002 112.824 -175.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 65.16 46.12 2.81 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.165 0.586 . . . . 1.5800000000000001 112.52 172.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.44 ' H ' ' HB3' ' A' ' 6' ' ' CYS . 99.6 mtt180 -114.57 127.23 55.68 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.623 -0.51 . . . . 3.6699999999999999 109.623 176.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.642 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 11.1 pt20 -88.28 135.2 33.57 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.223 0.535 . . . . 1.6399999999999999 111.882 -173.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -127.54 166.08 18.67 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.562 -0.745 . . . . 0.64000000000000001 110.481 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.56 -45.21 62.91 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.42 0.526 . . . . 0.40999999999999998 112.42 -176.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -117.17 144.44 33.74 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.248 -0.433 . . . . 1.9299999999999999 111.656 -166.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.485 ' HD3' ' CE1' ' A' ' 4' ' ' TYR . 39.4 Cg_endo -67.72 -26.26 39.19 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.792 2.328 . . . . 0.53000000000000003 110.909 176.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.52 -35.08 89.49 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.333 -0.849 . . . . 0.28000000000000003 111.627 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.49 -25.94 62.48 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 121.067 -0.253 . . . . 0.22 110.409 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.602 HD21 ' O ' ' A' ' 4' ' ' TYR . 3.1 mm? -70.38 -30.24 67.1 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.818 -0.808 . . . . 1.1000000000000001 108.818 177.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.539 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 83.0 mm-40 -70.02 -43.31 71.59 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.772 0.796 . . . . 2.23 110.177 178.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.39 -33.17 75.32 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.359 -1.291 . . . . 3.6000000000000001 108.359 175.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.598 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 59.0 t60 -69.36 -45.38 69.53 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 114.532 -1.213 . . . . 0.39000000000000001 111.414 -176.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 19' ' ' LEU . 95.7 t -65.82 -32.53 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 C-N-CA 119.982 -0.687 . . . . 0.34000000000000002 109.822 -175.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 20' ' ' GLN . 14.9 mmm180 -67.11 -19.82 65.69 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.174 -0.466 . . . . 2.96 111.597 174.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.598 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 72.2 mt -68.23 -47.8 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 109.862 -0.421 . . . . 1.3 109.862 174.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -65.13 -42.18 94.13 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.247 0.546 . . . . 0.28999999999999998 109.586 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.3 m -83.18 49.47 1.55 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.436 -0.802 . . . . 1.6799999999999999 109.76 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.56 33.59 2.54 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.556 -0.747 . . . . 2.3599999999999999 112.624 -176.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.619 ' HG3' ' HG3' ' A' ' 30' ' ' LYS . 11.1 pt-20 -85.18 -21.5 29.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.17 0.509 . . . . 3.9199999999999999 109.719 176.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.619 ' HG3' ' HG3' ' A' ' 29' ' ' GLU . 28.0 mtpp . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.365 -0.826 . . . . 6.9100000000000001 109.469 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.2 mmm . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 120.959 0.409 . . . . 7.1399999999999997 111.346 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -85.72 116.14 64.46 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.196 -0.668 . . . . 4.9699999999999998 109.196 171.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.06 175.74 7.13 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.484 2.123 . . . . 1.1399999999999999 111.439 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.525 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . 96.5 m-85 -90.91 102.37 15.14 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.331 -0.618 . . . . 1.1100000000000001 109.331 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 12' ' ' GLN . 32.7 m -95.17 148.05 5.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.661 -0.7 . . . . 0.34999999999999998 111.478 -175.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.515 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 45.0 t -65.61 125.08 24.1 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.253 -0.885 . . . . 0.20999999999999999 110.484 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.6 mm -68.75 -22.04 26.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.783 -0.644 . . . . 0.67000000000000004 111.05 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -91.6 -38.58 12.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.023 -0.535 . . . . 1.3 111.713 -173.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.4 p -128.88 -0.36 5.34 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 119.793 -0.763 . . . . 0.27000000000000002 112.727 -171.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 65.53 43.65 3.29 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.816 0.673 . . . . 1.5800000000000001 112.816 175.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.498 ' H ' ' HB3' ' A' ' 6' ' ' CYS . 19.6 mmm180 -97.27 136.44 37.75 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.843 -0.428 . . . . 3.6699999999999999 109.843 175.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.459 ' HA ' HG12 ' A' ' 5' ' ' VAL . 88.6 mt-30 -88.98 124.31 34.13 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.134 0.271 . . . . 1.6399999999999999 111.573 -172.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -130.77 162.5 29.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.152 0.501 . . . . 0.64000000000000001 110.952 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.67 -32.53 23.57 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.55 -0.75 . . . . 0.40999999999999998 112.192 -171.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -123.53 142.79 39.85 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.767 -0.651 . . . . 1.9299999999999999 111.63 -168.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.422 ' HD3' ' CE1' ' A' ' 4' ' ' TYR . 41.5 Cg_endo -67.57 -24.15 42.31 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.691 2.261 . . . . 0.53000000000000003 111.02 174.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.642 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . -69.51 -32.1 71.27 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.559 -0.746 . . . . 0.28000000000000003 111.44 174.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -75.36 -26.79 58.83 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 122.564 -0.374 . . . . 0.22 110.813 178.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.6 ' O ' HG23 ' A' ' 23' ' ' VAL . 12.6 mt -70.49 -34.28 72.18 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 109.468 -0.567 . . . . 1.1000000000000001 109.468 178.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.642 ' HG3' ' O ' ' A' ' 17' ' ' GLY . 5.2 pp0? -78.03 -31.78 50.62 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 119.375 -0.93 . . . . 2.23 110.171 -177.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -67.69 -37.74 82.71 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 113.928 -1.487 . . . . 3.6000000000000001 108.291 171.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.568 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 66.1 t60 -67.49 -44.69 77.91 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.354 -1.294 . . . . 0.39000000000000001 111.358 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 19' ' ' LEU . 93.8 t -68.08 -29.8 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 C-N-CA 120.147 -0.621 . . . . 0.34000000000000002 110.011 -175.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -61.32 -24.76 66.67 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.753 -0.658 . . . . 2.96 111.035 171.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.568 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 75.7 mt -70.01 -47.66 67.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.399 -0.364 . . . . 1.3 110.882 175.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -63.28 -35.5 80.55 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.661 -0.416 . . . . 0.28999999999999998 110.159 176.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.72 28.57 1.49 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.85 -0.614 . . . . 1.6799999999999999 109.85 177.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.82 68.72 2.5 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.481 -0.781 . . . . 2.3599999999999999 111.562 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -87.1 -22.08 25.62 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.538 0.685 . . . . 3.9199999999999999 109.609 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 41.3 mmtm . . . . . 0 C--O 1.251 1.179 0 CA-C-N 114.774 -1.103 . . . . 6.9100000000000001 109.39 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ptm . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 121.35 0.595 . . . . 7.1399999999999997 110.783 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.509 ' HD3' ' HD2' ' A' ' 3' ' ' PRO . 0.0 OUTLIER 179.71 118.84 0.21 Allowed Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.435 -0.802 . . . . 4.9699999999999998 109.39 178.52 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.509 ' HD2' ' HD3' ' A' ' 2' ' ' LYS . 72.9 Cg_endo -74.47 167.56 26.85 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.803 1.669 . . . . 1.1399999999999999 111.607 176.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.521 ' O ' HD21 ' A' ' 19' ' ' LEU . 84.3 m-85 -129.25 123.38 31.78 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.454 -0.794 . . . . 1.1100000000000001 109.558 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.546 HG12 ' HG2' ' A' ' 12' ' ' GLN . 27.1 m -106.87 147.31 12.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 115.675 -0.693 . . . . 0.34999999999999998 111.166 -175.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.463 ' HB3' ' H ' ' A' ' 11' ' ' ARG . 47.3 t -66.55 132.06 47.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.35 -0.841 . . . . 0.20999999999999999 110.977 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.491 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.4 mp -71.83 -27.76 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-N 115.015 -0.993 . . . . 0.67000000000000004 110.101 -176.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -89.4 -50.07 6.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.911 -0.586 . . . . 1.3 111.595 -172.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.1 p -114.58 -2.32 13.15 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.308 -0.557 . . . . 0.27000000000000002 112.138 -170.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 59.67 58.94 2.69 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.265 -0.879 . . . . 1.5800000000000001 112.702 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.616 ' HA ' ' NE ' ' A' ' 11' ' ' ARG . 5.2 mmp_? -112.38 141.51 46.03 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.477 -0.564 . . . . 3.6699999999999999 109.477 173.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.546 ' HG2' HG12 ' A' ' 5' ' ' VAL . 86.9 mt-30 -89.97 128.62 36.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.985 0.421 . . . . 1.6399999999999999 111.966 -173.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -128.69 -179.49 5.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.645 -0.707 . . . . 0.64000000000000001 109.782 172.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -105.99 -35.23 7.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.878 0.37 . . . . 0.40999999999999998 111.991 -173.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 1.0 OUTLIER -115.58 147.36 38.69 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.298 -0.41 . . . . 1.9299999999999999 110.658 -173.531 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 15' ' ' ASP . 20.2 Cg_exo -65.28 -22.37 60.56 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.532 2.155 . . . . 0.53000000000000003 109.277 170.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -53.45 -53.21 36.48 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.316 -1.311 . . . . 0.28000000000000003 111.954 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.603 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -73.91 -21.99 59.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.833 -0.183 . . . . 0.22 111.438 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.586 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.7 mm? -73.49 -32.08 64.09 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 109.675 -0.491 . . . . 1.1000000000000001 109.675 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -76.57 -39.31 53.06 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.764 0.792 . . . . 2.23 110.201 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.548 ' HD3' ' HD2' ' A' ' 24' ' ' ARG . 8.6 tpp180 -64.9 -31.82 73.23 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.217 -1.356 . . . . 3.6000000000000001 108.418 174.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.639 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 35.6 t60 -68.4 -45.78 71.77 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.214 -1.357 . . . . 0.39000000000000001 111.783 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 19' ' ' LEU . 85.9 t -66.32 -38.38 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 C-N-CA 119.97 -0.692 . . . . 0.34000000000000002 110.351 -173.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.548 ' HD2' ' HD3' ' A' ' 21' ' ' ARG . 9.1 ptp180 -70.44 -10.93 60.43 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.056 0.455 . . . . 2.96 110.75 177.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.639 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 45.9 mt -73.75 -42.23 54.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.477 -0.329 . . . . 1.3 110.284 171.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -65.59 -33.52 76.09 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.338 -0.392 . . . . 0.28999999999999998 111.276 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.21 -41.77 60.86 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.431 -0.508 . . . . 1.6799999999999999 110.868 175.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.18 -22.76 2.94 Favored Glycine 0 CA--C 1.52 0.373 0 CA-C-N 116.018 -0.537 . . . . 2.3599999999999999 113.27 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -61.95 -46.04 91.06 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.003 0.43 . . . . 3.9199999999999999 111.615 -176.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.4 tptm . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.644 -0.693 . . . . 6.9100000000000001 110.046 -177.405 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 110.25 -0.278 . . . . 7.1399999999999997 110.25 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -77.77 123.27 86.47 Favored Pre-proline 0 C--N 1.331 -0.196 0 N-CA-C 109.917 -0.401 . . . . 4.9699999999999998 109.917 176.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.77 175.05 11.44 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.708 2.272 . . . . 1.1399999999999999 112.432 -177.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -104.58 106.41 16.89 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.79 -0.818 . . . . 1.1100000000000001 108.79 177.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.515 HG12 ' HG2' ' A' ' 12' ' ' GLN . 12.6 m -92.04 144.72 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.412 0.625 . . . . 0.34999999999999998 111.665 -173.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.449 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 44.8 t -56.43 132.15 50.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.142 -0.935 . . . . 0.20999999999999999 111.262 178.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.497 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.5 mp -74.31 -25.94 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 115.1 -0.955 . . . . 0.67000000000000004 110.654 -176.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -93.34 -43.28 8.86 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.597 -0.441 . . . . 1.3 112.076 -173.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.9 p -121.44 -0.69 9.75 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 119.761 -0.776 . . . . 0.27000000000000002 112.326 -173.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 60.38 81.4 0.18 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.66 -0.7 . . . . 1.5800000000000001 112.057 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 28.9 ttm180 -138.17 136.86 37.06 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 108.969 -0.752 . . . . 3.6699999999999999 108.969 177.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.515 ' HG2' HG12 ' A' ' 5' ' ' VAL . 86.0 mt-30 -81.82 125.79 31.09 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.838 0.352 . . . . 1.6399999999999999 111.865 -172.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -128.66 149.7 50.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.909 -0.587 . . . . 0.64000000000000001 110.59 175.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.12 -33.45 67.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.429 -0.805 . . . . 0.40999999999999998 112.638 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 58.1 m-20 -121.83 142.39 36.04 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 115.867 -0.606 . . . . 1.9299999999999999 110.983 -168.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 15' ' ' ASP . 17.7 Cg_exo -66.11 -28.38 48.83 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.612 2.208 . . . . 0.53000000000000003 110.304 173.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.601 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . -68.76 -22.5 75.47 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.3 -0.864 . . . . 0.28000000000000003 111.735 174.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -80.57 -26.63 37.82 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 122.561 -0.376 . . . . 0.22 110.3 175.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.696 ' O ' HG23 ' A' ' 23' ' ' VAL . 12.0 mt -71.97 -35.76 69.63 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 109.205 -0.665 . . . . 1.1000000000000001 109.205 177.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.601 ' HG3' ' O ' ' A' ' 17' ' ' GLY . 1.7 pp0? -73.55 -36.27 65.62 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 119.553 -0.859 . . . . 2.23 109.974 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -59.88 -41.78 92.31 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.336 -1.302 . . . . 3.6000000000000001 108.668 171.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.599 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 39.3 t60 -66.5 -36.56 83.01 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 113.346 -1.752 . . . . 0.39000000000000001 112.064 -176.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 19' ' ' LEU . 49.0 t -72.83 -27.82 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 C-N-CA 119.093 -1.043 . . . . 0.34000000000000002 109.695 -175.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 20' ' ' GLN . 13.6 mmt180 -59.35 -36.09 75.07 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.109 -0.7 . . . . 2.96 109.109 171.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.599 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 19.0 mm -61.29 -43.76 97.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 114.841 -1.072 . . . . 1.3 111.627 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -74.75 -51.83 13.15 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.494 0.553 . . . . 0.28999999999999998 112.494 -175.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.478 HG23 ' H ' ' A' ' 29' ' ' GLU . 14.9 t -127.5 -32.49 2.41 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.187 -0.605 . . . . 1.6799999999999999 111.738 -173.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 24' ' ' ARG . . . 82.25 -13.75 37.71 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.746 -0.74 . . . . 2.3599999999999999 112.885 176.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.478 ' H ' HG23 ' A' ' 27' ' ' THR . 36.4 mt-10 -63.55 -46.15 87.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.243 0.544 . . . . 3.9199999999999999 110.203 178.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.4 mttm . . . . . 0 C--O 1.245 0.845 0 CA-C-O 118.068 -0.968 . . . . 6.9100000000000001 110.011 -176.909 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 121.068 0.461 . . . . 7.1399999999999997 110.478 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.615 ' HD3' ' HD2' ' A' ' 3' ' ' PRO . 16.9 tppt? -142.23 121.94 8.03 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.953 -0.567 . . . . 4.9699999999999998 109.969 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.615 ' HD2' ' HD3' ' A' ' 2' ' ' LYS . 96.6 Cg_endo -78.15 174.42 12.49 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.316 2.011 . . . . 1.1399999999999999 111.648 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.506 ' O ' HD21 ' A' ' 19' ' ' LEU . 61.2 m-85 -106.49 111.32 23.84 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.849 -0.797 . . . . 1.1100000000000001 108.849 -178.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.48 HG12 ' HG2' ' A' ' 12' ' ' GLN . 33.3 m -101.99 148.45 7.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.225 0.536 . . . . 0.34999999999999998 111.36 -173.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.522 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 35.7 t -70.91 124.58 24.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.598 -0.728 . . . . 0.20999999999999999 110.183 177.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.504 HD12 ' H ' ' A' ' 7' ' ' ILE . 3.7 mp -70.2 -24.09 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 115.401 -0.818 . . . . 0.67000000000000004 110.462 -176.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -91.76 -41.6 10.59 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.693 -0.403 . . . . 1.3 111.788 -172.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.6 p -121.55 1.42 10.07 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 119.988 -0.685 . . . . 0.27000000000000002 112.575 -172.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 66.03 48.06 1.83 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.929 0.714 . . . . 1.5800000000000001 112.929 170.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -117.4 144.31 45.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.652 -0.249 . . . . 3.6699999999999999 110.437 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.48 ' HG2' HG12 ' A' ' 5' ' ' VAL . 68.8 mt-30 -91.72 128.22 37.47 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.253 0.346 . . . . 1.6399999999999999 111.628 -172.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -124.72 164.37 20.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.129 0.49 . . . . 0.64000000000000001 110.525 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.65 -37.37 15.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.491 -0.777 . . . . 0.40999999999999998 112.219 -172.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.412 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 45.9 m-20 -117.94 139.86 27.06 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.976 -0.556 . . . . 1.9299999999999999 110.949 -167.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.563 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 38.0 Cg_exo -59.83 -34.74 95.54 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.822 2.348 . . . . 0.53000000000000003 110.946 174.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.97 -35.69 91.77 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.365 -0.834 . . . . 0.28000000000000003 112.032 176.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -68.85 -31.86 71.13 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 121.19 -0.204 . . . . 0.22 110.847 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.534 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.8 mm? -68.86 -29.36 67.65 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 108.942 -0.762 . . . . 1.1000000000000001 108.942 178.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.563 ' HG2' ' O ' ' A' ' 16' ' ' PRO . 10.3 mm-40 -74.81 -41.15 60.49 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-O 121.65 0.738 . . . . 2.23 109.899 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.417 ' O ' HG12 ' A' ' 25' ' ' ILE . 1.1 mpt_? -67.77 -32.42 72.99 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.423 -1.262 . . . . 3.6000000000000001 109.111 176.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.529 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 60.4 t60 -72.35 -45.26 60.65 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 114.88 -1.054 . . . . 0.39000000000000001 111.32 -175.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 19' ' ' LEU . 84.4 t -67.16 -32.34 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 C-N-CA 119.945 -0.702 . . . . 0.34000000000000002 109.967 -175.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 17.6 mtp180 -63.09 -28.78 70.31 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.969 -0.56 . . . . 2.96 110.986 174.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.529 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 26.8 mm -64.69 -45.41 95.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-O 120.827 0.346 . . . . 1.3 110.723 175.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -66.23 -27.82 68.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.068 0.461 . . . . 0.28999999999999998 110.677 177.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.1 m -93.5 25.63 3.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.545 0.688 . . . . 1.6799999999999999 110.306 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.85 64.71 3.0 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 111.279 -0.728 . . . . 2.3599999999999999 111.279 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -74.21 -8.94 57.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.023 0.44 . . . . 3.9199999999999999 110.879 -177.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.561 -0.733 . . . . 6.9100000000000001 109.059 175.15 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 120.65 0.262 . . . . 7.1399999999999997 110.358 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.655 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . 28.0 tptp -156.83 -53.2 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.943 -0.572 . . . . 4.9699999999999998 109.821 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.655 ' HD3' ' HB3' ' A' ' 2' ' ' LYS . 97.3 Cg_endo -84.7 -173.75 1.58 Allowed 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 122.124 1.883 . . . . 1.1399999999999999 111.346 171.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.455 ' CE1' ' HD3' ' A' ' 16' ' ' PRO . 73.3 m-85 -76.99 122.49 24.97 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.435 -0.58 . . . . 1.1100000000000001 109.435 178.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.468 HG12 ' HG2' ' A' ' 12' ' ' GLN . 16.8 m -112.26 147.82 15.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.386 -0.37 . . . . 0.34999999999999998 110.938 -174.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.521 ' HB3' ' H ' ' A' ' 11' ' ' ARG . 53.5 t -68.51 127.37 32.77 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.953 -0.567 . . . . 0.20999999999999999 110.449 177.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.498 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.1 mp -73.14 -26.98 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 115.103 -0.953 . . . . 0.67000000000000004 109.93 -177.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -86.48 -45.03 11.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.664 -0.698 . . . . 1.3 111.974 -172.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.7 p -121.83 0.45 9.77 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 119.88 -0.728 . . . . 0.27000000000000002 112.778 -173.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 66.86 52.99 0.89 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.677 0.621 . . . . 1.5800000000000001 112.677 172.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.665 ' HE ' ' HA ' ' A' ' 11' ' ' ARG . 1.3 mmp_? -115.99 134.71 54.68 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.313 -0.625 . . . . 3.6699999999999999 109.313 177.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.613 ' HB3' ' HG2' ' A' ' 3' ' ' PRO . 23.7 mt-30 -92.65 131.74 37.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.456 0.17 . . . . 1.6399999999999999 111.245 -173.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.494 ' O ' ' HB2' ' A' ' 3' ' ' PRO . 56.1 m-85 -135.07 148.38 49.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.731 0.776 . . . . 0.64000000000000001 110.918 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.83 -36.12 82.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.469 -1.241 . . . . 0.40999999999999998 113.384 -171.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -129.04 142.87 46.65 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.921 0.391 . . . . 1.9299999999999999 110.966 -169.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.517 ' O ' ' HG3' ' A' ' 20' ' ' GLN . 32.5 Cg_endo -64.86 -24.6 60.95 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.859 2.373 . . . . 0.53000000000000003 111.311 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.97 -42.13 98.18 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.89 -0.672 . . . . 0.28000000000000003 111.438 173.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -70.86 -22.38 62.31 Favored 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 122.946 -0.149 . . . . 0.22 110.845 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.554 ' O ' HG23 ' A' ' 23' ' ' VAL . 3.4 mm? -75.65 -26.4 57.67 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.185 -0.672 . . . . 1.1000000000000001 109.185 175.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.517 ' HG3' ' O ' ' A' ' 16' ' ' PRO . 72.4 mt-30 -74.12 -42.82 59.44 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.909 0.862 . . . . 2.23 109.356 176.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.6 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -61.19 -35.93 78.49 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.945 -1.48 . . . . 3.6000000000000001 109.19 172.716 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.547 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 10.0 t60 -67.08 -48.78 67.17 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.616 -1.175 . . . . 0.39000000000000001 111.584 -175.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 19' ' ' LEU . 93.4 t -67.28 -35.89 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 C-N-CA 119.98 -0.688 . . . . 0.34000000000000002 110.805 -172.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -71.7 -9.93 59.01 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.874 -0.331 . . . . 2.96 111.0 176.46 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.6 HG12 ' O ' ' A' ' 21' ' ' ARG . 19.5 mm -75.59 -42.93 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 109.683 -0.488 . . . . 1.3 109.683 172.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -70.24 -51.62 29.32 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.01 0.433 . . . . 0.28999999999999998 110.428 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.546 ' O ' HG23 ' A' ' 27' ' ' THR . 7.6 t -92.19 52.77 2.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.889 0.852 . . . . 1.6799999999999999 109.494 -178.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.99 53.99 0.39 Allowed Glycine 0 C--N 1.335 0.474 0 CA-C-N 115.158 -0.928 . . . . 2.3599999999999999 113.471 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -74.78 -31.66 61.81 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 121.667 0.746 . . . . 3.9199999999999999 109.521 176.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.6 tptm . . . . . 0 C--O 1.248 1.014 0 CA-C-N 114.86 -1.064 . . . . 6.9100000000000001 109.089 177.753 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 mmt . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 120.862 0.363 . . . . 7.1399999999999997 110.487 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.582 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . 60.5 tttp -68.87 -56.33 9.45 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.043 -0.526 . . . . 4.9699999999999998 110.745 175.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 2' ' ' LYS . 87.2 Cg_endo -79.96 177.5 8.26 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.76 1.64 . . . . 1.1399999999999999 112.097 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.511 ' O ' HD21 ' A' ' 19' ' ' LEU . 48.2 m-85 -99.85 124.4 45.1 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.539 -0.755 . . . . 1.1100000000000001 109.018 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.601 HG12 ' HG2' ' A' ' 12' ' ' GLN . 17.8 m -103.43 146.66 10.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.265 0.555 . . . . 0.34999999999999998 111.893 -172.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.541 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 35.2 t -74.01 130.27 39.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.42 -0.809 . . . . 0.20999999999999999 110.337 178.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.488 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.8 mp -79.07 -22.17 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 CA-C-N 115.609 -0.723 . . . . 0.67000000000000004 109.865 -177.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.402 ' HB3' ' CD2' ' A' ' 26' ' ' HIS . 4.9 t60 -89.95 -46.52 8.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.834 -0.621 . . . . 1.3 111.678 -172.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 18.7 p -114.07 -4.86 13.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.028 -0.669 . . . . 0.27000000000000002 112.258 -173.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 67.38 57.87 0.56 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.693 -0.685 . . . . 1.5800000000000001 112.153 175.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -128.88 141.78 51.17 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.241 -0.436 . . . . 3.6699999999999999 110.084 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.601 ' HG2' HG12 ' A' ' 5' ' ' VAL . 66.8 mt-30 -92.74 125.27 37.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.507 -0.315 . . . . 1.6399999999999999 111.501 -173.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.416 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 96.0 m-85 -126.37 141.52 51.87 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.873 0.844 . . . . 0.64000000000000001 111.515 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.19 -36.38 77.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.258 -1.337 . . . . 0.40999999999999998 113.736 -172.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.477 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 23.4 m-20 -115.37 141.71 27.62 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 116.098 -0.501 . . . . 1.9299999999999999 111.482 -164.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.488 ' HG3' ' CE1' ' A' ' 4' ' ' TYR . 12.6 Cg_exo -67.45 -32.24 32.44 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.747 2.298 . . . . 0.53000000000000003 110.322 174.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.19 -36.93 92.49 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.134 -0.939 . . . . 0.28000000000000003 111.736 176.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.581 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -69.44 -28.17 65.89 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.984 -0.108 . . . . 0.22 110.937 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.526 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.6 mm? -71.41 -31.35 67.15 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.125 -0.694 . . . . 1.1000000000000001 109.125 177.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.612 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 79.8 mt-30 -68.97 -44.32 73.18 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 119.951 -0.7 . . . . 2.23 109.985 177.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.722 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.3 OUTLIER -61.16 -40.38 93.65 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.257 -1.338 . . . . 3.6000000000000001 108.553 174.988 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.623 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 39.4 t60 -65.64 -49.65 67.87 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 113.607 -1.633 . . . . 0.39000000000000001 111.927 -171.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 19' ' ' LEU . 59.3 t -66.58 -34.63 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 C-N-CA 119.843 -0.743 . . . . 0.34000000000000002 109.868 -175.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.614 ' HA ' HG22 ' A' ' 27' ' ' THR . 78.4 mtt-85 -66.32 -27.04 67.59 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.629 -0.714 . . . . 2.96 110.558 175.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.722 HG12 ' O ' ' A' ' 21' ' ' ARG . 24.6 mm -62.11 -50.39 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.063 -0.517 . . . . 1.3 110.548 175.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.402 ' CD2' ' HB3' ' A' ' 8' ' ' HIS . 33.2 m-70 -62.96 -42.91 99.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.177 -0.465 . . . . 0.28999999999999998 111.212 -179.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.614 HG22 ' HA ' ' A' ' 24' ' ' ARG . 12.0 t -80.69 -0.38 38.0 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.081 -0.509 . . . . 1.6799999999999999 111.552 -173.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.02 14.07 67.65 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.103 -0.57 . . . . 2.3599999999999999 112.479 176.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.526 ' HB3' HG23 ' A' ' 27' ' ' THR . 15.1 tt0 -80.95 -35.07 32.73 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.829 0.347 . . . . 3.9199999999999999 110.528 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.3 tptt . . . . . 0 C--O 1.243 0.742 0 CA-C-O 118.339 -0.839 . . . . 6.9100000000000001 109.876 179.406 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 ttt . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 120.927 0.394 . . . . 7.1399999999999997 110.639 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -107.32 99.24 26.67 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.343 -0.614 . . . . 4.9699999999999998 109.343 174.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.72 173.11 15.0 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.249 1.966 . . . . 1.1399999999999999 111.85 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.486 ' HB3' ' HG ' ' A' ' 19' ' ' LEU . 9.9 m-85 -108.34 120.79 43.39 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.435 -0.802 . . . . 1.1100000000000001 109.756 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.517 HG12 ' HG2' ' A' ' 12' ' ' GLN . 23.3 m -108.72 144.31 17.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 116.35 -0.386 . . . . 0.34999999999999998 110.62 -175.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.429 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 33.8 t -68.34 125.29 25.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.076 -0.511 . . . . 0.20999999999999999 109.947 177.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.539 HD12 ' H ' ' A' ' 7' ' ' ILE . 3.8 mp -74.3 -23.08 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 115.696 -0.683 . . . . 0.67000000000000004 110.029 -175.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -95.47 -44.85 7.34 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.339 -0.544 . . . . 1.3 111.971 -171.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.0 p -112.38 -3.05 14.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.821 -0.752 . . . . 0.27000000000000002 111.469 -175.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 63.45 64.98 0.78 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.896 -1.047 . . . . 1.5800000000000001 112.824 174.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -129.73 134.54 47.67 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.926 -0.579 . . . . 3.6699999999999999 110.234 175.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.517 ' HG2' HG12 ' A' ' 5' ' ' VAL . 73.0 mt-30 -83.18 134.16 34.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.257 -0.429 . . . . 1.6399999999999999 111.431 -176.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.416 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 98.5 m-85 -131.58 169.16 16.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.64000000000000001 110.126 173.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.2 -51.64 8.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.232 0.539 . . . . 0.40999999999999998 112.139 -174.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -105.53 142.25 24.35 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.291 -0.868 . . . . 1.9299999999999999 111.859 -165.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 4' ' ' TYR . 24.7 Cg_endo -63.26 -27.53 72.14 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.89 2.393 . . . . 0.53000000000000003 110.753 171.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.509 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -69.27 -24.18 76.08 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.459 -0.791 . . . . 0.28000000000000003 111.753 176.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -84.27 -28.1 27.41 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 122.587 -0.361 . . . . 0.22 110.854 178.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.561 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.4 mm? -74.26 -29.83 61.85 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 109.509 -0.552 . . . . 1.1000000000000001 109.509 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 13.1 pt20 -75.89 -35.55 59.81 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.41 -0.916 . . . . 2.23 109.752 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.404 ' O ' HG13 ' A' ' 25' ' ' ILE . 30.3 tpt180 -64.28 -39.8 94.67 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.18 -1.373 . . . . 3.6000000000000001 108.764 170.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.515 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 48.1 t60 -67.06 -49.35 65.4 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.092 -1.413 . . . . 0.39000000000000001 111.952 -174.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 19' ' ' LEU . 63.3 t -66.58 -31.86 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 C-N-CA 120.029 -0.668 . . . . 0.34000000000000002 109.755 -175.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -69.51 -7.38 37.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.503 -0.771 . . . . 2.96 111.465 174.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.515 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 81.0 mt -83.86 -47.48 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 109.616 -0.512 . . . . 1.3 109.616 171.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -68.75 -51.64 39.02 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.267 0.556 . . . . 0.28999999999999998 110.661 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.6 m -105.54 34.95 3.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.861 0.838 . . . . 1.6799999999999999 110.392 -176.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.1 10.49 65.79 Favored Glycine 0 CA--C 1.507 -0.421 0 CA-C-N 115.554 -0.748 . . . . 2.3599999999999999 111.579 176.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -62.62 -38.81 91.66 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.303 0.573 . . . . 3.9199999999999999 110.518 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt . . . . . 0 C--O 1.245 0.862 0 CA-C-O 118.333 -0.841 . . . . 6.9100000000000001 109.793 -178.371 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 mtt . . . . . 0 N--CA 1.478 0.97 0 CA-C-O 120.991 0.424 . . . . 7.1399999999999997 111.075 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -143.55 95.62 5.85 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-O 121.166 0.508 . . . . 4.9699999999999998 110.107 172.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.87 176.17 10.23 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.304 2.003 . . . . 1.1399999999999999 111.163 176.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.581 ' O ' HD21 ' A' ' 19' ' ' LEU . 54.5 m-85 -101.32 116.01 31.82 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.838 -0.801 . . . . 1.1100000000000001 108.838 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.618 HG12 ' HG3' ' A' ' 12' ' ' GLN . 16.5 m -105.56 149.5 8.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.322 0.582 . . . . 0.34999999999999998 112.053 -168.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.637 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 4.0 t -76.27 124.05 26.87 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.352 -0.84 . . . . 0.20999999999999999 109.685 176.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.453 HD12 ' H ' ' A' ' 7' ' ' ILE . 3.9 mp -74.55 -19.25 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-N 115.891 -0.595 . . . . 0.67000000000000004 110.101 -175.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -98.65 -35.85 10.06 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.239 -0.584 . . . . 1.3 112.327 -172.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.451 ' SG ' ' HG2' ' A' ' 11' ' ' ARG . 15.2 p -118.48 -0.13 11.48 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 119.864 -0.734 . . . . 0.27000000000000002 112.133 -175.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 62.85 53.02 2.54 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.521 -0.763 . . . . 1.5800000000000001 112.365 174.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.451 ' HG2' ' SG ' ' A' ' 9' ' ' CYS . 24.1 mmt180 -123.58 149.67 45.03 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.932 -0.395 . . . . 3.6699999999999999 109.932 178.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.618 ' HG3' HG12 ' A' ' 5' ' ' VAL . 2.1 mp0 -94.11 136.0 34.87 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.585 -0.279 . . . . 1.6399999999999999 111.104 -176.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.553 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 92.0 m-85 -131.8 158.58 40.89 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.266 0.555 . . . . 0.64000000000000001 110.663 176.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.53 -36.46 26.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.36 -0.836 . . . . 0.40999999999999998 112.909 -171.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 6.2 m-20 -124.01 138.92 31.47 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-O 120.827 0.346 . . . . 1.9299999999999999 111.128 -168.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.435 ' HG3' ' CE1' ' A' ' 4' ' ' TYR . 27.0 Cg_exo -62.45 -29.73 79.31 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.125 2.55 . . . . 0.53000000000000003 111.278 176.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.54 -36.33 93.05 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.747 -0.66 . . . . 0.28000000000000003 111.566 175.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.99 -31.84 64.78 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.608 -0.296 . . . . 0.22 111.015 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.581 HD21 ' O ' ' A' ' 4' ' ' TYR . 2.7 mm? -66.29 -34.67 78.52 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 109.292 -0.632 . . . . 1.1000000000000001 109.292 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -73.78 -38.31 64.71 Favored 'General case' 0 N--CA 1.432 -1.325 0 C-N-CA 119.125 -1.03 . . . . 2.23 110.556 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.587 ' O ' HG12 ' A' ' 25' ' ' ILE . 7.1 tpt180 -65.42 -37.09 85.89 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.713 -1.131 . . . . 3.6000000000000001 108.641 175.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.637 ' HD2' ' SG ' ' A' ' 6' ' ' CYS . 63.3 t60 -73.66 -48.13 34.69 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.041 -1.436 . . . . 0.39000000000000001 111.559 -174.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 19' ' ' LEU . 72.8 t -64.63 -31.62 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 CA-C-N 116.014 -0.539 . . . . 0.34000000000000002 110.557 -173.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -76.56 -14.31 60.02 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 120.382 -0.527 . . . . 2.96 110.685 177.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.587 HG12 ' O ' ' A' ' 21' ' ' ARG . 18.7 mm -69.37 -45.56 78.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 109.747 -0.464 . . . . 1.3 109.747 173.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -65.83 -48.76 70.56 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.293 0.568 . . . . 0.28999999999999998 109.52 172.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.3 m -84.28 49.85 1.75 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.197 -0.91 . . . . 1.6799999999999999 110.377 -177.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -77.36 71.18 2.31 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.153 -0.779 . . . . 2.3599999999999999 111.153 177.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -84.52 -38.63 19.81 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.106 0.479 . . . . 3.9199999999999999 110.865 -177.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.3 mttp . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.6 -0.714 . . . . 6.9100000000000001 109.857 -178.491 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 120.783 0.325 . . . . 7.1399999999999997 110.919 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.484 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . 53.8 tptt -79.42 -51.65 1.21 Allowed Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.634 -0.257 . . . . 4.9699999999999998 110.419 175.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 2' ' ' LYS . 89.0 Cg_endo -78.37 176.22 10.18 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 121.867 1.711 . . . . 1.1399999999999999 111.338 172.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.421 ' O ' HD21 ' A' ' 19' ' ' LEU . 97.8 m-85 -94.86 114.2 26.03 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.942 0.401 . . . . 1.1100000000000001 110.035 -178.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.495 HG12 ' HA ' ' A' ' 12' ' ' GLN . 33.6 m -101.81 146.64 9.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.898 -0.592 . . . . 0.34999999999999998 110.821 -177.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.497 ' HB2' ' HE2' ' A' ' 13' ' ' PHE . 42.2 t -63.92 126.86 29.03 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.876 -0.602 . . . . 0.20999999999999999 110.234 178.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.489 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.2 mp -67.33 -27.35 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 115.014 -0.993 . . . . 0.67000000000000004 110.515 -174.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -96.76 -45.86 6.5 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.25 -0.58 . . . . 1.3 112.162 -171.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.4 p -111.43 -2.0 15.73 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 119.618 -0.833 . . . . 0.27000000000000002 111.916 -172.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 61.36 55.59 2.85 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.102 -0.953 . . . . 1.5800000000000001 112.967 174.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.433 ' H ' ' HB3' ' A' ' 6' ' ' CYS . 87.2 mtt180 -109.29 141.11 42.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.531 -0.544 . . . . 3.6699999999999999 109.531 172.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.495 ' HA ' HG12 ' A' ' 5' ' ' VAL . 25.5 mt-30 -85.54 129.82 34.73 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.701 0.286 . . . . 1.6399999999999999 111.31 -177.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.497 ' HE2' ' HB2' ' A' ' 6' ' ' CYS . 93.2 m-85 -129.16 155.18 45.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.443 0.639 . . . . 0.64000000000000001 110.762 178.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.02 -28.77 29.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.02 -0.991 . . . . 0.40999999999999998 111.351 -175.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -120.76 135.46 24.73 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.28 -0.873 . . . . 1.9299999999999999 110.981 -166.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.37 -25.45 35.93 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.241 1.961 . . . . 0.53000000000000003 110.27 172.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.51 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -67.95 -27.95 73.54 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.961 -1.018 . . . . 0.28000000000000003 111.478 173.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -78.4 -25.91 46.27 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 120.943 -0.303 . . . . 0.22 110.667 178.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.646 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.7 mm? -69.62 -35.25 75.1 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 109.663 -0.495 . . . . 1.1000000000000001 109.663 178.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.51 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 12.0 pt20 -76.18 -36.02 58.87 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 119.415 -0.914 . . . . 2.23 110.105 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.431 ' O ' HG13 ' A' ' 25' ' ' ILE . 7.2 tpm_? -61.08 -40.21 92.84 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.857 -1.519 . . . . 3.6000000000000001 108.191 172.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.621 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 37.8 t60 -70.33 -44.46 68.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.723 -1.58 . . . . 0.39000000000000001 112.183 -174.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 19' ' ' LEU . 61.4 t -66.15 -35.77 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 C-N-CA 119.682 -0.807 . . . . 0.34000000000000002 110.101 -174.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.601 ' HA ' HG22 ' A' ' 27' ' ' THR . 27.2 mmt180 -62.2 -25.52 67.83 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.127 -0.488 . . . . 2.96 111.126 173.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.621 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 79.9 mt -67.96 -44.07 85.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 1.3 110.791 176.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -68.36 -42.72 78.79 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.565 0.221 . . . . 0.28999999999999998 111.359 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.601 HG22 ' HA ' ' A' ' 24' ' ' ARG . 9.0 t -71.49 -28.41 63.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.903 0.382 . . . . 1.6799999999999999 110.504 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.2 -13.36 61.86 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.811 -0.709 . . . . 2.3599999999999999 112.876 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.483 ' H ' HG23 ' A' ' 27' ' ' THR . 42.0 mt-10 -53.22 -47.11 69.25 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.001 0.429 . . . . 3.9199999999999999 111.46 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.403 ' HD2' ' C ' ' A' ' 29' ' ' GLU . 4.5 mptp? . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.351 -0.833 . . . . 6.9100000000000001 109.492 177.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 ptp . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 120.528 0.204 . . . . 7.1399999999999997 110.668 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.46 ' HB2' ' HD3' ' A' ' 3' ' ' PRO . 98.1 mttt -82.99 -53.82 0.58 Allowed Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.809 -0.441 . . . . 4.9699999999999998 109.809 175.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.46 ' HD3' ' HB2' ' A' ' 2' ' ' LYS . 83.4 Cg_endo -81.19 174.52 10.67 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.646 1.564 . . . . 1.1399999999999999 110.132 163.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.408 ' O ' HD21 ' A' ' 19' ' ' LEU . 92.0 m-85 -109.72 119.72 40.27 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.967 0.413 . . . . 1.1100000000000001 110.229 -177.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.458 HG12 ' HG2' ' A' ' 12' ' ' GLN . 31.7 m -104.13 145.2 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 116.003 -0.544 . . . . 0.34999999999999998 110.811 -177.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.555 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 47.2 t -63.85 120.97 12.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.83 -0.623 . . . . 0.20999999999999999 110.158 178.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.49 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.3 mp -71.55 -24.53 23.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.48 0.657 . . . . 0.67000000000000004 110.061 -178.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -85.27 -41.66 15.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.712 -0.676 . . . . 1.3 111.764 -172.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.5 p -124.9 -5.13 7.47 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 119.771 -0.772 . . . . 0.27000000000000002 112.344 -174.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 67.99 79.4 0.22 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.008 0.523 . . . . 1.5800000000000001 112.258 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.504 ' HD2' ' CZ ' ' A' ' 13' ' ' PHE . 22.9 ttm180 -142.53 144.44 32.94 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.959 -0.756 . . . . 3.6699999999999999 108.959 174.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.458 ' HG2' HG12 ' A' ' 5' ' ' VAL . 75.0 mt-30 -88.76 129.93 35.45 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.38 0.511 . . . . 1.6399999999999999 112.38 -173.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.504 ' CZ ' ' HD2' ' A' ' 11' ' ' ARG . 96.4 m-85 -129.12 167.05 18.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.9 -0.591 . . . . 0.64000000000000001 110.705 176.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.03 -2.45 37.19 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.153 0.797 . . . . 0.40999999999999998 113.153 -170.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -155.51 150.33 20.5 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 120.816 -0.354 . . . . 1.9299999999999999 110.109 -176.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.44 -22.61 65.57 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.855 2.37 . . . . 0.53000000000000003 109.531 169.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.557 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -57.22 -48.36 80.69 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 114.382 -1.281 . . . . 0.28000000000000003 111.89 172.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -72.73 -25.41 61.21 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 121.07 -0.252 . . . . 0.22 110.781 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.529 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.5 mm? -72.1 -36.22 69.41 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.094 -0.706 . . . . 1.1000000000000001 109.094 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 17.0 pt20 -77.81 -33.84 52.29 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 119.729 -0.788 . . . . 2.23 109.94 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.47 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.5 OUTLIER -65.44 -36.2 83.22 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.648 -1.16 . . . . 3.6000000000000001 108.741 173.29 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.569 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 47.1 t60 -73.42 -46.1 50.58 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 114.7 -1.136 . . . . 0.39000000000000001 111.683 -174.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 19' ' ' LEU . 97.5 t -66.07 -34.38 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 C-N-CA 119.866 -0.734 . . . . 0.34000000000000002 110.019 -175.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 16.8 mtp180 -62.73 -26.81 68.88 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.109 -0.496 . . . . 2.96 111.077 173.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 18.3 mm -69.22 -44.32 80.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.427 -0.351 . . . . 1.3 110.63 176.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -65.81 -30.79 71.47 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.217 0.532 . . . . 0.28999999999999998 110.626 176.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.5 m -93.14 34.72 1.1 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.426 0.632 . . . . 1.6799999999999999 110.194 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.2 58.86 4.99 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.941 -0.647 . . . . 2.3599999999999999 111.63 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -88.87 -18.86 26.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.86 0.362 . . . . 3.9199999999999999 110.961 -176.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.0 mttm . . . . . 0 C--O 1.247 0.953 0 CA-C-O 118.353 -0.832 . . . . 6.9100000000000001 109.925 178.104 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 109.497 -0.557 . . . . 7.1399999999999997 109.497 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt 55.8 71.43 1.23 Allowed Pre-proline 0 C--O 1.234 0.266 0 O-C-N 123.57 0.544 . . . . 4.9699999999999998 110.492 -174.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -77.69 173.14 14.59 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.332 2.022 . . . . 1.1399999999999999 112.309 -177.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.509 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . 88.1 m-85 -113.47 99.9 8.11 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.338 -0.846 . . . . 1.1100000000000001 108.721 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.601 HG12 ' HG2' ' A' ' 12' ' ' GLN . 11.3 m -89.91 142.66 12.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.403 0.621 . . . . 0.34999999999999998 111.959 -171.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.56 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 21.6 t -65.64 119.38 11.03 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.276 -0.874 . . . . 0.20999999999999999 110.132 175.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.5 mp -71.92 -21.66 21.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.44 0.638 . . . . 0.67000000000000004 110.032 -178.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.459 ' HB3' ' CD2' ' A' ' 26' ' ' HIS . 6.4 t60 -86.72 -36.88 18.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.833 -0.621 . . . . 1.3 111.607 -171.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.7 p -126.67 -5.31 6.4 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 120.016 -0.674 . . . . 0.27000000000000002 111.844 -176.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 67.73 56.42 0.57 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.284 -0.871 . . . . 1.5800000000000001 112.442 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.413 ' H ' ' HB3' ' A' ' 6' ' ' CYS . 63.1 mtt85 -130.85 138.63 49.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.864 -0.607 . . . . 3.6699999999999999 109.705 175.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.601 ' HG2' HG12 ' A' ' 5' ' ' VAL . 36.1 mt-30 -87.8 138.58 31.34 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.562 0.579 . . . . 1.6399999999999999 112.562 -167.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -124.65 169.33 12.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.381 -0.827 . . . . 0.64000000000000001 110.35 173.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.61 -36.19 13.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.238 -0.437 . . . . 0.40999999999999998 112.125 -173.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.7 OUTLIER -113.58 151.58 44.66 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-O 120.977 0.417 . . . . 1.9299999999999999 110.369 -174.685 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.449 ' HG3' ' CE2' ' A' ' 4' ' ' TYR . 12.2 Cg_exo -71.61 -23.53 23.0 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.159 2.573 . . . . 0.53000000000000003 108.465 170.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.07 -41.87 98.21 Favored Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 113.889 -1.505 . . . . 0.28000000000000003 111.553 172.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -77.49 -25.52 50.45 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 121.158 -0.217 . . . . 0.22 111.417 -177.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.557 ' O ' HG23 ' A' ' 23' ' ' VAL . 8.0 mt -71.29 -38.47 71.78 Favored 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 120.014 -0.674 . . . . 1.1000000000000001 109.208 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.444 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 21.4 mt-30 -76.69 -31.96 57.59 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 119.294 -0.962 . . . . 2.23 110.701 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.406 ' O ' HG13 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -65.07 -38.17 89.9 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.998 -1.001 . . . . 3.6000000000000001 108.489 171.86 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.617 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 71.3 t60 -73.56 -45.72 51.72 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 114.427 -1.261 . . . . 0.39000000000000001 112.01 -174.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 19' ' ' LEU . 99.0 t -66.29 -31.06 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 C-N-CA 119.721 -0.792 . . . . 0.34000000000000002 110.14 -174.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 32.9 mtm180 -75.06 -6.96 52.26 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.993 -0.549 . . . . 2.96 110.652 175.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.617 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 68.6 mt -78.41 -50.25 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.683 -0.488 . . . . 1.3 109.683 169.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.459 ' CD2' ' HB3' ' A' ' 8' ' ' HIS . 46.0 m-70 -66.22 -52.07 51.44 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.275 0.559 . . . . 0.28999999999999998 110.458 177.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.3 m -112.06 49.55 0.9 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.49 -0.777 . . . . 1.6799999999999999 110.811 -172.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.22 53.88 4.88 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.975 -0.631 . . . . 2.3599999999999999 111.637 177.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -56.68 -47.77 79.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.111 0.481 . . . . 3.9199999999999999 111.105 -176.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.6 mttp . . . . . 0 C--O 1.247 0.93 0 CA-C-N 115.652 -0.703 . . . . 6.9100000000000001 110.048 178.556 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtm . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.829 0.347 . . . . 7.1399999999999997 111.704 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.62 ' H ' ' HD2' ' A' ' 3' ' ' PRO . 87.9 tttt -118.35 -51.93 0.04 OUTLIER Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.049 -0.723 . . . . 4.9699999999999998 109.049 167.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.62 ' HD2' ' H ' ' A' ' 2' ' ' LYS . 95.3 Cg_endo -80.45 175.7 9.92 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.671 1.581 . . . . 1.1399999999999999 109.815 163.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.435 ' CE1' ' HG3' ' A' ' 16' ' ' PRO . 53.1 m-85 -112.3 99.85 8.34 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.397 0.618 . . . . 1.1100000000000001 110.001 -176.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.532 HG12 ' HG2' ' A' ' 12' ' ' GLN . 28.8 m -97.4 150.01 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.359 -0.837 . . . . 0.34999999999999998 112.079 -171.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.615 ' HB2' ' HE2' ' A' ' 13' ' ' PHE . 23.6 t -75.81 127.12 32.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.24 -0.891 . . . . 0.20999999999999999 110.111 177.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.491 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.5 mp -78.8 -22.04 12.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.507 0.67 . . . . 0.67000000000000004 109.691 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.464 ' HB3' ' CD2' ' A' ' 26' ' ' HIS . 5.0 t60 -83.76 -44.29 14.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.543 -0.753 . . . . 1.3 111.575 -173.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.7 p -121.86 -4.11 9.14 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 119.942 -0.703 . . . . 0.27000000000000002 112.33 -173.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 67.19 57.84 0.58 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.612 -0.722 . . . . 1.5800000000000001 112.469 175.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -119.97 159.86 23.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.668 -0.864 . . . . 3.6699999999999999 108.668 174.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.532 ' HG2' HG12 ' A' ' 5' ' ' VAL . 38.7 mt-30 -106.5 130.15 54.33 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 117.611 0.187 . . . . 1.6399999999999999 110.604 -175.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.615 ' HE2' ' HB2' ' A' ' 6' ' ' CYS . 97.9 m-85 -127.27 166.39 17.87 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.33 0.586 . . . . 0.64000000000000001 111.431 -177.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.41 -28.09 21.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.147 -0.933 . . . . 0.40999999999999998 113.266 -167.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -136.71 150.17 69.27 Favored Pre-proline 0 C--N 1.327 -0.378 0 C-N-CA 121.102 -0.239 . . . . 1.9299999999999999 110.436 -176.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.435 ' HG3' ' CE1' ' A' ' 4' ' ' TYR . 20.4 Cg_exo -65.03 -24.05 60.37 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.536 2.157 . . . . 0.53000000000000003 109.184 168.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.573 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -59.12 -37.31 91.51 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 114.281 -1.327 . . . . 0.28000000000000003 111.842 172.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.562 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -80.33 -28.69 38.1 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.733 -0.387 . . . . 0.22 110.651 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.53 ' O ' HG23 ' A' ' 23' ' ' VAL . 13.8 mt -71.13 -30.11 66.08 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 120.346 -0.541 . . . . 1.1000000000000001 109.614 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.573 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 27.6 pt20 -74.93 -40.69 60.69 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 119.373 -0.931 . . . . 2.23 109.964 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.44 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.7 OUTLIER -70.95 -27.04 63.45 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.49 -1.232 . . . . 3.6000000000000001 109.336 177.075 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.562 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 63.1 t60 -73.46 -48.04 36.69 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 114.934 -1.03 . . . . 0.39000000000000001 111.536 -177.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 19' ' ' LEU . 84.6 t -66.35 -29.27 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 C-N-CA 119.823 -0.751 . . . . 0.34000000000000002 109.649 -175.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 41.9 mtt180 -61.98 -35.58 78.91 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.915 -0.584 . . . . 2.96 110.992 171.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.511 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 26.4 mm -61.72 -45.4 98.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.335 -0.393 . . . . 1.3 110.635 177.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.464 ' CD2' ' HB3' ' A' ' 8' ' ' HIS . 24.5 m-70 -66.1 -45.89 79.58 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.131 -0.486 . . . . 0.28999999999999998 110.244 176.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.7 m -84.73 46.22 1.23 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.662 0.744 . . . . 1.6799999999999999 109.741 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.76 15.49 14.49 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.467 -0.788 . . . . 2.3599999999999999 112.616 -177.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -62.58 -45.26 93.74 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.229 0.538 . . . . 3.9199999999999999 109.864 175.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.191 -0.909 . . . . 6.9100000000000001 109.328 176.599 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 120.908 0.385 . . . . 1.64 111.045 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -109.09 173.98 6.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.066 -0.515 . . . . 0.64 111.071 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.79 -53.45 4.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.099 0.476 . . . . 0.41 111.73 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -106.74 146.6 33.4 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.622 -0.717 . . . . 1.93 110.994 -169.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.96 -28.58 41.86 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.848 2.366 . . . . 0.53 111.231 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.521 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . -64.32 -32.1 83.08 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.779 -0.646 . . . . 0.28 111.507 175.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.3 -28.68 59.81 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 121.014 -0.275 . . . . 0.22 110.839 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 23' ' ' VAL . 8.6 mt -68.47 -34.22 75.56 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 109.458 -0.571 . . . . 1.1 109.458 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -76.11 -33.94 59.47 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 119.037 -1.065 . . . . 2.23 109.746 -177.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.586 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.5 OUTLIER -66.54 -35.36 80.05 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.479 -1.237 . . . . 3.6 108.944 172.147 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.651 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 71.6 t60 -72.29 -49.51 34.22 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.05 -0.977 . . . . 0.39 111.459 -176.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 19' ' ' LEU . 74.6 t -64.24 -37.57 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 115.695 -0.684 . . . . 0.34 110.556 -172.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -69.81 -20.66 63.44 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.057 -0.52 . . . . 2.96 110.446 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.651 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 9.9 mm -64.93 -34.79 72.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.396 -0.366 . . . . 1.3 110.17 172.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 . . . . . 0 CA--C 1.519 -0.237 0 C-N-CA 120.895 -0.322 . . . . 0.29 110.871 177.138 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 . . . . . 0 C--O 1.233 0.185 0 N-CA-C 112.278 0.473 . . . . 1.64 112.278 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -132.62 165.25 24.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.549 -0.75 . . . . 0.64 109.859 175.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.29 -35.32 13.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.936 -0.574 . . . . 0.41 112.44 -171.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.88 147.81 49.58 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 120.589 0.233 . . . . 1.93 110.806 -174.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.42 -22.93 51.54 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.605 2.203 . . . . 0.53 109.082 168.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.557 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -61.22 -43.35 99.5 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 114.48 -1.237 . . . . 0.28 111.845 172.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -76.65 -27.91 55.81 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 120.775 -0.37 . . . . 0.22 110.868 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.698 ' O ' HG23 ' A' ' 23' ' ' VAL . 9.5 mt -66.66 -39.25 88.1 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 109.277 -0.638 . . . . 1.1 109.277 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 9.1 pt20 -72.47 -37.66 68.43 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.977 0.894 . . . . 2.23 110.468 -175.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.563 ' O ' ' HD3' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -67.54 -34.29 76.78 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 113.899 -1.501 . . . . 3.6 107.969 176.368 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.748 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 74.8 t60 -69.25 -39.54 78.4 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 114.317 -1.31 . . . . 0.39 111.845 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 19' ' ' LEU . 87.7 t -67.07 -36.47 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 C-N-CA 119.364 -0.935 . . . . 0.34 109.874 -174.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.2 mmm-85 -63.08 -28.59 70.18 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.198 -0.455 . . . . 2.96 110.413 173.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.748 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 20.0 mm -59.44 -50.53 79.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.773 -0.649 . . . . 1.3 110.63 176.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 . . . . . 0 CA--C 1.519 -0.245 0 CA-C-N 116.204 -0.453 . . . . 0.29 110.922 178.708 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 . . . . . 0 C--O 1.237 0.435 0 CA-C-O 120.905 0.383 . . . . 1.64 111.266 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -125.6 149.23 48.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.64 110.383 174.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.11 -12.72 59.98 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.7 1.0 . . . . 0.41 113.7 -167.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -142.87 151.15 55.73 Favored Pre-proline 0 C--N 1.324 -0.505 0 C-N-CA 120.831 -0.348 . . . . 1.93 110.939 -173.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -66.06 -22.28 55.05 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.628 2.219 . . . . 0.53 109.445 168.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.4 -53.26 47.33 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 114.462 -1.245 . . . . 0.28 111.66 171.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -65.32 -26.19 67.94 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 115.719 -0.241 . . . . 0.22 111.154 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.501 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.8 mm? -70.45 -34.3 72.29 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 109.315 -0.624 . . . . 1.1 109.315 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -72.35 -41.8 66.05 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 119.735 -0.786 . . . . 2.23 110.324 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.596 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -61.3 -39.43 90.42 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.498 -1.228 . . . . 3.6 108.765 175.213 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.608 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 59.5 t60 -75.17 -46.85 31.49 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 114.311 -1.313 . . . . 0.39 112.02 -170.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 19' ' ' LEU . 95.8 t -67.54 -34.55 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 C-N-CA 119.849 -0.74 . . . . 0.34 110.498 -172.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -75.16 -11.79 60.16 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.109 -0.636 . . . . 2.96 110.61 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.608 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 9.5 mm -70.67 -45.73 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.935 -0.394 . . . . 1.3 109.935 171.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 40.5 m-70 . . . . . 0 CA--C 1.519 -0.218 0 CA-C-O 121.083 0.468 . . . . 0.29 110.224 177.245 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 . . . . . 0 C--O 1.233 0.198 0 N-CA-C 111.651 0.241 . . . . 1.64 111.651 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.414 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 98.4 m-85 -108.97 165.83 11.29 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.793 0.33 . . . . 0.64 110.432 176.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.77 -39.01 18.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.923 -0.58 . . . . 0.41 112.415 -175.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.466 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 13.4 m-20 -118.43 142.12 30.86 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.081 -0.508 . . . . 1.93 111.844 -168.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 15' ' ' ASP . 17.0 Cg_exo -66.28 -25.36 49.76 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.982 2.454 . . . . 0.53 111.015 175.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.549 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -62.83 -33.29 86.56 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.574 -0.739 . . . . 0.28 111.884 176.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -80.24 -29.4 38.42 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.549 -0.46 . . . . 0.22 110.674 177.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.523 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.7 mm? -68.55 -34.17 75.36 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 109.633 -0.506 . . . . 1.1 109.633 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.549 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 3.9 pt20 -74.26 -37.82 63.64 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 119.514 -0.875 . . . . 2.23 110.256 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.58 ' O ' HG13 ' A' ' 25' ' ' ILE . 1.1 tmt_? -68.09 -34.86 77.2 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.305 -1.316 . . . . 3.6 108.293 175.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.607 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 33.1 t60 -71.37 -50.04 36.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.735 -1.121 . . . . 0.39 111.747 -175.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 19' ' ' LEU . 99.4 t -65.45 -34.08 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-N 115.824 -0.625 . . . . 0.34 110.102 -173.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 59.7 mtp180 -75.0 -8.87 57.75 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.924 -0.58 . . . . 2.96 110.874 177.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.607 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 57.1 mt -74.14 -48.95 35.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.923 -0.399 . . . . 1.3 109.923 172.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 . . . . . 0 N--CA 1.463 0.212 0 CA-C-N 115.967 -0.561 . . . . 0.29 111.297 -178.947 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 . . . . . 0 CA--C 1.517 -0.299 0 CA-C-O 121.038 0.447 . . . . 1.64 111.176 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.406 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 81.5 m-85 -137.39 162.77 32.72 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.332 -0.849 . . . . 0.64 110.286 174.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.0 -20.18 22.39 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.771 0.656 . . . . 0.41 112.771 -170.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -141.08 150.03 57.61 Favored Pre-proline 0 C--N 1.326 -0.445 0 C-N-CA 121.033 -0.267 . . . . 1.93 110.776 -174.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.427 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 17.1 Cg_exo -67.09 -22.0 48.13 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.811 2.34 . . . . 0.53 109.193 169.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.602 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -57.13 -44.68 93.07 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 114.532 -1.213 . . . . 0.28 111.885 172.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.574 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -77.84 -22.38 50.03 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 121.037 -0.265 . . . . 0.22 110.992 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.575 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.6 mm? -73.38 -35.14 65.88 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 109.528 -0.545 . . . . 1.1 109.528 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.602 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 16.9 pt20 -75.16 -35.52 61.61 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.672 -0.811 . . . . 2.23 109.91 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -68.18 -32.29 72.44 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.433 -1.258 . . . . 3.6 108.829 173.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.576 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 46.6 t60 -71.59 -46.41 59.37 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 114.756 -1.111 . . . . 0.39 111.787 -176.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 19' ' ' LEU . 60.8 t -66.62 -32.7 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 C-N-CA 119.822 -0.751 . . . . 0.34 109.719 -175.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -59.3 -29.97 67.99 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.609 -0.723 . . . . 2.96 111.49 171.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.576 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 79.6 mt -64.82 -52.85 49.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.308 -0.406 . . . . 1.3 110.68 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 121.15 0.5 . . . . 0.29 110.6 178.137 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.969 0.414 . . . . 1.64 111.815 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.569 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 97.0 m-85 -129.46 176.42 7.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.878 -0.601 . . . . 0.64 110.458 174.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -95.52 -40.28 9.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.178 0.513 . . . . 0.41 112.16 -173.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -112.26 139.91 23.04 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.657 -0.702 . . . . 1.93 111.672 -167.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -64.47 -32.83 59.22 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.799 2.332 . . . . 0.53 110.333 173.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.471 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -63.6 -29.94 76.15 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.226 -0.897 . . . . 0.28 112.042 177.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -82.01 -30.78 31.34 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 120.801 -0.36 . . . . 0.22 111.154 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.569 ' CD2' ' HB2' ' A' ' 13' ' ' PHE . 2.2 mm? -70.92 -31.4 68.0 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 109.746 -0.464 . . . . 1.1 109.746 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 12.8 pt20 -75.56 -36.93 60.29 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 119.367 -0.933 . . . . 2.23 110.229 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.46 ' HD2' ' HA ' ' A' ' 21' ' ' ARG . 0.9 OUTLIER -70.22 -32.54 70.46 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.34 -1.3 . . . . 3.6 108.777 174.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.513 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 55.7 t60 -66.69 -47.89 71.01 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 114.32 -1.309 . . . . 0.39 111.053 -177.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 19' ' ' LEU . 98.0 t -64.51 -34.49 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 115.666 -0.697 . . . . 0.34 109.895 -176.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -63.55 -25.65 68.34 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 112.314 0.487 . . . . 2.96 112.314 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.513 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 83.8 mt -65.25 -45.15 94.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.966 -0.383 . . . . 1.3 109.966 175.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.29 110.17 175.594 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 . . . . . 0 N--CA 1.451 -0.397 0 CA-C-O 120.626 0.251 . . . . 1.64 111.203 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -128.17 156.73 42.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.273 0.559 . . . . 0.64 110.981 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.68 -40.81 61.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.434 -0.803 . . . . 0.41 112.58 -176.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -109.31 137.05 20.14 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 115.804 -0.634 . . . . 1.93 111.413 -166.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.91 -30.85 57.43 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.509 2.139 . . . . 0.53 110.308 174.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.75 -37.08 89.29 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.269 -0.878 . . . . 0.28 111.907 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.575 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -76.15 -25.23 55.11 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 111.401 0.148 . . . . 0.22 111.401 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.472 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.7 mm? -75.43 -29.32 59.69 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 109.15 -0.685 . . . . 1.1 109.15 177.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -70.34 -43.21 70.68 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.302 -0.863 . . . . 2.23 109.823 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.647 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -64.68 -34.41 78.24 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.064 -1.425 . . . . 3.6 108.71 174.268 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.575 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 29.0 t60 -67.93 -53.6 25.07 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 114.537 -1.21 . . . . 0.39 111.419 -174.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 19' ' ' LEU . 98.1 t -64.4 -34.71 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 115.59 -0.732 . . . . 0.34 110.175 -174.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -69.47 -20.15 63.75 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.239 -0.437 . . . . 2.96 111.459 176.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.647 HG12 ' O ' ' A' ' 21' ' ' ARG . 27.6 mm -65.6 -49.1 79.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 109.586 -0.524 . . . . 1.3 109.586 173.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 . . . . . 0 CA--C 1.52 -0.184 0 CA-C-N 115.797 -0.638 . . . . 0.29 111.261 -179.321 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 121.223 0.535 . . . . 1.64 111.882 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -127.54 166.08 18.67 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.562 -0.745 . . . . 0.64 110.481 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.56 -45.21 62.91 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.42 0.526 . . . . 0.41 112.42 -176.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -117.17 144.44 33.74 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.248 -0.433 . . . . 1.93 111.656 -166.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.72 -26.26 39.19 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.792 2.328 . . . . 0.53 110.909 176.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.52 -35.08 89.49 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.333 -0.849 . . . . 0.28 111.627 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.49 -25.94 62.48 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 121.067 -0.253 . . . . 0.22 110.409 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.566 ' O ' HG23 ' A' ' 23' ' ' VAL . 3.1 mm? -70.38 -30.24 67.1 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.818 -0.808 . . . . 1.1 108.818 177.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.539 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 83.0 mm-40 -70.02 -43.31 71.59 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.772 0.796 . . . . 2.23 110.177 178.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.39 -33.17 75.32 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.359 -1.291 . . . . 3.6 108.359 175.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.598 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 59.0 t60 -69.36 -45.38 69.53 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 114.532 -1.213 . . . . 0.39 111.414 -176.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 19' ' ' LEU . 95.7 t -65.82 -32.53 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 C-N-CA 119.982 -0.687 . . . . 0.34 109.822 -175.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 20' ' ' GLN . 14.9 mmm180 -67.11 -19.82 65.69 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.174 -0.466 . . . . 2.96 111.597 174.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.598 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 72.2 mt -68.23 -47.8 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 109.862 -0.421 . . . . 1.3 109.862 174.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 . . . . . 0 CA--C 1.518 -0.258 0 CA-C-O 121.247 0.546 . . . . 0.29 109.586 174.584 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 . . . . . 0 C--O 1.235 0.338 0 N-CA-C 111.573 0.212 . . . . 1.64 111.573 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -130.77 162.5 29.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.152 0.501 . . . . 0.64 110.952 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.67 -32.53 23.57 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.55 -0.75 . . . . 0.41 112.192 -171.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -123.53 142.79 39.85 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.767 -0.651 . . . . 1.93 111.63 -168.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.57 -24.15 42.31 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.691 2.261 . . . . 0.53 111.02 174.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.642 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . -69.51 -32.1 71.27 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.559 -0.746 . . . . 0.28 111.44 174.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -75.36 -26.79 58.83 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 122.564 -0.374 . . . . 0.22 110.813 178.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.6 ' O ' HG23 ' A' ' 23' ' ' VAL . 12.6 mt -70.49 -34.28 72.18 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 109.468 -0.567 . . . . 1.1 109.468 178.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.642 ' HG3' ' O ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -78.03 -31.78 50.62 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 119.375 -0.93 . . . . 2.23 110.171 -177.218 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -67.69 -37.74 82.71 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 113.928 -1.487 . . . . 3.6 108.291 171.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.568 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 66.1 t60 -67.49 -44.69 77.91 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.354 -1.294 . . . . 0.39 111.358 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 19' ' ' LEU . 93.8 t -68.08 -29.8 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 C-N-CA 120.147 -0.621 . . . . 0.34 110.011 -175.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -61.32 -24.76 66.67 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.753 -0.658 . . . . 2.96 111.035 171.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.568 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 75.7 mt -70.01 -47.66 67.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.399 -0.364 . . . . 1.3 110.882 175.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 . . . . . 0 N--CA 1.467 0.386 0 C-N-CA 120.661 -0.416 . . . . 0.29 110.159 176.566 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 . . . . . 0 C--O 1.235 0.33 0 CA-C-O 120.985 0.421 . . . . 1.64 111.966 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -128.69 -179.49 5.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.645 -0.707 . . . . 0.64 109.782 172.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -105.99 -35.23 7.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.878 0.37 . . . . 0.41 111.991 -173.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 1.0 OUTLIER -115.58 147.36 38.69 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.298 -0.41 . . . . 1.93 110.658 -173.531 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 15' ' ' ASP . 20.2 Cg_exo -65.28 -22.37 60.56 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.532 2.155 . . . . 0.53 109.277 170.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -53.45 -53.21 36.48 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.316 -1.311 . . . . 0.28 111.954 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.603 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -73.91 -21.99 59.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.833 -0.183 . . . . 0.22 111.438 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.586 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.7 mm? -73.49 -32.08 64.09 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 109.675 -0.491 . . . . 1.1 109.675 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -76.57 -39.31 53.06 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.764 0.792 . . . . 2.23 110.201 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.548 ' HD3' ' HD2' ' A' ' 24' ' ' ARG . 8.6 tpp180 -64.9 -31.82 73.23 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.217 -1.356 . . . . 3.6 108.418 174.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.639 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 35.6 t60 -68.4 -45.78 71.77 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.214 -1.357 . . . . 0.39 111.783 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 19' ' ' LEU . 85.9 t -66.32 -38.38 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 C-N-CA 119.97 -0.692 . . . . 0.34 110.351 -173.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.548 ' HD2' ' HD3' ' A' ' 21' ' ' ARG . 9.1 ptp180 -70.44 -10.93 60.43 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.056 0.455 . . . . 2.96 110.75 177.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.639 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 45.9 mt -73.75 -42.23 54.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.477 -0.329 . . . . 1.3 110.284 171.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 . . . . . 0 N--CA 1.463 0.203 0 CA-C-N 116.338 -0.392 . . . . 0.29 111.276 -179.091 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 120.838 0.352 . . . . 1.64 111.865 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -128.66 149.7 50.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.909 -0.587 . . . . 0.64 110.59 175.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.12 -33.45 67.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.429 -0.805 . . . . 0.41 112.638 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 58.1 m-20 -121.83 142.39 36.04 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 115.867 -0.606 . . . . 1.93 110.983 -168.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 15' ' ' ASP . 17.7 Cg_exo -66.11 -28.38 48.83 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.612 2.208 . . . . 0.53 110.304 173.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.601 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . -68.76 -22.5 75.47 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.3 -0.864 . . . . 0.28 111.735 174.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -80.57 -26.63 37.82 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 122.561 -0.376 . . . . 0.22 110.3 175.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.696 ' O ' HG23 ' A' ' 23' ' ' VAL . 12.0 mt -71.97 -35.76 69.63 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 109.205 -0.665 . . . . 1.1 109.205 177.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.601 ' HG3' ' O ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -73.55 -36.27 65.62 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 119.553 -0.859 . . . . 2.23 109.974 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -59.88 -41.78 92.31 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.336 -1.302 . . . . 3.6 108.668 171.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.599 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 39.3 t60 -66.5 -36.56 83.01 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 113.346 -1.752 . . . . 0.39 112.064 -176.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 19' ' ' LEU . 49.0 t -72.83 -27.82 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 C-N-CA 119.093 -1.043 . . . . 0.34 109.695 -175.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 20' ' ' GLN . 13.6 mmt180 -59.35 -36.09 75.07 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.109 -0.7 . . . . 2.96 109.109 171.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.599 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 19.0 mm -61.29 -43.76 97.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 114.841 -1.072 . . . . 1.3 111.627 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 . . . . . 0 C--N 1.328 -0.352 0 N-CA-C 112.494 0.553 . . . . 0.29 112.494 -175.564 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 . . . . . 0 C--O 1.232 0.154 0 N-CA-C 111.628 0.232 . . . . 1.64 111.628 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -124.72 164.37 20.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.129 0.49 . . . . 0.64 110.525 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.65 -37.37 15.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.491 -0.777 . . . . 0.41 112.219 -172.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.412 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 45.9 m-20 -117.94 139.86 27.06 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.976 -0.556 . . . . 1.93 110.949 -167.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.563 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 38.0 Cg_exo -59.83 -34.74 95.54 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.822 2.348 . . . . 0.53 110.946 174.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.97 -35.69 91.77 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.365 -0.834 . . . . 0.28 112.032 176.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -68.85 -31.86 71.13 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 121.19 -0.204 . . . . 0.22 110.847 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.534 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.8 mm? -68.86 -29.36 67.65 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 108.942 -0.762 . . . . 1.1 108.942 178.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.563 ' HG2' ' O ' ' A' ' 16' ' ' PRO . 10.3 mm-40 -74.81 -41.15 60.49 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-O 121.65 0.738 . . . . 2.23 109.899 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.417 ' O ' HG12 ' A' ' 25' ' ' ILE . 1.1 mpt_? -67.77 -32.42 72.99 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.423 -1.262 . . . . 3.6 109.111 176.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.529 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 60.4 t60 -72.35 -45.26 60.65 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 114.88 -1.054 . . . . 0.39 111.32 -175.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 19' ' ' LEU . 84.4 t -67.16 -32.34 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 C-N-CA 119.945 -0.702 . . . . 0.34 109.967 -175.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 17.6 mtp180 -63.09 -28.78 70.31 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.969 -0.56 . . . . 2.96 110.986 174.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.529 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 26.8 mm -64.69 -45.41 95.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-O 120.827 0.346 . . . . 1.3 110.723 175.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 . . . . . 0 C--N 1.33 -0.259 0 CA-C-O 121.068 0.461 . . . . 0.29 110.677 177.394 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 120.456 0.17 . . . . 1.64 111.245 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -135.07 148.38 49.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.731 0.776 . . . . 0.64 110.918 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.83 -36.12 82.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.469 -1.241 . . . . 0.41 113.384 -171.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -129.04 142.87 46.65 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.921 0.391 . . . . 1.93 110.966 -169.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.517 ' O ' ' HG3' ' A' ' 20' ' ' GLN . 32.5 Cg_endo -64.86 -24.6 60.95 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.859 2.373 . . . . 0.53 111.311 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.97 -42.13 98.18 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.89 -0.672 . . . . 0.28 111.438 173.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -70.86 -22.38 62.31 Favored 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 122.946 -0.149 . . . . 0.22 110.845 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.554 ' O ' HG23 ' A' ' 23' ' ' VAL . 3.4 mm? -75.65 -26.4 57.67 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.185 -0.672 . . . . 1.1 109.185 175.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.517 ' HG3' ' O ' ' A' ' 16' ' ' PRO . 72.4 mt-30 -74.12 -42.82 59.44 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.909 0.862 . . . . 2.23 109.356 176.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.6 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -61.19 -35.93 78.49 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.945 -1.48 . . . . 3.6 109.19 172.716 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.547 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 10.0 t60 -67.08 -48.78 67.17 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.616 -1.175 . . . . 0.39 111.584 -175.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 19' ' ' LEU . 93.4 t -67.28 -35.89 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 C-N-CA 119.98 -0.688 . . . . 0.34 110.805 -172.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -71.7 -9.93 59.01 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.874 -0.331 . . . . 2.96 111.0 176.46 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.6 HG12 ' O ' ' A' ' 21' ' ' ARG . 19.5 mm -75.59 -42.93 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 109.683 -0.488 . . . . 1.3 109.683 172.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 . . . . . 0 CA--C 1.519 -0.228 0 CA-C-O 121.01 0.433 . . . . 0.29 110.428 176.899 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 . . . . . 0 C--O 1.235 0.334 0 CA-C-O 120.631 0.253 . . . . 1.64 111.501 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.416 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 96.0 m-85 -126.37 141.52 51.87 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.873 0.844 . . . . 0.64 111.515 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.19 -36.38 77.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.258 -1.337 . . . . 0.41 113.736 -172.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.477 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 23.4 m-20 -115.37 141.71 27.62 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 116.098 -0.501 . . . . 1.93 111.482 -164.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 15' ' ' ASP . 12.6 Cg_exo -67.45 -32.24 32.44 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.747 2.298 . . . . 0.53 110.322 174.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.19 -36.93 92.49 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.134 -0.939 . . . . 0.28 111.736 176.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.581 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -69.44 -28.17 65.89 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.984 -0.108 . . . . 0.22 110.937 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.526 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.6 mm? -71.41 -31.35 67.15 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.125 -0.694 . . . . 1.1 109.125 177.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.612 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 79.8 mt-30 -68.97 -44.32 73.18 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 119.951 -0.7 . . . . 2.23 109.985 177.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.722 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.3 OUTLIER -61.16 -40.38 93.65 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.257 -1.338 . . . . 3.6 108.553 174.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.623 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 39.4 t60 -65.64 -49.65 67.87 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 113.607 -1.633 . . . . 0.39 111.927 -171.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 19' ' ' LEU . 59.3 t -66.58 -34.63 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 C-N-CA 119.843 -0.743 . . . . 0.34 109.868 -175.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.612 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 78.4 mtt-85 -66.32 -27.04 67.59 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.629 -0.714 . . . . 2.96 110.558 175.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.722 HG12 ' O ' ' A' ' 21' ' ' ARG . 24.6 mm -62.11 -50.39 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.063 -0.517 . . . . 1.3 110.548 175.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 116.177 -0.465 . . . . 0.29 111.212 -179.096 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.705 0.288 . . . . 1.64 111.431 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.416 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 98.5 m-85 -131.58 169.16 16.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.64 110.126 173.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.2 -51.64 8.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.232 0.539 . . . . 0.41 112.139 -174.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -105.53 142.25 24.35 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.291 -0.868 . . . . 1.93 111.859 -165.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -63.26 -27.53 72.14 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.89 2.393 . . . . 0.53 110.753 171.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.509 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -69.27 -24.18 76.08 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.459 -0.791 . . . . 0.28 111.753 176.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -84.27 -28.1 27.41 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 122.587 -0.361 . . . . 0.22 110.854 178.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.561 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.4 mm? -74.26 -29.83 61.85 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 109.509 -0.552 . . . . 1.1 109.509 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 13.1 pt20 -75.89 -35.55 59.81 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.41 -0.916 . . . . 2.23 109.752 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.404 ' O ' HG13 ' A' ' 25' ' ' ILE . 30.3 tpt180 -64.28 -39.8 94.67 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.18 -1.373 . . . . 3.6 108.764 170.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.515 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 48.1 t60 -67.06 -49.35 65.4 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.092 -1.413 . . . . 0.39 111.952 -174.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 19' ' ' LEU . 63.3 t -66.58 -31.86 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 C-N-CA 120.029 -0.668 . . . . 0.34 109.755 -175.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -69.51 -7.38 37.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.503 -0.771 . . . . 2.96 111.465 174.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.515 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 81.0 mt -83.86 -47.48 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 109.616 -0.512 . . . . 1.3 109.616 171.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 121.267 0.556 . . . . 0.29 110.661 178.259 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 120.662 0.267 . . . . 1.64 111.104 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.553 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 92.0 m-85 -131.8 158.58 40.89 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.266 0.555 . . . . 0.64 110.663 176.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.53 -36.46 26.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.36 -0.836 . . . . 0.41 112.909 -171.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 6.2 m-20 -124.01 138.92 31.47 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-O 120.827 0.346 . . . . 1.93 111.128 -168.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 15' ' ' ASP . 27.0 Cg_exo -62.45 -29.73 79.31 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.125 2.55 . . . . 0.53 111.278 176.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.54 -36.33 93.05 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.747 -0.66 . . . . 0.28 111.566 175.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.99 -31.84 64.78 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.608 -0.296 . . . . 0.22 111.015 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.553 ' CD2' ' HB2' ' A' ' 13' ' ' PHE . 2.7 mm? -66.29 -34.67 78.52 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 109.292 -0.632 . . . . 1.1 109.292 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -73.78 -38.31 64.71 Favored 'General case' 0 N--CA 1.432 -1.325 0 C-N-CA 119.125 -1.03 . . . . 2.23 110.556 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.587 ' O ' HG12 ' A' ' 25' ' ' ILE . 7.1 tpt180 -65.42 -37.09 85.89 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.713 -1.131 . . . . 3.6 108.641 175.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.545 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 63.3 t60 -73.66 -48.13 34.69 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.041 -1.436 . . . . 0.39 111.559 -174.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 19' ' ' LEU . 72.8 t -64.63 -31.62 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 CA-C-N 116.014 -0.539 . . . . 0.34 110.557 -173.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -76.56 -14.31 60.02 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 120.382 -0.527 . . . . 2.96 110.685 177.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.587 HG12 ' O ' ' A' ' 21' ' ' ARG . 18.7 mm -69.37 -45.56 78.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 109.747 -0.464 . . . . 1.3 109.747 173.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 . . . . . 0 CA--C 1.519 -0.214 0 CA-C-O 121.293 0.568 . . . . 0.29 109.52 172.963 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.701 0.286 . . . . 1.64 111.31 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -129.16 155.18 45.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.443 0.639 . . . . 0.64 110.762 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.02 -28.77 29.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.02 -0.991 . . . . 0.41 111.351 -175.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -120.76 135.46 24.73 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.28 -0.873 . . . . 1.93 110.981 -166.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.37 -25.45 35.93 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.241 1.961 . . . . 0.53 110.27 172.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.51 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -67.95 -27.95 73.54 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.961 -1.018 . . . . 0.28 111.478 173.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -78.4 -25.91 46.27 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 120.943 -0.303 . . . . 0.22 110.667 178.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.646 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.7 mm? -69.62 -35.25 75.1 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 109.663 -0.495 . . . . 1.1 109.663 178.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.51 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 12.0 pt20 -76.18 -36.02 58.87 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 119.415 -0.914 . . . . 2.23 110.105 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.431 ' O ' HG13 ' A' ' 25' ' ' ILE . 7.2 tpm_? -61.08 -40.21 92.84 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.857 -1.519 . . . . 3.6 108.191 172.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.621 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 37.8 t60 -70.33 -44.46 68.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.723 -1.58 . . . . 0.39 112.183 -174.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 19' ' ' LEU . 61.4 t -66.15 -35.77 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 C-N-CA 119.682 -0.807 . . . . 0.34 110.101 -174.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -62.2 -25.52 67.83 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.127 -0.488 . . . . 2.96 111.126 173.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.621 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 79.9 mt -67.96 -44.07 85.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 1.3 110.791 176.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 . . . . . 0 N--CA 1.465 0.276 0 CA-C-O 120.565 0.221 . . . . 0.29 111.359 179.762 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 . . . . . 0 C--O 1.233 0.217 0 N-CA-C 112.38 0.511 . . . . 1.64 112.38 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -129.12 167.05 18.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.9 -0.591 . . . . 0.64 110.705 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.03 -2.45 37.19 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.153 0.797 . . . . 0.41 113.153 -170.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -155.51 150.33 20.5 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 120.816 -0.354 . . . . 1.93 110.109 -176.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.44 -22.61 65.57 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.855 2.37 . . . . 0.53 109.531 169.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.557 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -57.22 -48.36 80.69 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 114.382 -1.281 . . . . 0.28 111.89 172.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -72.73 -25.41 61.21 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 121.07 -0.252 . . . . 0.22 110.781 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.529 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.5 mm? -72.1 -36.22 69.41 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.094 -0.706 . . . . 1.1 109.094 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 17.0 pt20 -77.81 -33.84 52.29 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 119.729 -0.788 . . . . 2.23 109.94 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.47 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.5 OUTLIER -65.44 -36.2 83.22 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.648 -1.16 . . . . 3.6 108.741 173.29 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.569 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 47.1 t60 -73.42 -46.1 50.58 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 114.7 -1.136 . . . . 0.39 111.683 -174.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 19' ' ' LEU . 97.5 t -66.07 -34.38 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 C-N-CA 119.866 -0.734 . . . . 0.34 110.019 -175.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 16.8 mtp180 -62.73 -26.81 68.88 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.109 -0.496 . . . . 2.96 111.077 173.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 18.3 mm -69.22 -44.32 80.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.427 -0.351 . . . . 1.3 110.63 176.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 . . . . . 0 N--CA 1.464 0.263 0 CA-C-O 121.217 0.532 . . . . 0.29 110.626 176.354 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 . . . . . 0 N--CA 1.454 -0.249 0 N-CA-C 112.562 0.579 . . . . 1.64 112.562 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -124.65 169.33 12.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.381 -0.827 . . . . 0.64 110.35 173.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.61 -36.19 13.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.238 -0.437 . . . . 0.41 112.125 -173.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.7 OUTLIER -113.58 151.58 44.66 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-O 120.977 0.417 . . . . 1.93 110.369 -174.685 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 15' ' ' ASP . 12.2 Cg_exo -71.61 -23.53 23.0 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.159 2.573 . . . . 0.53 108.465 170.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.07 -41.87 98.21 Favored Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 113.889 -1.505 . . . . 0.28 111.553 172.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -77.49 -25.52 50.45 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 121.158 -0.217 . . . . 0.22 111.417 -177.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.557 ' O ' HG23 ' A' ' 23' ' ' VAL . 8.0 mt -71.29 -38.47 71.78 Favored 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 120.014 -0.674 . . . . 1.1 109.208 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.444 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 21.4 mt-30 -76.69 -31.96 57.59 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 119.294 -0.962 . . . . 2.23 110.701 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.406 ' O ' HG13 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -65.07 -38.17 89.9 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.998 -1.001 . . . . 3.6 108.489 171.86 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.617 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 71.3 t60 -73.56 -45.72 51.72 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 114.427 -1.261 . . . . 0.39 112.01 -174.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 19' ' ' LEU . 99.0 t -66.29 -31.06 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 C-N-CA 119.721 -0.792 . . . . 0.34 110.14 -174.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 32.9 mtm180 -75.06 -6.96 52.26 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.993 -0.549 . . . . 2.96 110.652 175.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.617 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 68.6 mt -78.41 -50.25 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.683 -0.488 . . . . 1.3 109.683 169.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 . . . . . 0 N--CA 1.462 0.146 0 CA-C-O 121.275 0.559 . . . . 0.29 110.458 177.953 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 110.604 -0.147 . . . . 1.64 110.604 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -127.27 166.39 17.87 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.33 0.586 . . . . 0.64 111.431 -177.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.41 -28.09 21.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.147 -0.933 . . . . 0.41 113.266 -167.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -136.71 150.17 69.27 Favored Pre-proline 0 C--N 1.327 -0.378 0 C-N-CA 121.102 -0.239 . . . . 1.93 110.436 -176.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -65.03 -24.05 60.37 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.536 2.157 . . . . 0.53 109.184 168.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.573 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -59.12 -37.31 91.51 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 114.281 -1.327 . . . . 0.28 111.842 172.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.562 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -80.33 -28.69 38.1 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.733 -0.387 . . . . 0.22 110.651 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.53 ' O ' HG23 ' A' ' 23' ' ' VAL . 13.8 mt -71.13 -30.11 66.08 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 120.346 -0.541 . . . . 1.1 109.614 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.573 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 27.6 pt20 -74.93 -40.69 60.69 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 119.373 -0.931 . . . . 2.23 109.964 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.44 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.7 OUTLIER -70.95 -27.04 63.45 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.49 -1.232 . . . . 3.6 109.336 177.075 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.562 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 63.1 t60 -73.46 -48.04 36.69 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 114.934 -1.03 . . . . 0.39 111.536 -177.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 19' ' ' LEU . 84.6 t -66.35 -29.27 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 C-N-CA 119.823 -0.751 . . . . 0.34 109.649 -175.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 41.9 mtt180 -61.98 -35.58 78.91 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.915 -0.584 . . . . 2.96 110.992 171.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.511 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 26.4 mm -61.72 -45.4 98.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.335 -0.393 . . . . 1.3 110.635 177.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 . . . . . 0 CA--C 1.519 -0.231 0 CA-C-N 116.131 -0.486 . . . . 0.29 110.244 176.588 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.7 mtt . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 120.612 0.244 . . . . 7.14 111.01 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -95.84 117.57 66.34 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.261 0.553 . . . . 4.97 110.977 -177.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -91.86 178.33 1.62 Allowed 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.906 2.404 . . . . 1.14 112.116 173.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.591 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . 65.0 m-85 -113.18 102.49 10.43 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.396 -0.965 . . . . 1.11 108.396 171.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.591 HG12 ' HG2' ' A' ' 12' ' ' GLN . 16.8 m -90.56 143.13 11.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.306 0.574 . . . . 0.35 111.685 -172.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.595 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 46.9 t -68.25 121.45 16.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.249 -0.887 . . . . 0.21 110.148 175.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.1 mm -67.02 -21.29 28.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.203 -0.453 . . . . 0.67 111.074 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -93.34 -35.01 13.27 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.351 0.5 . . . . 1.3 112.351 -172.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.9 p -128.41 -3.13 5.53 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.029 -0.668 . . . . 0.27 112.514 -175.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 64.87 52.05 1.67 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.579 -0.737 . . . . 1.58 112.617 175.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.428 ' H ' ' HB3' ' A' ' 6' ' ' CYS . 25.6 mmt180 -106.12 128.41 53.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.658 -0.701 . . . . 3.67 109.246 174.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.591 ' HG2' HG12 ' A' ' 5' ' ' VAL . 64.8 mt-30 -85.33 114.45 22.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.908 0.385 . . . . 1.64 111.045 -175.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -109.09 173.98 6.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.066 -0.515 . . . . 0.64 111.071 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.79 -53.45 4.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.099 0.476 . . . . 0.41 111.73 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -106.74 146.6 33.4 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.622 -0.717 . . . . 1.93 110.994 -169.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.96 -28.58 41.86 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.848 2.366 . . . . 0.53 111.231 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.521 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . -64.32 -32.1 83.08 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.779 -0.646 . . . . 0.28 111.507 175.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.3 -28.68 59.81 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 121.014 -0.275 . . . . 0.22 110.839 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.591 ' CD1' ' HB3' ' A' ' 4' ' ' TYR . 8.6 mt -68.47 -34.22 75.56 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 109.458 -0.571 . . . . 1.1 109.458 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -76.11 -33.94 59.47 Favored 'General case' 0 N--CA 1.433 -1.287 0 C-N-CA 119.037 -1.065 . . . . 2.23 109.746 -177.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.586 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.5 OUTLIER -66.54 -35.36 80.05 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.479 -1.237 . . . . 3.6 108.944 172.147 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.651 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 71.6 t60 -72.29 -49.51 34.22 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.05 -0.977 . . . . 0.39 111.459 -176.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 19' ' ' LEU . 74.6 t -64.24 -37.57 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 115.695 -0.684 . . . . 0.34 110.556 -172.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 11.0 ptm180 -69.81 -20.66 63.44 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.057 -0.52 . . . . 2.96 110.446 178.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.651 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 9.9 mm -64.93 -34.79 72.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.396 -0.366 . . . . 1.3 110.17 172.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -68.24 -36.81 80.04 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 120.895 -0.322 . . . . 0.29 110.871 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -39.88 79.28 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 120.194 -0.602 . . . . 1.68 110.16 175.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.83 -56.69 3.49 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.816 -0.629 . . . . 2.36 112.064 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -66.71 -29.74 69.8 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.194 0.521 . . . . 3.92 110.683 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 47.5 pttt . . . . . 0 C--O 1.251 1.139 0 CA-C-O 117.923 -1.037 . . . . 6.91 110.185 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.541 ' HG2' ' HG3' ' A' ' 2' ' ' LYS . 51.3 ttm . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 120.702 0.287 . . . . 7.14 110.484 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.541 ' HG3' ' HG2' ' A' ' 1' ' ' MET . 91.4 mttt -118.65 128.16 26.13 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.44 -0.346 . . . . 4.97 110.106 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.72 173.13 11.37 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 121.897 1.732 . . . . 1.14 110.212 171.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.528 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . 91.0 m-85 -89.52 89.58 7.9 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.438 0.637 . . . . 1.11 109.478 -176.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.501 HG12 ' HG2' ' A' ' 12' ' ' GLN . 32.9 m -84.39 144.94 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 114.947 -1.024 . . . . 0.35 110.98 -177.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.518 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 37.9 t -60.51 130.86 48.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.022 -0.99 . . . . 0.21 110.547 177.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.522 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.2 mp -70.66 -25.64 26.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.311 -0.859 . . . . 0.67 110.288 -175.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -91.68 -53.77 4.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.531 . . . . 1.3 111.306 -175.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.2 p -108.71 1.4 21.12 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.213 0.53 . . . . 0.27 111.596 -169.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 59.23 43.23 17.29 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.149 -0.932 . . . . 1.58 112.895 173.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.725 ' HA ' ' HE ' ' A' ' 11' ' ' ARG . 0.5 OUTLIER -103.83 140.92 36.99 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.036 -0.357 . . . . 3.67 110.036 175.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.501 ' HG2' HG12 ' A' ' 5' ' ' VAL . 28.4 mt-30 -77.63 132.96 38.5 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.278 0.473 . . . . 1.64 112.278 -174.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -132.62 165.25 24.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.549 -0.75 . . . . 0.64 109.859 175.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.29 -35.32 13.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.936 -0.574 . . . . 0.41 112.44 -171.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.88 147.81 49.58 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 120.589 0.233 . . . . 1.93 110.806 -174.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.42 -22.93 51.54 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.605 2.203 . . . . 0.53 109.082 168.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.557 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -61.22 -43.35 99.5 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 114.48 -1.237 . . . . 0.28 111.845 172.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -76.65 -27.91 55.81 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 120.775 -0.37 . . . . 0.22 110.868 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.698 ' O ' HG23 ' A' ' 23' ' ' VAL . 9.5 mt -66.66 -39.25 88.1 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 109.277 -0.638 . . . . 1.1 109.277 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 9.1 pt20 -72.47 -37.66 68.43 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.977 0.894 . . . . 2.23 110.468 -175.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.639 HH22 ' HG3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -67.54 -34.29 76.78 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 113.899 -1.501 . . . . 3.6 107.969 176.368 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.748 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 74.8 t60 -69.25 -39.54 78.4 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 114.317 -1.31 . . . . 0.39 111.845 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 19' ' ' LEU . 87.7 t -67.07 -36.47 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 C-N-CA 119.364 -0.935 . . . . 0.34 109.874 -174.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.2 mmm-85 -63.08 -28.59 70.18 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.198 -0.455 . . . . 2.96 110.413 173.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.748 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 20.0 mm -59.44 -50.53 79.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.773 -0.649 . . . . 1.3 110.63 176.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -62.35 -30.55 71.26 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.204 -0.453 . . . . 0.29 110.922 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.454 ' HB ' ' HG2' ' A' ' 29' ' ' GLU . 1.3 m -68.7 -24.53 64.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.124 -0.489 . . . . 1.68 110.542 -176.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.67 -11.49 52.15 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.074 -0.584 . . . . 2.36 113.282 174.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.454 ' HG2' ' HB ' ' A' ' 27' ' ' THR . 8.0 pt-20 -73.95 -31.85 63.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.604 0.24 . . . . 3.92 111.601 -177.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.639 ' HG3' HH22 ' A' ' 21' ' ' ARG . 52.6 tptt . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.35 -0.833 . . . . 6.91 109.923 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 N--CA 1.481 1.093 0 CA-C-O 121.048 0.451 . . . . 7.14 110.974 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.561 ' HB2' ' HD3' ' A' ' 3' ' ' PRO . 5.2 mptp? -66.79 -50.24 45.18 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 116.126 -0.488 . . . . 4.97 110.571 175.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.561 ' HD3' ' HB2' ' A' ' 2' ' ' LYS . 55.5 Cg_exo -59.89 173.63 1.65 Allowed 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.367 2.045 . . . . 1.14 113.15 173.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.504 ' O ' HD21 ' A' ' 19' ' ' LEU . 79.8 m-85 -117.35 126.35 52.53 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.015 -1.448 . . . . 1.11 109.769 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.676 HG12 ' HG2' ' A' ' 12' ' ' GLN . 3.5 m -94.47 149.34 4.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 115.975 -0.557 . . . . 0.35 111.066 -174.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.456 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 48.6 t -71.43 128.67 36.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.745 -0.661 . . . . 0.21 110.534 177.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.493 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.3 mp -71.06 -27.82 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 CA-C-N 115.402 -0.817 . . . . 0.67 110.498 -176.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -90.32 -44.2 9.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 1.3 111.584 -171.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.7 p -120.31 0.48 10.61 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 119.694 -0.803 . . . . 0.27 112.423 -171.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 63.99 57.02 1.36 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.417 -0.811 . . . . 1.58 112.385 172.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.442 ' H ' ' HB3' ' A' ' 6' ' ' CYS . 1.6 mmp_? -121.59 130.98 53.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.811 -0.631 . . . . 3.67 109.606 177.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.676 ' HG2' HG12 ' A' ' 5' ' ' VAL . 30.2 mt-30 -77.54 131.17 37.75 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 120.905 0.383 . . . . 1.64 111.266 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -125.6 149.23 48.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.64 110.383 174.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.11 -12.72 59.98 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.7 1.0 . . . . 0.41 113.7 -167.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -142.87 151.15 55.73 Favored Pre-proline 0 C--N 1.324 -0.505 0 C-N-CA 120.831 -0.348 . . . . 1.93 110.939 -173.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.469 ' HG3' ' CE1' ' A' ' 4' ' ' TYR . 18.2 Cg_exo -66.06 -22.28 55.05 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.628 2.219 . . . . 0.53 109.445 168.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.4 -53.26 47.33 Favored Glycine 0 N--CA 1.44 -1.037 0 CA-C-N 114.462 -1.245 . . . . 0.28 111.66 171.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -65.32 -26.19 67.94 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 115.719 -0.241 . . . . 0.22 111.154 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.504 HD21 ' O ' ' A' ' 4' ' ' TYR . 2.8 mm? -70.45 -34.3 72.29 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 109.315 -0.624 . . . . 1.1 109.315 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -72.35 -41.8 66.05 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 119.735 -0.786 . . . . 2.23 110.324 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.596 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -61.3 -39.43 90.42 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.498 -1.228 . . . . 3.6 108.765 175.213 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.608 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 59.5 t60 -75.17 -46.85 31.49 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 114.311 -1.313 . . . . 0.39 112.02 -170.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 19' ' ' LEU . 95.8 t -67.54 -34.55 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 C-N-CA 119.849 -0.74 . . . . 0.34 110.498 -172.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.451 ' HA ' HG22 ' A' ' 27' ' ' THR . 10.0 ptp180 -75.16 -11.79 60.16 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.109 -0.636 . . . . 2.96 110.61 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.608 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 9.5 mm -70.67 -45.73 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.935 -0.394 . . . . 1.3 109.935 171.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 40.5 m-70 -65.86 -50.96 62.69 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.083 0.468 . . . . 0.29 110.224 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 27' ' ' THR . 9.3 t -87.71 52.03 2.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.931 0.872 . . . . 1.68 110.418 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.26 59.03 0.42 Allowed Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.479 -0.782 . . . . 2.36 111.75 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -78.71 -40.83 32.64 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 123.459 0.704 . . . . 3.92 110.813 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.421 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 19.8 tptm . . . . . 0 C--N 1.316 -0.855 0 CA-C-O 118.538 -0.744 . . . . 6.91 109.695 178.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 121.003 0.43 . . . . 7.14 110.208 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.502 ' HD2' ' HD2' ' A' ' 3' ' ' PRO . 58.5 tptt -88.93 113.06 54.49 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.018 -0.537 . . . . 4.97 110.615 -178.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.502 ' HD2' ' HD2' ' A' ' 2' ' ' LYS . 71.3 Cg_endo -84.4 174.76 7.7 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.664 2.243 . . . . 1.14 111.304 175.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.587 ' O ' HD21 ' A' ' 19' ' ' LEU . 87.4 m-85 -119.38 113.15 20.35 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 109.206 -0.664 . . . . 1.11 109.206 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.523 HG12 ' HA ' ' A' ' 12' ' ' GLN . 29.7 m -106.37 139.69 26.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.761 -0.654 . . . . 0.35 111.097 -171.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.503 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 39.1 t -63.42 122.76 17.03 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.905 -0.589 . . . . 0.21 109.548 175.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.587 ' H ' HD12 ' A' ' 7' ' ' ILE . 4.0 mp -70.67 -25.92 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-N 115.573 -0.74 . . . . 0.67 109.964 -176.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -90.99 -43.05 10.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.953 -0.567 . . . . 1.3 111.885 -169.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.6 p -118.04 -3.2 11.14 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 119.752 -0.779 . . . . 0.27 112.055 -175.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 65.07 79.65 0.25 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.506 -0.77 . . . . 1.58 112.654 175.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 96.5 mtt180 -138.47 132.88 31.97 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.783 -0.644 . . . . 3.67 109.337 174.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.523 ' HA ' HG12 ' A' ' 5' ' ' VAL . 30.0 mt-30 -87.36 112.58 22.25 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.651 0.241 . . . . 1.64 111.651 -177.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.414 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 98.4 m-85 -108.97 165.83 11.29 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.793 0.33 . . . . 0.64 110.432 176.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.77 -39.01 18.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.923 -0.58 . . . . 0.41 112.415 -175.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.466 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 13.4 m-20 -118.43 142.12 30.86 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.081 -0.508 . . . . 1.93 111.844 -168.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 15' ' ' ASP . 17.0 Cg_exo -66.28 -25.36 49.76 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.982 2.454 . . . . 0.53 111.015 175.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.549 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -62.83 -33.29 86.56 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.574 -0.739 . . . . 0.28 111.884 176.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -80.24 -29.4 38.42 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.549 -0.46 . . . . 0.22 110.674 177.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.587 HD21 ' O ' ' A' ' 4' ' ' TYR . 2.7 mm? -68.55 -34.17 75.36 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 109.633 -0.506 . . . . 1.1 109.633 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.549 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 3.9 pt20 -74.26 -37.82 63.64 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 119.514 -0.875 . . . . 2.23 110.256 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.58 ' O ' HG13 ' A' ' 25' ' ' ILE . 1.1 tmt_? -68.09 -34.86 77.2 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.305 -1.316 . . . . 3.6 108.293 175.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.607 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 33.1 t60 -71.37 -50.04 36.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.735 -1.121 . . . . 0.39 111.747 -175.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 19' ' ' LEU . 99.4 t -65.45 -34.08 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-N 115.824 -0.625 . . . . 0.34 110.102 -173.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 59.7 mtp180 -75.0 -8.87 57.75 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.924 -0.58 . . . . 2.96 110.874 177.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.607 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 57.1 mt -74.14 -48.95 35.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.923 -0.399 . . . . 1.3 109.923 172.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 -62.11 -50.56 71.44 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.967 -0.561 . . . . 0.29 111.297 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.474 HG21 ' HB2' ' A' ' 30' ' ' LYS . 5.6 m -86.46 -26.38 24.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.077 -0.51 . . . . 1.68 111.992 -173.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.0 -62.28 3.32 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.025 -0.607 . . . . 2.36 112.944 177.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -80.11 -54.06 6.12 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.497 0.665 . . . . 3.92 110.822 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.474 ' HB2' HG21 ' A' ' 27' ' ' THR . 17.5 mmtp . . . . . 0 C--O 1.246 0.906 0 CA-C-N 114.809 -1.087 . . . . 6.91 109.806 -175.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtm . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 110.048 -0.353 . . . . 7.14 110.048 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.554 ' HB2' ' HD3' ' A' ' 3' ' ' PRO . 55.2 mtpt -75.3 -54.46 2.44 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 109.493 -0.558 . . . . 4.97 109.493 176.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.554 ' HD3' ' HB2' ' A' ' 2' ' ' LYS . 88.4 Cg_endo -80.22 170.58 16.1 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.502 1.468 . . . . 1.14 110.276 165.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.585 ' CE2' ' HD3' ' A' ' 16' ' ' PRO . 84.8 m-85 -124.05 117.33 24.46 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 116.169 -0.469 . . . . 1.11 109.801 -174.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.9 m -101.99 147.68 8.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.047 -0.524 . . . . 0.35 111.186 -173.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 10' ' ' GLN . 52.6 t -67.71 129.96 41.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.988 -0.551 . . . . 0.21 109.888 175.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.6 mp -78.3 -25.25 13.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.756 -0.656 . . . . 0.67 109.785 -176.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 39.7 t60 -87.53 -47.13 8.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.8 -0.636 . . . . 1.3 111.327 -171.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.7 p -115.27 -9.39 12.22 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 119.956 -0.698 . . . . 0.27 111.655 -176.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 6' ' ' CYS . 96.2 mt-30 67.64 79.36 0.22 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.454 -0.794 . . . . 1.58 112.593 175.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.401 ' HA ' ' HD3' ' A' ' 11' ' ' ARG . 2.9 mmt180 -142.01 144.23 33.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.463 -0.789 . . . . 3.67 109.566 176.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -80.69 138.72 36.37 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.038 0.447 . . . . 1.64 111.176 -173.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.406 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 81.5 m-85 -137.39 162.77 32.72 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.332 -0.849 . . . . 0.64 110.286 174.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.0 -20.18 22.39 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.771 0.656 . . . . 0.41 112.771 -170.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -141.08 150.03 57.61 Favored Pre-proline 0 C--N 1.326 -0.445 0 C-N-CA 121.033 -0.267 . . . . 1.93 110.776 -174.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.585 ' HD3' ' CE2' ' A' ' 4' ' ' TYR . 17.1 Cg_exo -67.09 -22.0 48.13 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.811 2.34 . . . . 0.53 109.193 169.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.602 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -57.13 -44.68 93.07 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 114.532 -1.213 . . . . 0.28 111.885 172.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.574 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -77.84 -22.38 50.03 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 121.037 -0.265 . . . . 0.22 110.992 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.575 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.6 mm? -73.38 -35.14 65.88 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 109.528 -0.545 . . . . 1.1 109.528 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.602 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 16.9 pt20 -75.16 -35.52 61.61 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.672 -0.811 . . . . 2.23 109.91 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -68.18 -32.29 72.44 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.433 -1.258 . . . . 3.6 108.829 173.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.576 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 46.6 t60 -71.59 -46.41 59.37 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 114.756 -1.111 . . . . 0.39 111.787 -176.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 19' ' ' LEU . 60.8 t -66.62 -32.7 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 C-N-CA 119.822 -0.751 . . . . 0.34 109.719 -175.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -59.3 -29.97 67.99 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.609 -0.723 . . . . 2.96 111.49 171.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.576 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 79.6 mt -64.82 -52.85 49.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.308 -0.406 . . . . 1.3 110.68 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -62.19 -47.6 83.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.15 0.5 . . . . 0.29 110.6 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.1 m -85.49 49.57 1.79 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.434 0.635 . . . . 1.68 110.793 -176.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.69 37.32 2.08 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.813 -0.631 . . . . 2.36 113.04 -178.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -81.19 -34.24 32.45 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.126 -0.694 . . . . 3.92 109.126 176.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.7 tttm . . . . . 0 C--O 1.25 1.081 0 CA-C-N 115.239 -0.891 . . . . 6.91 109.529 175.47 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 120.869 0.366 . . . . 7.14 110.264 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -108.12 140.31 21.55 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.325 -0.62 . . . . 4.97 109.325 177.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -54.12 167.27 1.26 Allowed 'Trans proline' 0 CA--C 1.512 -0.624 0 C-N-CA 123.258 2.639 . . . . 1.14 113.713 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.574 ' CZ ' ' HG3' ' A' ' 16' ' ' PRO . 91.9 m-85 -104.66 123.87 48.35 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 113.971 -1.468 . . . . 1.11 109.564 -174.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.6 HG12 ' HG2' ' A' ' 12' ' ' GLN . 22.3 m -111.17 149.65 13.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.951 -0.568 . . . . 0.35 111.092 -172.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.445 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 47.9 t -76.46 115.4 16.17 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.017 -0.538 . . . . 0.21 109.823 176.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.1 mp -69.42 -23.65 26.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.531 0.681 . . . . 0.67 109.602 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.425 ' HB3' ' CD2' ' A' ' 26' ' ' HIS . 2.5 t-80 -81.42 -40.92 22.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.151 -0.931 . . . . 1.3 112.018 -171.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.6 p -126.52 -5.65 6.46 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 120.163 -0.615 . . . . 0.27 112.129 -177.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 69.8 67.77 0.24 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.778 0.831 . . . . 1.58 112.266 175.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -134.44 135.48 42.56 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.627 -0.715 . . . . 3.67 109.716 175.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.6 ' HG2' HG12 ' A' ' 5' ' ' VAL . 70.4 mt-30 -84.23 133.95 34.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.969 0.414 . . . . 1.64 111.815 -176.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.569 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 97.0 m-85 -129.46 176.42 7.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.878 -0.601 . . . . 0.64 110.458 174.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -95.52 -40.28 9.53 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.178 0.513 . . . . 0.41 112.16 -173.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -112.26 139.91 23.04 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.657 -0.702 . . . . 1.93 111.672 -167.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.574 ' HG3' ' CZ ' ' A' ' 4' ' ' TYR . 17.4 Cg_exo -64.47 -32.83 59.22 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.799 2.332 . . . . 0.53 110.333 173.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.471 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -63.6 -29.94 76.15 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.226 -0.897 . . . . 0.28 112.042 177.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -82.01 -30.78 31.34 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 120.801 -0.36 . . . . 0.22 111.154 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.569 ' CD2' ' HB2' ' A' ' 13' ' ' PHE . 2.2 mm? -70.92 -31.4 68.0 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 109.746 -0.464 . . . . 1.1 109.746 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 12.8 pt20 -75.56 -36.93 60.29 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 119.367 -0.933 . . . . 2.23 110.229 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.46 ' HD2' ' HA ' ' A' ' 21' ' ' ARG . 0.9 OUTLIER -70.22 -32.54 70.46 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.34 -1.3 . . . . 3.6 108.777 174.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.513 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 55.7 t60 -66.69 -47.89 71.01 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 114.32 -1.309 . . . . 0.39 111.053 -177.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 19' ' ' LEU . 98.0 t -64.51 -34.49 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 115.666 -0.697 . . . . 0.34 109.895 -176.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -63.55 -25.65 68.34 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 112.314 0.487 . . . . 2.96 112.314 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.513 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 83.8 mt -65.25 -45.15 94.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.966 -0.383 . . . . 1.3 109.966 175.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.425 ' CD2' ' HB3' ' A' ' 8' ' ' HIS . 74.8 m-70 -71.02 -50.82 29.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.29 110.17 175.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.2 m -84.01 51.49 2.07 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.46 -0.791 . . . . 1.68 111.111 -174.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.11 63.99 4.22 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.043 -0.599 . . . . 2.36 111.784 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -69.4 -60.58 2.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.031 0.444 . . . . 3.92 110.512 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt . . . . . 0 C--O 1.247 0.964 0 CA-C-N 115.478 -0.783 . . . . 6.91 110.01 179.642 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptp . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.545 0.212 . . . . 7.14 111.197 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.52 100.42 2.05 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 109.349 -0.611 . . . . 4.97 109.349 -178.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -59.85 178.19 0.4 Allowed 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 123.513 2.809 . . . . 1.14 114.324 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.44 ' CE1' ' HD3' ' A' ' 16' ' ' PRO . 95.6 m-85 -103.3 122.04 43.97 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.126 -1.397 . . . . 1.11 108.847 177.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.517 HG12 ' HG2' ' A' ' 12' ' ' GLN . 17.3 m -110.93 151.12 13.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.008 0.432 . . . . 0.35 111.675 -172.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.427 ' HB3' ' H ' ' A' ' 11' ' ' ARG . 48.9 t -77.44 129.76 36.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.688 -0.687 . . . . 0.21 109.828 177.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.491 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.8 mp -79.3 -23.72 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 115.459 -0.792 . . . . 0.67 110.066 -178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -91.46 -36.87 13.52 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.274 0.472 . . . . 1.3 112.274 -171.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.444 ' SG ' ' HG2' ' A' ' 11' ' ' ARG . 15.7 p -124.53 -1.09 8.06 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 119.592 -0.843 . . . . 0.27 112.627 -176.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 67.01 60.66 0.51 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.775 -0.648 . . . . 1.58 112.1 173.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.444 ' HG2' ' SG ' ' A' ' 9' ' ' CYS . 37.1 mmt180 -121.56 151.35 40.45 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.462 -0.57 . . . . 3.67 109.462 175.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.517 ' HG2' HG12 ' A' ' 5' ' ' VAL . 70.7 mt-30 -109.39 123.79 49.92 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.626 0.251 . . . . 1.64 111.203 -174.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -128.17 156.73 42.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.273 0.559 . . . . 0.64 110.981 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.68 -40.81 61.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.434 -0.803 . . . . 0.41 112.58 -176.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -109.31 137.05 20.14 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 115.804 -0.634 . . . . 1.93 111.413 -166.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.44 ' HD3' ' CE1' ' A' ' 4' ' ' TYR . 32.1 Cg_endo -64.91 -30.85 57.43 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.509 2.139 . . . . 0.53 110.308 174.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.75 -37.08 89.29 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.269 -0.878 . . . . 0.28 111.907 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.575 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -76.15 -25.23 55.11 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 111.401 0.148 . . . . 0.22 111.401 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.472 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.7 mm? -75.43 -29.32 59.69 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 109.15 -0.685 . . . . 1.1 109.15 177.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -70.34 -43.21 70.68 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.302 -0.863 . . . . 2.23 109.823 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.647 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -64.68 -34.41 78.24 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.064 -1.425 . . . . 3.6 108.71 174.268 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.575 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 29.0 t60 -67.93 -53.6 25.07 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 114.537 -1.21 . . . . 0.39 111.419 -174.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 19' ' ' LEU . 98.1 t -64.4 -34.71 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 CA-C-N 115.59 -0.732 . . . . 0.34 110.175 -174.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.6 ' HB3' ' HB3' ' A' ' 30' ' ' LYS . 35.5 mtt180 -69.47 -20.15 63.75 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.239 -0.437 . . . . 2.96 111.459 176.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.647 HG12 ' O ' ' A' ' 21' ' ' ARG . 27.6 mm -65.6 -49.1 79.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 109.586 -0.524 . . . . 1.3 109.586 173.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -63.34 -51.2 66.93 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.797 -0.638 . . . . 0.29 111.261 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.692 HG23 ' H ' ' A' ' 29' ' ' GLU . 12.2 t -79.49 -17.4 54.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.255 -0.43 . . . . 1.68 111.743 -172.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.98 11.46 74.36 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.629 -0.796 . . . . 2.36 112.887 177.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.692 ' H ' HG23 ' A' ' 27' ' ' THR . 47.5 mt-10 -86.4 11.85 11.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.869 0.366 . . . . 3.92 111.545 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.6 ' HB3' ' HB3' ' A' ' 24' ' ' ARG . 19.2 pttp . . . . . 0 C--O 1.244 0.807 0 CA-C-O 118.307 -0.854 . . . . 6.91 110.14 177.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 120.652 0.263 . . . . 7.14 110.731 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 2' ' ' LYS . 39.0 pttt -114.76 82.54 8.25 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 121.276 0.56 . . . . 4.97 110.062 172.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -69.54 177.18 5.68 Favored 'Trans proline' 0 CA--C 1.513 -0.569 0 C-N-CA 122.682 2.255 . . . . 1.14 112.957 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.602 ' O ' HD21 ' A' ' 19' ' ' LEU . 83.8 m-85 -113.41 118.15 33.74 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 113.989 -1.46 . . . . 1.11 108.577 177.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.642 ' HA ' ' HA ' ' A' ' 12' ' ' GLN . 19.3 m -101.04 150.85 5.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 121.236 0.541 . . . . 0.35 111.364 -173.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.44 ' HB3' ' H ' ' A' ' 11' ' ' ARG . 43.0 t -71.37 122.06 19.66 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.446 -0.797 . . . . 0.21 110.534 176.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 mp -66.76 -26.58 37.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.486 -0.779 . . . . 0.67 110.959 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -88.9 -34.69 16.85 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.191 0.441 . . . . 1.3 112.191 -171.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.6 p -129.98 2.24 4.81 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 119.672 -0.811 . . . . 0.27 112.824 -175.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 65.16 46.12 2.81 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.165 0.586 . . . . 1.58 112.52 172.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.44 ' H ' ' HB3' ' A' ' 6' ' ' CYS . 99.6 mtt180 -114.57 127.23 55.68 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.623 -0.51 . . . . 3.67 109.623 176.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.642 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 11.1 pt20 -88.28 135.2 33.57 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.223 0.535 . . . . 1.64 111.882 -173.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -127.54 166.08 18.67 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.562 -0.745 . . . . 0.64 110.481 177.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.56 -45.21 62.91 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.42 0.526 . . . . 0.41 112.42 -176.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -117.17 144.44 33.74 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.248 -0.433 . . . . 1.93 111.656 -166.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.485 ' HD3' ' CE1' ' A' ' 4' ' ' TYR . 39.4 Cg_endo -67.72 -26.26 39.19 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.792 2.328 . . . . 0.53 110.909 176.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.52 -35.08 89.49 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.333 -0.849 . . . . 0.28 111.627 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.49 -25.94 62.48 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 121.067 -0.253 . . . . 0.22 110.409 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.602 HD21 ' O ' ' A' ' 4' ' ' TYR . 3.1 mm? -70.38 -30.24 67.1 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.818 -0.808 . . . . 1.1 108.818 177.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.539 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 83.0 mm-40 -70.02 -43.31 71.59 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.772 0.796 . . . . 2.23 110.177 178.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.39 -33.17 75.32 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.359 -1.291 . . . . 3.6 108.359 175.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.598 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 59.0 t60 -69.36 -45.38 69.53 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 114.532 -1.213 . . . . 0.39 111.414 -176.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 19' ' ' LEU . 95.7 t -65.82 -32.53 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 C-N-CA 119.982 -0.687 . . . . 0.34 109.822 -175.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 20' ' ' GLN . 14.9 mmm180 -67.11 -19.82 65.69 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.174 -0.466 . . . . 2.96 111.597 174.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.598 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 72.2 mt -68.23 -47.8 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 109.862 -0.421 . . . . 1.3 109.862 174.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -65.13 -42.18 94.13 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.247 0.546 . . . . 0.29 109.586 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.3 m -83.18 49.47 1.55 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.436 -0.802 . . . . 1.68 109.76 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.56 33.59 2.54 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.556 -0.747 . . . . 2.36 112.624 -176.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.619 ' HG3' ' HG3' ' A' ' 30' ' ' LYS . 11.1 pt-20 -85.18 -21.5 29.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.17 0.509 . . . . 3.92 109.719 176.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.619 ' HG3' ' HG3' ' A' ' 29' ' ' GLU . 28.0 mtpp . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.365 -0.826 . . . . 6.91 109.469 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.2 mmm . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 120.959 0.409 . . . . 7.14 111.346 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -85.72 116.14 64.46 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.196 -0.668 . . . . 4.97 109.196 171.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.06 175.74 7.13 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.484 2.123 . . . . 1.14 111.439 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.525 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . 96.5 m-85 -90.91 102.37 15.14 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.331 -0.618 . . . . 1.11 109.331 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 12' ' ' GLN . 32.7 m -95.17 148.05 5.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.661 -0.7 . . . . 0.35 111.478 -175.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.515 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 45.0 t -65.61 125.08 24.1 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.253 -0.885 . . . . 0.21 110.484 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.6 mm -68.75 -22.04 26.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.783 -0.644 . . . . 0.67 111.05 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -91.6 -38.58 12.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.023 -0.535 . . . . 1.3 111.713 -173.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.4 p -128.88 -0.36 5.34 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 119.793 -0.763 . . . . 0.27 112.727 -171.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 65.53 43.65 3.29 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.816 0.673 . . . . 1.58 112.816 175.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.498 ' H ' ' HB3' ' A' ' 6' ' ' CYS . 19.6 mmm180 -97.27 136.44 37.75 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.843 -0.428 . . . . 3.67 109.843 175.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.459 ' HA ' HG12 ' A' ' 5' ' ' VAL . 88.6 mt-30 -88.98 124.31 34.13 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.134 0.271 . . . . 1.64 111.573 -172.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -130.77 162.5 29.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.152 0.501 . . . . 0.64 110.952 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.67 -32.53 23.57 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.55 -0.75 . . . . 0.41 112.192 -171.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -123.53 142.79 39.85 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.767 -0.651 . . . . 1.93 111.63 -168.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.422 ' HD3' ' CE1' ' A' ' 4' ' ' TYR . 41.5 Cg_endo -67.57 -24.15 42.31 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.691 2.261 . . . . 0.53 111.02 174.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.642 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . -69.51 -32.1 71.27 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.559 -0.746 . . . . 0.28 111.44 174.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -75.36 -26.79 58.83 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 122.564 -0.374 . . . . 0.22 110.813 178.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.6 ' O ' HG23 ' A' ' 23' ' ' VAL . 12.6 mt -70.49 -34.28 72.18 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 109.468 -0.567 . . . . 1.1 109.468 178.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.642 ' HG3' ' O ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -78.03 -31.78 50.62 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 119.375 -0.93 . . . . 2.23 110.171 -177.218 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -67.69 -37.74 82.71 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 113.928 -1.487 . . . . 3.6 108.291 171.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.568 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 66.1 t60 -67.49 -44.69 77.91 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.354 -1.294 . . . . 0.39 111.358 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 19' ' ' LEU . 93.8 t -68.08 -29.8 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 C-N-CA 120.147 -0.621 . . . . 0.34 110.011 -175.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -61.32 -24.76 66.67 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.753 -0.658 . . . . 2.96 111.035 171.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.568 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 75.7 mt -70.01 -47.66 67.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.399 -0.364 . . . . 1.3 110.882 175.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -63.28 -35.5 80.55 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.661 -0.416 . . . . 0.29 110.159 176.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.72 28.57 1.49 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.85 -0.614 . . . . 1.68 109.85 177.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.82 68.72 2.5 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.481 -0.781 . . . . 2.36 111.562 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -87.1 -22.08 25.62 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.538 0.685 . . . . 3.92 109.609 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 41.3 mmtm . . . . . 0 C--O 1.251 1.179 0 CA-C-N 114.774 -1.103 . . . . 6.91 109.39 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ptm . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 121.35 0.595 . . . . 7.14 110.783 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.509 ' HD3' ' HD2' ' A' ' 3' ' ' PRO . 0.0 OUTLIER 179.71 118.84 0.21 Allowed Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.435 -0.802 . . . . 4.97 109.39 178.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.509 ' HD2' ' HD3' ' A' ' 2' ' ' LYS . 72.9 Cg_endo -74.47 167.56 26.85 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.803 1.669 . . . . 1.14 111.607 176.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.521 ' O ' HD21 ' A' ' 19' ' ' LEU . 84.3 m-85 -129.25 123.38 31.78 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.454 -0.794 . . . . 1.11 109.558 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.546 HG12 ' HG2' ' A' ' 12' ' ' GLN . 27.1 m -106.87 147.31 12.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 115.675 -0.693 . . . . 0.35 111.166 -175.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.463 ' HB3' ' H ' ' A' ' 11' ' ' ARG . 47.3 t -66.55 132.06 47.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.35 -0.841 . . . . 0.21 110.977 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.491 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.4 mp -71.83 -27.76 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-N 115.015 -0.993 . . . . 0.67 110.101 -176.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -89.4 -50.07 6.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.911 -0.586 . . . . 1.3 111.595 -172.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.1 p -114.58 -2.32 13.15 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.308 -0.557 . . . . 0.27 112.138 -170.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 59.67 58.94 2.69 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.265 -0.879 . . . . 1.58 112.702 177.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.616 ' NE ' ' HA ' ' A' ' 11' ' ' ARG . 5.2 mmp_? -112.38 141.51 46.03 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.477 -0.564 . . . . 3.67 109.477 173.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.546 ' HG2' HG12 ' A' ' 5' ' ' VAL . 86.9 mt-30 -89.97 128.62 36.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.985 0.421 . . . . 1.64 111.966 -173.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -128.69 -179.49 5.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.645 -0.707 . . . . 0.64 109.782 172.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -105.99 -35.23 7.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.878 0.37 . . . . 0.41 111.991 -173.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 1.0 OUTLIER -115.58 147.36 38.69 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.298 -0.41 . . . . 1.93 110.658 -173.531 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 15' ' ' ASP . 20.2 Cg_exo -65.28 -22.37 60.56 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.532 2.155 . . . . 0.53 109.277 170.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -53.45 -53.21 36.48 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.316 -1.311 . . . . 0.28 111.954 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.603 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -73.91 -21.99 59.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.833 -0.183 . . . . 0.22 111.438 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.586 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.7 mm? -73.49 -32.08 64.09 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 109.675 -0.491 . . . . 1.1 109.675 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -76.57 -39.31 53.06 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.764 0.792 . . . . 2.23 110.201 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.548 ' HD3' ' HD2' ' A' ' 24' ' ' ARG . 8.6 tpp180 -64.9 -31.82 73.23 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.217 -1.356 . . . . 3.6 108.418 174.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.639 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 35.6 t60 -68.4 -45.78 71.77 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.214 -1.357 . . . . 0.39 111.783 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 19' ' ' LEU . 85.9 t -66.32 -38.38 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 C-N-CA 119.97 -0.692 . . . . 0.34 110.351 -173.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.548 ' HD2' ' HD3' ' A' ' 21' ' ' ARG . 9.1 ptp180 -70.44 -10.93 60.43 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.056 0.455 . . . . 2.96 110.75 177.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.639 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 45.9 mt -73.75 -42.23 54.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.477 -0.329 . . . . 1.3 110.284 171.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -65.59 -33.52 76.09 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.338 -0.392 . . . . 0.29 111.276 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.21 -41.77 60.86 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.431 -0.508 . . . . 1.68 110.868 175.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.18 -22.76 2.94 Favored Glycine 0 CA--C 1.52 0.373 0 CA-C-N 116.018 -0.537 . . . . 2.36 113.27 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -61.95 -46.04 91.06 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.003 0.43 . . . . 3.92 111.615 -176.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.4 tptm . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.644 -0.693 . . . . 6.91 110.046 -177.405 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 110.25 -0.278 . . . . 7.14 110.25 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -77.77 123.27 86.47 Favored Pre-proline 0 C--N 1.331 -0.196 0 N-CA-C 109.917 -0.401 . . . . 4.97 109.917 176.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.77 175.05 11.44 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.708 2.272 . . . . 1.14 112.432 -177.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -104.58 106.41 16.89 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.79 -0.818 . . . . 1.11 108.79 177.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.515 HG12 ' HG2' ' A' ' 12' ' ' GLN . 12.6 m -92.04 144.72 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.412 0.625 . . . . 0.35 111.665 -173.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.449 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 44.8 t -56.43 132.15 50.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.142 -0.935 . . . . 0.21 111.262 178.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.497 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.5 mp -74.31 -25.94 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 115.1 -0.955 . . . . 0.67 110.654 -176.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -93.34 -43.28 8.86 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.597 -0.441 . . . . 1.3 112.076 -173.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.9 p -121.44 -0.69 9.75 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 119.761 -0.776 . . . . 0.27 112.326 -173.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 60.38 81.4 0.18 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.66 -0.7 . . . . 1.58 112.057 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 28.9 ttm180 -138.17 136.86 37.06 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 108.969 -0.752 . . . . 3.67 108.969 177.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.515 ' HG2' HG12 ' A' ' 5' ' ' VAL . 86.0 mt-30 -81.82 125.79 31.09 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.838 0.352 . . . . 1.64 111.865 -172.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -128.66 149.7 50.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.909 -0.587 . . . . 0.64 110.59 175.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.12 -33.45 67.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.429 -0.805 . . . . 0.41 112.638 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 58.1 m-20 -121.83 142.39 36.04 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 115.867 -0.606 . . . . 1.93 110.983 -168.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 15' ' ' ASP . 17.7 Cg_exo -66.11 -28.38 48.83 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.612 2.208 . . . . 0.53 110.304 173.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.601 ' O ' ' HG3' ' A' ' 20' ' ' GLN . . . -68.76 -22.5 75.47 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.3 -0.864 . . . . 0.28 111.735 174.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -80.57 -26.63 37.82 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 122.561 -0.376 . . . . 0.22 110.3 175.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.696 ' O ' HG23 ' A' ' 23' ' ' VAL . 12.0 mt -71.97 -35.76 69.63 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 109.205 -0.665 . . . . 1.1 109.205 177.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.601 ' HG3' ' O ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -73.55 -36.27 65.62 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 119.553 -0.859 . . . . 2.23 109.974 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -59.88 -41.78 92.31 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.336 -1.302 . . . . 3.6 108.668 171.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.599 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 39.3 t60 -66.5 -36.56 83.01 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 113.346 -1.752 . . . . 0.39 112.064 -176.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 19' ' ' LEU . 49.0 t -72.83 -27.82 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 C-N-CA 119.093 -1.043 . . . . 0.34 109.695 -175.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.535 ' HG2' ' O ' ' A' ' 20' ' ' GLN . 13.6 mmt180 -59.35 -36.09 75.07 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.109 -0.7 . . . . 2.96 109.109 171.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.599 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 19.0 mm -61.29 -43.76 97.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 114.841 -1.072 . . . . 1.3 111.627 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -74.75 -51.83 13.15 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.494 0.553 . . . . 0.29 112.494 -175.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.478 HG23 ' H ' ' A' ' 29' ' ' GLU . 14.9 t -127.5 -32.49 2.41 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.187 -0.605 . . . . 1.68 111.738 -173.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 24' ' ' ARG . . . 82.25 -13.75 37.71 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.746 -0.74 . . . . 2.36 112.885 176.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.478 ' H ' HG23 ' A' ' 27' ' ' THR . 36.4 mt-10 -63.55 -46.15 87.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.243 0.544 . . . . 3.92 110.203 178.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.4 mttm . . . . . 0 C--O 1.245 0.845 0 CA-C-O 118.068 -0.968 . . . . 6.91 110.011 -176.909 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 121.068 0.461 . . . . 7.14 110.478 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.615 ' HD3' ' HD2' ' A' ' 3' ' ' PRO . 16.9 tppt? -142.23 121.94 8.03 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.953 -0.567 . . . . 4.97 109.969 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.615 ' HD2' ' HD3' ' A' ' 2' ' ' LYS . 96.6 Cg_endo -78.15 174.42 12.49 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.316 2.011 . . . . 1.14 111.648 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.506 ' O ' HD21 ' A' ' 19' ' ' LEU . 61.2 m-85 -106.49 111.32 23.84 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.849 -0.797 . . . . 1.11 108.849 -178.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.48 HG12 ' HG2' ' A' ' 12' ' ' GLN . 33.3 m -101.99 148.45 7.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.225 0.536 . . . . 0.35 111.36 -173.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.522 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 35.7 t -70.91 124.58 24.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.598 -0.728 . . . . 0.21 110.183 177.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.504 ' H ' HD12 ' A' ' 7' ' ' ILE . 3.7 mp -70.2 -24.09 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 115.401 -0.818 . . . . 0.67 110.462 -176.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -91.76 -41.6 10.59 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.693 -0.403 . . . . 1.3 111.788 -172.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.6 p -121.55 1.42 10.07 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 119.988 -0.685 . . . . 0.27 112.575 -172.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 66.03 48.06 1.83 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.929 0.714 . . . . 1.58 112.929 170.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -117.4 144.31 45.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.652 -0.249 . . . . 3.67 110.437 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.48 ' HG2' HG12 ' A' ' 5' ' ' VAL . 68.8 mt-30 -91.72 128.22 37.47 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.253 0.346 . . . . 1.64 111.628 -172.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -124.72 164.37 20.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.129 0.49 . . . . 0.64 110.525 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.65 -37.37 15.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.491 -0.777 . . . . 0.41 112.219 -172.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.412 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 45.9 m-20 -117.94 139.86 27.06 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.976 -0.556 . . . . 1.93 110.949 -167.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.563 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 38.0 Cg_exo -59.83 -34.74 95.54 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.822 2.348 . . . . 0.53 110.946 174.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.97 -35.69 91.77 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.365 -0.834 . . . . 0.28 112.032 176.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -68.85 -31.86 71.13 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 121.19 -0.204 . . . . 0.22 110.847 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.534 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.8 mm? -68.86 -29.36 67.65 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 108.942 -0.762 . . . . 1.1 108.942 178.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.563 ' HG2' ' O ' ' A' ' 16' ' ' PRO . 10.3 mm-40 -74.81 -41.15 60.49 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-O 121.65 0.738 . . . . 2.23 109.899 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.417 ' O ' HG12 ' A' ' 25' ' ' ILE . 1.1 mpt_? -67.77 -32.42 72.99 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.423 -1.262 . . . . 3.6 109.111 176.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.529 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 60.4 t60 -72.35 -45.26 60.65 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 114.88 -1.054 . . . . 0.39 111.32 -175.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 19' ' ' LEU . 84.4 t -67.16 -32.34 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 C-N-CA 119.945 -0.702 . . . . 0.34 109.967 -175.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 17.6 mtp180 -63.09 -28.78 70.31 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.969 -0.56 . . . . 2.96 110.986 174.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.529 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 26.8 mm -64.69 -45.41 95.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-O 120.827 0.346 . . . . 1.3 110.723 175.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -66.23 -27.82 68.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.068 0.461 . . . . 0.29 110.677 177.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.1 m -93.5 25.63 3.37 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.545 0.688 . . . . 1.68 110.306 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.85 64.71 3.0 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 111.279 -0.728 . . . . 2.36 111.279 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -74.21 -8.94 57.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.023 0.44 . . . . 3.92 110.879 -177.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.561 -0.733 . . . . 6.91 109.059 175.15 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 120.65 0.262 . . . . 7.14 110.358 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.655 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . 28.0 tptp -156.83 -53.2 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.943 -0.572 . . . . 4.97 109.821 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.655 ' HD3' ' HB3' ' A' ' 2' ' ' LYS . 97.3 Cg_endo -84.7 -173.75 1.58 Allowed 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 122.124 1.883 . . . . 1.14 111.346 171.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.455 ' CE1' ' HD3' ' A' ' 16' ' ' PRO . 73.3 m-85 -76.99 122.49 24.97 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.435 -0.58 . . . . 1.11 109.435 178.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.468 HG12 ' HG2' ' A' ' 12' ' ' GLN . 16.8 m -112.26 147.82 15.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.386 -0.37 . . . . 0.35 110.938 -174.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.521 ' HB3' ' H ' ' A' ' 11' ' ' ARG . 53.5 t -68.51 127.37 32.77 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.953 -0.567 . . . . 0.21 110.449 177.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.498 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.1 mp -73.14 -26.98 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 115.103 -0.953 . . . . 0.67 109.93 -177.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -86.48 -45.03 11.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.664 -0.698 . . . . 1.3 111.974 -172.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.7 p -121.83 0.45 9.77 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 119.88 -0.728 . . . . 0.27 112.778 -173.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 66.86 52.99 0.89 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.677 0.621 . . . . 1.58 112.677 172.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.665 ' HA ' ' HE ' ' A' ' 11' ' ' ARG . 1.3 mmp_? -115.99 134.71 54.68 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.313 -0.625 . . . . 3.67 109.313 177.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.613 ' HB3' ' HG2' ' A' ' 3' ' ' PRO . 23.7 mt-30 -92.65 131.74 37.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.456 0.17 . . . . 1.64 111.245 -173.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.494 ' O ' ' HB2' ' A' ' 3' ' ' PRO . 56.1 m-85 -135.07 148.38 49.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.731 0.776 . . . . 0.64 110.918 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.83 -36.12 82.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.469 -1.241 . . . . 0.41 113.384 -171.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -129.04 142.87 46.65 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 120.921 0.391 . . . . 1.93 110.966 -169.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.517 ' O ' ' HG3' ' A' ' 20' ' ' GLN . 32.5 Cg_endo -64.86 -24.6 60.95 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.859 2.373 . . . . 0.53 111.311 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.97 -42.13 98.18 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.89 -0.672 . . . . 0.28 111.438 173.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -70.86 -22.38 62.31 Favored 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 122.946 -0.149 . . . . 0.22 110.845 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.554 ' O ' HG23 ' A' ' 23' ' ' VAL . 3.4 mm? -75.65 -26.4 57.67 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.185 -0.672 . . . . 1.1 109.185 175.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.517 ' HG3' ' O ' ' A' ' 16' ' ' PRO . 72.4 mt-30 -74.12 -42.82 59.44 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.909 0.862 . . . . 2.23 109.356 176.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.6 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -61.19 -35.93 78.49 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.945 -1.48 . . . . 3.6 109.19 172.716 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.547 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 10.0 t60 -67.08 -48.78 67.17 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.616 -1.175 . . . . 0.39 111.584 -175.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 19' ' ' LEU . 93.4 t -67.28 -35.89 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 C-N-CA 119.98 -0.688 . . . . 0.34 110.805 -172.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -71.7 -9.93 59.01 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.874 -0.331 . . . . 2.96 111.0 176.46 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.6 HG12 ' O ' ' A' ' 21' ' ' ARG . 19.5 mm -75.59 -42.93 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 109.683 -0.488 . . . . 1.3 109.683 172.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -70.24 -51.62 29.32 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.01 0.433 . . . . 0.29 110.428 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 27' ' ' THR . 7.6 t -92.19 52.77 2.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.889 0.852 . . . . 1.68 109.494 -178.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.99 53.99 0.39 Allowed Glycine 0 C--N 1.335 0.474 0 CA-C-N 115.158 -0.928 . . . . 2.36 113.471 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -74.78 -31.66 61.81 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 121.667 0.746 . . . . 3.92 109.521 176.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.6 tptm . . . . . 0 C--O 1.248 1.014 0 CA-C-N 114.86 -1.064 . . . . 6.91 109.089 177.753 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 mmt . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 120.862 0.363 . . . . 7.14 110.487 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.582 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . 60.5 tttp -68.87 -56.33 9.45 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.043 -0.526 . . . . 4.97 110.745 175.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 2' ' ' LYS . 87.2 Cg_endo -79.96 177.5 8.26 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.76 1.64 . . . . 1.14 112.097 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.511 ' O ' HD21 ' A' ' 19' ' ' LEU . 48.2 m-85 -99.85 124.4 45.1 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.539 -0.755 . . . . 1.11 109.018 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.601 HG12 ' HG2' ' A' ' 12' ' ' GLN . 17.8 m -103.43 146.66 10.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.265 0.555 . . . . 0.35 111.893 -172.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.541 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 35.2 t -74.01 130.27 39.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.42 -0.809 . . . . 0.21 110.337 178.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.488 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.8 mp -79.07 -22.17 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 CA-C-N 115.609 -0.723 . . . . 0.67 109.865 -177.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.402 ' HB3' ' CD2' ' A' ' 26' ' ' HIS . 4.9 t60 -89.95 -46.52 8.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.834 -0.621 . . . . 1.3 111.678 -172.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 18.7 p -114.07 -4.86 13.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.028 -0.669 . . . . 0.27 112.258 -173.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 67.38 57.87 0.56 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.693 -0.685 . . . . 1.58 112.153 175.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -128.88 141.78 51.17 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.241 -0.436 . . . . 3.67 110.084 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.601 ' HG2' HG12 ' A' ' 5' ' ' VAL . 66.8 mt-30 -92.74 125.27 37.28 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.507 -0.315 . . . . 1.64 111.501 -173.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.416 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 96.0 m-85 -126.37 141.52 51.87 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.873 0.844 . . . . 0.64 111.515 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.19 -36.38 77.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.258 -1.337 . . . . 0.41 113.736 -172.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.477 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 23.4 m-20 -115.37 141.71 27.62 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 116.098 -0.501 . . . . 1.93 111.482 -164.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.488 ' HG3' ' CE1' ' A' ' 4' ' ' TYR . 12.6 Cg_exo -67.45 -32.24 32.44 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.747 2.298 . . . . 0.53 110.322 174.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.19 -36.93 92.49 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.134 -0.939 . . . . 0.28 111.736 176.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.581 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -69.44 -28.17 65.89 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.984 -0.108 . . . . 0.22 110.937 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.526 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.6 mm? -71.41 -31.35 67.15 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.125 -0.694 . . . . 1.1 109.125 177.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.612 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 79.8 mt-30 -68.97 -44.32 73.18 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 119.951 -0.7 . . . . 2.23 109.985 177.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.722 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.3 OUTLIER -61.16 -40.38 93.65 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.257 -1.338 . . . . 3.6 108.553 174.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.623 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 39.4 t60 -65.64 -49.65 67.87 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 113.607 -1.633 . . . . 0.39 111.927 -171.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 19' ' ' LEU . 59.3 t -66.58 -34.63 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 C-N-CA 119.843 -0.743 . . . . 0.34 109.868 -175.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.614 ' HA ' HG22 ' A' ' 27' ' ' THR . 78.4 mtt-85 -66.32 -27.04 67.59 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.629 -0.714 . . . . 2.96 110.558 175.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.722 HG12 ' O ' ' A' ' 21' ' ' ARG . 24.6 mm -62.11 -50.39 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.063 -0.517 . . . . 1.3 110.548 175.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.402 ' CD2' ' HB3' ' A' ' 8' ' ' HIS . 33.2 m-70 -62.96 -42.91 99.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.177 -0.465 . . . . 0.29 111.212 -179.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.614 HG22 ' HA ' ' A' ' 24' ' ' ARG . 12.0 t -80.69 -0.38 38.0 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.081 -0.509 . . . . 1.68 111.552 -173.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.02 14.07 67.65 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.103 -0.57 . . . . 2.36 112.479 176.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.526 ' HB3' HG23 ' A' ' 27' ' ' THR . 15.1 tt0 -80.95 -35.07 32.73 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.829 0.347 . . . . 3.92 110.528 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.3 tptt . . . . . 0 C--O 1.243 0.742 0 CA-C-O 118.339 -0.839 . . . . 6.91 109.876 179.406 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 ttt . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 120.927 0.394 . . . . 7.14 110.639 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -107.32 99.24 26.67 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.343 -0.614 . . . . 4.97 109.343 174.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.72 173.11 15.0 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.249 1.966 . . . . 1.14 111.85 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.486 ' HB3' ' HG ' ' A' ' 19' ' ' LEU . 9.9 m-85 -108.34 120.79 43.39 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.435 -0.802 . . . . 1.11 109.756 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.517 HG12 ' HG2' ' A' ' 12' ' ' GLN . 23.3 m -108.72 144.31 17.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 116.35 -0.386 . . . . 0.35 110.62 -175.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.429 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 33.8 t -68.34 125.29 25.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.076 -0.511 . . . . 0.21 109.947 177.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.539 ' H ' HD12 ' A' ' 7' ' ' ILE . 3.8 mp -74.3 -23.08 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 115.696 -0.683 . . . . 0.67 110.029 -175.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -95.47 -44.85 7.34 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.339 -0.544 . . . . 1.3 111.971 -171.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.0 p -112.38 -3.05 14.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.821 -0.752 . . . . 0.27 111.469 -175.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 63.45 64.98 0.78 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.896 -1.047 . . . . 1.58 112.824 174.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -129.73 134.54 47.67 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.926 -0.579 . . . . 3.67 110.234 175.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.517 ' HG2' HG12 ' A' ' 5' ' ' VAL . 15.1 mt-30 -83.18 134.16 34.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.257 -0.429 . . . . 1.64 111.431 -176.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.416 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 98.5 m-85 -131.58 169.16 16.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.64 110.126 173.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.2 -51.64 8.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.232 0.539 . . . . 0.41 112.139 -174.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -105.53 142.25 24.35 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.291 -0.868 . . . . 1.93 111.859 -165.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 4' ' ' TYR . 24.7 Cg_endo -63.26 -27.53 72.14 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.89 2.393 . . . . 0.53 110.753 171.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.509 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -69.27 -24.18 76.08 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.459 -0.791 . . . . 0.28 111.753 176.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -84.27 -28.1 27.41 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 122.587 -0.361 . . . . 0.22 110.854 178.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.561 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.4 mm? -74.26 -29.83 61.85 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 109.509 -0.552 . . . . 1.1 109.509 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 13.1 pt20 -75.89 -35.55 59.81 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.41 -0.916 . . . . 2.23 109.752 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.404 ' O ' HG13 ' A' ' 25' ' ' ILE . 30.3 tpt180 -64.28 -39.8 94.67 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.18 -1.373 . . . . 3.6 108.764 170.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.515 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 48.1 t60 -67.06 -49.35 65.4 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.092 -1.413 . . . . 0.39 111.952 -174.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 19' ' ' LEU . 63.3 t -66.58 -31.86 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 C-N-CA 120.029 -0.668 . . . . 0.34 109.755 -175.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -69.51 -7.38 37.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.503 -0.771 . . . . 2.96 111.465 174.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.515 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 81.0 mt -83.86 -47.48 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 109.616 -0.512 . . . . 1.3 109.616 171.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -68.75 -51.64 39.02 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.267 0.556 . . . . 0.29 110.661 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.6 m -105.54 34.95 3.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.861 0.838 . . . . 1.68 110.392 -176.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.1 10.49 65.79 Favored Glycine 0 CA--C 1.507 -0.421 0 CA-C-N 115.554 -0.748 . . . . 2.36 111.579 176.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -62.62 -38.81 91.66 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.303 0.573 . . . . 3.92 110.518 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt . . . . . 0 C--O 1.245 0.862 0 CA-C-O 118.333 -0.841 . . . . 6.91 109.793 -178.371 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 mtt . . . . . 0 N--CA 1.478 0.97 0 CA-C-O 120.991 0.424 . . . . 7.14 111.075 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -143.55 95.62 5.85 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-O 121.166 0.508 . . . . 4.97 110.107 172.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.87 176.17 10.23 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.304 2.003 . . . . 1.14 111.163 176.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.581 ' O ' HD21 ' A' ' 19' ' ' LEU . 54.5 m-85 -101.32 116.01 31.82 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.838 -0.801 . . . . 1.11 108.838 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.618 HG12 ' HG3' ' A' ' 12' ' ' GLN . 16.5 m -105.56 149.5 8.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.322 0.582 . . . . 0.35 112.053 -168.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.637 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 4.0 t -76.27 124.05 26.87 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.352 -0.84 . . . . 0.21 109.685 176.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.453 ' H ' HD12 ' A' ' 7' ' ' ILE . 3.9 mp -74.55 -19.25 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-N 115.891 -0.595 . . . . 0.67 110.101 -175.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -98.65 -35.85 10.06 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.239 -0.584 . . . . 1.3 112.327 -172.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.451 ' SG ' ' HG2' ' A' ' 11' ' ' ARG . 15.2 p -118.48 -0.13 11.48 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 119.864 -0.734 . . . . 0.27 112.133 -175.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 62.85 53.02 2.54 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.521 -0.763 . . . . 1.58 112.365 174.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.451 ' HG2' ' SG ' ' A' ' 9' ' ' CYS . 24.1 mmt180 -123.58 149.67 45.03 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.932 -0.395 . . . . 3.67 109.932 178.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.618 ' HG3' HG12 ' A' ' 5' ' ' VAL . 2.1 mp0 -94.11 136.0 34.87 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.585 -0.279 . . . . 1.64 111.104 -176.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.553 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 92.0 m-85 -131.8 158.58 40.89 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.266 0.555 . . . . 0.64 110.663 176.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.53 -36.46 26.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.36 -0.836 . . . . 0.41 112.909 -171.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 6.2 m-20 -124.01 138.92 31.47 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-O 120.827 0.346 . . . . 1.93 111.128 -168.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.435 ' HG3' ' CE1' ' A' ' 4' ' ' TYR . 27.0 Cg_exo -62.45 -29.73 79.31 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.125 2.55 . . . . 0.53 111.278 176.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.54 -36.33 93.05 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.747 -0.66 . . . . 0.28 111.566 175.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.99 -31.84 64.78 Favored 'General case' 0 C--O 1.218 -0.585 0 CA-C-N 115.608 -0.296 . . . . 0.22 111.015 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.581 HD21 ' O ' ' A' ' 4' ' ' TYR . 2.7 mm? -66.29 -34.67 78.52 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 109.292 -0.632 . . . . 1.1 109.292 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -73.78 -38.31 64.71 Favored 'General case' 0 N--CA 1.432 -1.325 0 C-N-CA 119.125 -1.03 . . . . 2.23 110.556 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.587 ' O ' HG12 ' A' ' 25' ' ' ILE . 7.1 tpt180 -65.42 -37.09 85.89 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.713 -1.131 . . . . 3.6 108.641 175.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.637 ' HD2' ' SG ' ' A' ' 6' ' ' CYS . 63.3 t60 -73.66 -48.13 34.69 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.041 -1.436 . . . . 0.39 111.559 -174.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 19' ' ' LEU . 72.8 t -64.63 -31.62 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 CA-C-N 116.014 -0.539 . . . . 0.34 110.557 -173.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -76.56 -14.31 60.02 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 120.382 -0.527 . . . . 2.96 110.685 177.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.587 HG12 ' O ' ' A' ' 21' ' ' ARG . 18.7 mm -69.37 -45.56 78.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 109.747 -0.464 . . . . 1.3 109.747 173.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -65.83 -48.76 70.56 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.293 0.568 . . . . 0.29 109.52 172.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.3 m -84.28 49.85 1.75 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.197 -0.91 . . . . 1.68 110.377 -177.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -77.36 71.18 2.31 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.153 -0.779 . . . . 2.36 111.153 177.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -84.52 -38.63 19.81 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.106 0.479 . . . . 3.92 110.865 -177.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.3 mttp . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.6 -0.714 . . . . 6.91 109.857 -178.491 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 120.783 0.325 . . . . 7.14 110.919 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.484 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . 53.8 tptt -79.42 -51.65 1.21 Allowed Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.634 -0.257 . . . . 4.97 110.419 175.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 2' ' ' LYS . 89.0 Cg_endo -78.37 176.22 10.18 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 121.867 1.711 . . . . 1.14 111.338 172.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.421 ' O ' HD21 ' A' ' 19' ' ' LEU . 97.8 m-85 -94.86 114.2 26.03 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.942 0.401 . . . . 1.11 110.035 -178.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.495 HG12 ' HA ' ' A' ' 12' ' ' GLN . 33.6 m -101.81 146.64 9.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.898 -0.592 . . . . 0.35 110.821 -177.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.497 ' HB2' ' HE2' ' A' ' 13' ' ' PHE . 42.2 t -63.92 126.86 29.03 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.876 -0.602 . . . . 0.21 110.234 178.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.489 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.2 mp -67.33 -27.35 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 115.014 -0.993 . . . . 0.67 110.515 -174.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -96.76 -45.86 6.5 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.25 -0.58 . . . . 1.3 112.162 -171.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.4 p -111.43 -2.0 15.73 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 119.618 -0.833 . . . . 0.27 111.916 -172.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 61.36 55.59 2.85 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.102 -0.953 . . . . 1.58 112.967 174.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.433 ' H ' ' HB3' ' A' ' 6' ' ' CYS . 87.2 mtt180 -109.29 141.11 42.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.531 -0.544 . . . . 3.67 109.531 172.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.495 ' HA ' HG12 ' A' ' 5' ' ' VAL . 25.5 mt-30 -85.54 129.82 34.73 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.701 0.286 . . . . 1.64 111.31 -177.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.497 ' HE2' ' HB2' ' A' ' 6' ' ' CYS . 93.2 m-85 -129.16 155.18 45.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.443 0.639 . . . . 0.64 110.762 178.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.02 -28.77 29.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.02 -0.991 . . . . 0.41 111.351 -175.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -120.76 135.46 24.73 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.28 -0.873 . . . . 1.93 110.981 -166.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.37 -25.45 35.93 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.241 1.961 . . . . 0.53 110.27 172.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.51 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -67.95 -27.95 73.54 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.961 -1.018 . . . . 0.28 111.478 173.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -78.4 -25.91 46.27 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 120.943 -0.303 . . . . 0.22 110.667 178.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.646 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.7 mm? -69.62 -35.25 75.1 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 109.663 -0.495 . . . . 1.1 109.663 178.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.51 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 12.0 pt20 -76.18 -36.02 58.87 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 119.415 -0.914 . . . . 2.23 110.105 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.431 ' O ' HG13 ' A' ' 25' ' ' ILE . 7.2 tpm_? -61.08 -40.21 92.84 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.857 -1.519 . . . . 3.6 108.191 172.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.621 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 37.8 t60 -70.33 -44.46 68.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.723 -1.58 . . . . 0.39 112.183 -174.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 19' ' ' LEU . 61.4 t -66.15 -35.77 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 C-N-CA 119.682 -0.807 . . . . 0.34 110.101 -174.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.601 ' HA ' HG22 ' A' ' 27' ' ' THR . 27.2 mmt180 -62.2 -25.52 67.83 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.127 -0.488 . . . . 2.96 111.126 173.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.621 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 79.9 mt -67.96 -44.07 85.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 1.3 110.791 176.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -68.36 -42.72 78.79 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.565 0.221 . . . . 0.29 111.359 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.601 HG22 ' HA ' ' A' ' 24' ' ' ARG . 9.0 t -71.49 -28.41 63.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.903 0.382 . . . . 1.68 110.504 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.2 -13.36 61.86 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.811 -0.709 . . . . 2.36 112.876 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.483 ' H ' HG23 ' A' ' 27' ' ' THR . 42.0 mt-10 -53.22 -47.11 69.25 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.001 0.429 . . . . 3.92 111.46 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.403 ' HD2' ' C ' ' A' ' 29' ' ' GLU . 4.5 mptp? . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.351 -0.833 . . . . 6.91 109.492 177.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 ptp . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 120.528 0.204 . . . . 7.14 110.668 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.46 ' HB2' ' HD3' ' A' ' 3' ' ' PRO . 98.1 mttt -82.99 -53.82 0.58 Allowed Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.809 -0.441 . . . . 4.97 109.809 175.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.46 ' HD3' ' HB2' ' A' ' 2' ' ' LYS . 83.4 Cg_endo -81.19 174.52 10.67 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.646 1.564 . . . . 1.14 110.132 163.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.408 ' O ' HD21 ' A' ' 19' ' ' LEU . 92.0 m-85 -109.72 119.72 40.27 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.967 0.413 . . . . 1.11 110.229 -177.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.458 HG12 ' HG2' ' A' ' 12' ' ' GLN . 31.7 m -104.13 145.2 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 116.003 -0.544 . . . . 0.35 110.811 -177.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.555 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 47.2 t -63.85 120.97 12.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.83 -0.623 . . . . 0.21 110.158 178.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.49 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.3 mp -71.55 -24.53 23.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.48 0.657 . . . . 0.67 110.061 -178.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -85.27 -41.66 15.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.712 -0.676 . . . . 1.3 111.764 -172.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.5 p -124.9 -5.13 7.47 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 119.771 -0.772 . . . . 0.27 112.344 -174.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 67.99 79.4 0.22 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.008 0.523 . . . . 1.58 112.258 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.504 ' HD2' ' CZ ' ' A' ' 13' ' ' PHE . 22.9 ttm180 -142.53 144.44 32.94 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.959 -0.756 . . . . 3.67 108.959 174.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.458 ' HG2' HG12 ' A' ' 5' ' ' VAL . 27.2 mt-30 -88.76 129.93 35.45 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.38 0.511 . . . . 1.64 112.38 -173.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.504 ' CZ ' ' HD2' ' A' ' 11' ' ' ARG . 96.4 m-85 -129.12 167.05 18.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.9 -0.591 . . . . 0.64 110.705 176.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.03 -2.45 37.19 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.153 0.797 . . . . 0.41 113.153 -170.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -155.51 150.33 20.5 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 120.816 -0.354 . . . . 1.93 110.109 -176.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.44 -22.61 65.57 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.855 2.37 . . . . 0.53 109.531 169.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.557 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -57.22 -48.36 80.69 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 114.382 -1.281 . . . . 0.28 111.89 172.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -72.73 -25.41 61.21 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 121.07 -0.252 . . . . 0.22 110.781 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.529 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.5 mm? -72.1 -36.22 69.41 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.094 -0.706 . . . . 1.1 109.094 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 17.0 pt20 -77.81 -33.84 52.29 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 119.729 -0.788 . . . . 2.23 109.94 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.47 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.5 OUTLIER -65.44 -36.2 83.22 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.648 -1.16 . . . . 3.6 108.741 173.29 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.569 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 47.1 t60 -73.42 -46.1 50.58 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 114.7 -1.136 . . . . 0.39 111.683 -174.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 19' ' ' LEU . 97.5 t -66.07 -34.38 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 C-N-CA 119.866 -0.734 . . . . 0.34 110.019 -175.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 16.8 mtp180 -62.73 -26.81 68.88 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.109 -0.496 . . . . 2.96 111.077 173.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 18.3 mm -69.22 -44.32 80.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.427 -0.351 . . . . 1.3 110.63 176.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -65.81 -30.79 71.47 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.217 0.532 . . . . 0.29 110.626 176.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.5 m -93.14 34.72 1.1 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.426 0.632 . . . . 1.68 110.194 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.2 58.86 4.99 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.941 -0.647 . . . . 2.36 111.63 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -88.87 -18.86 26.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.86 0.362 . . . . 3.92 110.961 -176.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.0 mttm . . . . . 0 C--O 1.247 0.953 0 CA-C-O 118.353 -0.832 . . . . 6.91 109.925 178.104 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 109.497 -0.557 . . . . 7.14 109.497 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt 55.8 71.43 1.23 Allowed Pre-proline 0 C--O 1.234 0.266 0 O-C-N 123.57 0.544 . . . . 4.97 110.492 -174.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -77.69 173.14 14.59 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.332 2.022 . . . . 1.14 112.309 -177.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.509 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . 88.1 m-85 -113.47 99.9 8.11 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.338 -0.846 . . . . 1.11 108.721 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.601 HG12 ' HG2' ' A' ' 12' ' ' GLN . 11.3 m -89.91 142.66 12.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.403 0.621 . . . . 0.35 111.959 -171.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.56 ' SG ' ' HD2' ' A' ' 22' ' ' HIS . 21.6 t -65.64 119.38 11.03 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.276 -0.874 . . . . 0.21 110.132 175.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.5 mp -71.92 -21.66 21.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.44 0.638 . . . . 0.67 110.032 -178.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.459 ' HB3' ' CD2' ' A' ' 26' ' ' HIS . 6.4 t60 -86.72 -36.88 18.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.833 -0.621 . . . . 1.3 111.607 -171.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.7 p -126.67 -5.31 6.4 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 120.016 -0.674 . . . . 0.27 111.844 -176.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 67.73 56.42 0.57 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.284 -0.871 . . . . 1.58 112.442 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.413 ' H ' ' HB3' ' A' ' 6' ' ' CYS . 63.1 mtt85 -130.85 138.63 49.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.864 -0.607 . . . . 3.67 109.705 175.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.601 ' HG2' HG12 ' A' ' 5' ' ' VAL . 36.1 mt-30 -87.8 138.58 31.34 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.562 0.579 . . . . 1.64 112.562 -167.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -124.65 169.33 12.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.381 -0.827 . . . . 0.64 110.35 173.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.61 -36.19 13.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.238 -0.437 . . . . 0.41 112.125 -173.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.7 OUTLIER -113.58 151.58 44.66 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-O 120.977 0.417 . . . . 1.93 110.369 -174.685 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.449 ' HG3' ' CE2' ' A' ' 4' ' ' TYR . 12.2 Cg_exo -71.61 -23.53 23.0 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.159 2.573 . . . . 0.53 108.465 170.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -60.07 -41.87 98.21 Favored Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 113.889 -1.505 . . . . 0.28 111.553 172.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -77.49 -25.52 50.45 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 121.158 -0.217 . . . . 0.22 111.417 -177.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.557 ' O ' HG23 ' A' ' 23' ' ' VAL . 8.0 mt -71.29 -38.47 71.78 Favored 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 120.014 -0.674 . . . . 1.1 109.208 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.444 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 21.4 mt-30 -76.69 -31.96 57.59 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 119.294 -0.962 . . . . 2.23 110.701 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.406 ' O ' HG13 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -65.07 -38.17 89.9 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.998 -1.001 . . . . 3.6 108.489 171.86 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.617 ' O ' ' HB ' ' A' ' 25' ' ' ILE . 71.3 t60 -73.56 -45.72 51.72 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 114.427 -1.261 . . . . 0.39 112.01 -174.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 19' ' ' LEU . 99.0 t -66.29 -31.06 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 C-N-CA 119.721 -0.792 . . . . 0.34 110.14 -174.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 32.9 mtm180 -75.06 -6.96 52.26 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.993 -0.549 . . . . 2.96 110.652 175.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.617 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 68.6 mt -78.41 -50.25 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 109.683 -0.488 . . . . 1.3 109.683 169.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.459 ' CD2' ' HB3' ' A' ' 8' ' ' HIS . 46.0 m-70 -66.22 -52.07 51.44 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.275 0.559 . . . . 0.29 110.458 177.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.3 m -112.06 49.55 0.9 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.49 -0.777 . . . . 1.68 110.811 -172.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.22 53.88 4.88 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.975 -0.631 . . . . 2.36 111.637 177.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -56.68 -47.77 79.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.111 0.481 . . . . 3.92 111.105 -176.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.6 mttp . . . . . 0 C--O 1.247 0.93 0 CA-C-N 115.652 -0.703 . . . . 6.91 110.048 178.556 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtm . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.829 0.347 . . . . 7.14 111.704 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.62 ' H ' ' HD2' ' A' ' 3' ' ' PRO . 87.9 tttt -118.35 -51.93 0.04 OUTLIER Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.049 -0.723 . . . . 4.97 109.049 167.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.62 ' HD2' ' H ' ' A' ' 2' ' ' LYS . 95.3 Cg_endo -80.45 175.7 9.92 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.671 1.581 . . . . 1.14 109.815 163.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.435 ' CE1' ' HG3' ' A' ' 16' ' ' PRO . 53.1 m-85 -112.3 99.85 8.34 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.397 0.618 . . . . 1.11 110.001 -176.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.532 HG12 ' HG2' ' A' ' 12' ' ' GLN . 28.8 m -97.4 150.01 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.359 -0.837 . . . . 0.35 112.079 -171.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.615 ' HB2' ' HE2' ' A' ' 13' ' ' PHE . 23.6 t -75.81 127.12 32.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.24 -0.891 . . . . 0.21 110.111 177.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.491 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.5 mp -78.8 -22.04 12.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.507 0.67 . . . . 0.67 109.691 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.464 ' HB3' ' CD2' ' A' ' 26' ' ' HIS . 5.0 t60 -83.76 -44.29 14.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.543 -0.753 . . . . 1.3 111.575 -173.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.7 p -121.86 -4.11 9.14 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 119.942 -0.703 . . . . 0.27 112.33 -173.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 67.19 57.84 0.58 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.612 -0.722 . . . . 1.58 112.469 175.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -119.97 159.86 23.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.668 -0.864 . . . . 3.67 108.668 174.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.532 ' HG2' HG12 ' A' ' 5' ' ' VAL . 38.7 mt-30 -106.5 130.15 54.33 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 117.611 0.187 . . . . 1.64 110.604 -175.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.615 ' HE2' ' HB2' ' A' ' 6' ' ' CYS . 97.9 m-85 -127.27 166.39 17.87 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.33 0.586 . . . . 0.64 111.431 -177.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.41 -28.09 21.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.147 -0.933 . . . . 0.41 113.266 -167.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -136.71 150.17 69.27 Favored Pre-proline 0 C--N 1.327 -0.378 0 C-N-CA 121.102 -0.239 . . . . 1.93 110.436 -176.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.435 ' HG3' ' CE1' ' A' ' 4' ' ' TYR . 20.4 Cg_exo -65.03 -24.05 60.37 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.536 2.157 . . . . 0.53 109.184 168.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.573 ' O ' ' HG2' ' A' ' 20' ' ' GLN . . . -59.12 -37.31 91.51 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 114.281 -1.327 . . . . 0.28 111.842 172.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.562 ' O ' ' HB2' ' A' ' 22' ' ' HIS . . . -80.33 -28.69 38.1 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.733 -0.387 . . . . 0.22 110.651 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.53 ' O ' HG23 ' A' ' 23' ' ' VAL . 13.8 mt -71.13 -30.11 66.08 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 120.346 -0.541 . . . . 1.1 109.614 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.573 ' HG2' ' O ' ' A' ' 17' ' ' GLY . 27.6 pt20 -74.93 -40.69 60.69 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 119.373 -0.931 . . . . 2.23 109.964 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.44 ' O ' HG12 ' A' ' 25' ' ' ILE . 0.7 OUTLIER -70.95 -27.04 63.45 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.49 -1.232 . . . . 3.6 109.336 177.075 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.562 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 63.1 t60 -73.46 -48.04 36.69 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 114.934 -1.03 . . . . 0.39 111.536 -177.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 19' ' ' LEU . 84.6 t -66.35 -29.27 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 C-N-CA 119.823 -0.751 . . . . 0.34 109.649 -175.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 41.9 mtt180 -61.98 -35.58 78.91 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.915 -0.584 . . . . 2.96 110.992 171.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.511 ' HB ' ' O ' ' A' ' 22' ' ' HIS . 26.4 mm -61.72 -45.4 98.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.335 -0.393 . . . . 1.3 110.635 177.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.464 ' CD2' ' HB3' ' A' ' 8' ' ' HIS . 24.5 m-70 -66.1 -45.89 79.58 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.131 -0.486 . . . . 0.29 110.244 176.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.7 m -84.73 46.22 1.23 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.662 0.744 . . . . 1.68 109.741 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.76 15.49 14.49 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.467 -0.788 . . . . 2.36 112.616 -177.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -62.58 -45.26 93.74 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.229 0.538 . . . . 3.92 109.864 175.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.191 -0.909 . . . . 6.91 109.328 176.599 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_